NO171017B - ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE CYCLIC AMINE DERIVATIVES - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE CYCLIC AMINE DERIVATIVES Download PDF

Info

Publication number
NO171017B
NO171017B NO882258A NO882258A NO171017B NO 171017 B NO171017 B NO 171017B NO 882258 A NO882258 A NO 882258A NO 882258 A NO882258 A NO 882258A NO 171017 B NO171017 B NO 171017B
Authority
NO
Norway
Prior art keywords
methyl
oxo
tetrahydro
dimethoxy
piperidyl
Prior art date
Application number
NO882258A
Other languages
Norwegian (no)
Other versions
NO171017C (en
NO882258D0 (en
NO882258L (en
Inventor
Joachim Heider
Manfred Psiorz
Andreas Bomhard
Norbert Hauel
Berthold Narr
Klaus Noll
Christian Lillie
Juergen Daemmgen
Walter Kobinger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO882258D0 publication Critical patent/NO882258D0/en
Publication of NO882258L publication Critical patent/NO882258L/en
Publication of NO171017B publication Critical patent/NO171017B/en
Publication of NO171017C publication Critical patent/NO171017C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Gears, Cams (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cyclic amine derivatives of the formula <IMAGE> in which A, B, E, G, R, R1, R2, m and n are as defined in Claim 1, their enantiomers, their diastereomers, their N-oxides and their acid addition salts have useful pharmacological properties, in particular a bradycardic action. The novel compounds can be prepared by processes known per se.

Description

I Britisk patentskrift 1 548 844 beskrives forbindelser med formel British patent specification 1 548 844 describes compounds with formula

og deres fysiologisk akseptable syreaddisjonssalter som har vist verdifulle farmakologiske egenskaper, så som en mild blodtrykksenkende virkning, spesielt en selektiv hjertefrekvens-senkende virkning. Overraskende er det nå funnet at de nye cykliske aminderivater med den generelle formel and their physiologically acceptable acid addition salts which have shown valuable pharmacological properties, such as a mild blood pressure lowering effect, especially a selective heart rate lowering effect. Surprisingly, it has now been found that the new cyclic amine derivatives with the general formula

deres N-oksyder og deres fysiologisk akseptable syreaddisjonssalter med uorganiske eller organiske syrer, oppviser enda mer verdifulle farmakologiske egenskaper, spesielt en blodtrykksenkende og en langtidsvirkende hjertefrekvens-senkende virkning og en reduserende virkning på hjertets 02-behov. their N-oxides and their physiologically acceptable acid addition salts with inorganic or organic acids exhibit even more valuable pharmacological properties, in particular a blood pressure-lowering and a long-acting heart rate-lowering effect and a reducing effect on the heart's O2 demand.

Foreliggende oppfinnelse angår således en fremgangsmåte for fremstilling av de nye cykliske aminderivater med den generelle formel I, deres N-oksyder, og deres fysiologisk akseptable syreaddisjonssalter med uorganiske eller organiske syrer. The present invention thus relates to a process for the production of the new cyclic amine derivatives of the general formula I, their N-oxides, and their physiologically acceptable acid addition salts with inorganic or organic acids.

I den ovenfor angitte generelle formel I betyr In the above general formula I means

A en -CH2-, -CH2-CH2- eller -CH=CH-gruppe, A a -CH2-, -CH2-CH2- or -CH=CH group,

B en -CH2-, -CH2-CH2-, -CO- eller -CH2CO-gruppe, B a -CH2-, -CH2-CH2-, -CO- or -CH2CO group,

X X

hvor karbonatomet merket med X, er knyttet til fenylkjernen, where the carbon atom marked with X is attached to the phenyl nucleus,

E en rettkjedet alkylengruppe med 1-3 karbonatomer som eventuelt er substituert med en alkylgruppe med 1-3 karbonatomer, E is a straight-chain alkylene group with 1-3 carbon atoms which is optionally substituted with an alkyl group with 1-3 carbon atoms,

G en rettkjedet alkylengruppe med 1-6 karbonatomer, hvor den metylengruppe som er forbundet med en aromatisk eller heteroaromatisk rest R, kan være erstattet med et oksygen-atom, G a straight-chain alkylene group with 1-6 carbon atoms, where the methylene group which is connected to an aromatic or heteroaromatic residue R can be replaced by an oxygen atom,

Rx og R2 hver en (C^-C^) alkyl- eller (c1~c3) alkoksy-gruppe, eller Rx and R2 each a (C^-C^) alkyl or (c1~c3) alkoxy group, or

Rx og R2 sammen utgjør en alkylendioksygruppe med 1 eller 2 karbonatomer, Rx and R2 together form an alkylenedioxy group with 1 or 2 carbon atoms,

m tallet 1, 2, 3, 4, 5 eller 6, og m the number 1, 2, 3, 4, 5 or 6, and

n tallet 0, 1, 2 eller 3, hvor imidlertid n + m må utgjøre tallet 3, 4, 5 eller 6, og n the number 0, 1, 2 or 3, where however n + m must be the number 3, 4, 5 or 6, and

R en eventuelt metylsubstituert furyl-, tienyl-, pyridyl-, benzo[b]furyl- eller benzo[b]tienylgruppe, en R an optionally methyl-substituted furyl, thienyl, pyridyl, benzo[b]furyl or benzo[b]thienyl group, a

benzo[b]tienylgruppe som er substituert med et halogenatom, en metoksy- eller metansulfonyloksygruppe, en naftylgruppe som eventuelt er mono- eller disubstituert med metyl- eller metoksygrupper, hvor substituentene kan være like eller forskjellige, eller når B utgjør en -CH2- eller CO-gruppe, en fenylgruppe som eventuelt er substituert med en metylendioksygruppe, en fenylgruppe som er mono- eller benzo[b]thienyl group which is substituted with a halogen atom, a methoxy or methanesulfonyloxy group, a naphthyl group which is optionally mono- or disubstituted with methyl or methoxy groups, where the substituents may be the same or different, or when B constitutes a -CH2- or CO group, a phenyl group which is optionally substituted with a methylenedioxy group, a phenyl group which is mono- or

disubstituert med metyl- eller metoksygrupper, hvor substituentene kan være like eller forskjellige. disubstituted with methyl or methoxy groups, where the substituents may be the same or different.

Foretrukne forbindelser med den generelle formel I er slike hvor Preferred compounds of the general formula I are those wherein

A, B, G, R, m og n er som innledningsvis definert, A, B, G, R, m and n are as initially defined,

E er en rettkjedet alkylengruppe med 1-3 karbonatomer, E is a straight-chain alkylene group with 1-3 carbon atoms,

Rx er en metyl- eller metoksygruppe, Rx is a methyl or methoxy group,

R2 er en metyl- eller metoksygruppe eller Rx og R2 sammen utgjør en metylendioksygruppe og R2 is a methyl or methoxy group or Rx and R2 together constitute a methylenedioxy group and

spesielt forbindelser med den generelle formel especially compounds of the general formula

hvor where

Ri, R2, R, A, B, E, G, m og n er som foran definert, samt deres N-oksyder og deres fysiologisk akseptable syreaddisjonssalter. R1, R2, R, A, B, E, G, m and n are as defined above, as well as their N-oxides and their physiologically acceptable acid addition salts.

Helt spesielt foretrukne forbindelser med den generelle formel I er slike hvor Particularly preferred compounds of the general formula I are those where

A betyr en -CH2CH2-gruppe, A means a -CH2CH2 group,

B er en -CH2-, -CH2-CH2-, -CO- eller -CH2CO-gruppe, B is a -CH2-, -CH2-CH2-, -CO- or -CH2CO group,

X X

hvor karbonatomet merket med X er knyttet til fenylkjernen, where the carbon atom marked with X is attached to the phenyl nucleus,

E er en metylen- eller etylengruppe, E is a methylene or ethylene group,

G er en rettkjedet alkylengruppe med 2-4 karbonatomer, hvor metylengruppen i en rettkjedet alkylengruppe med 3 eller 4 karbonatomer som er forbundet med en aromatisk eller heteroaromatisk rest R, kan være erstattet med et oksygenatom, G is a straight-chain alkylene group with 2-4 carbon atoms, where the methylene group in a straight-chain alkylene group with 3 or 4 carbon atoms which is connected to an aromatic or heteroaromatic residue R, can be replaced with an oxygen atom,

Rx er en metoksygruppe, Rx is a methoxy group,

R2 er en metoksygruppe eller Rx og R2 sammen utgjør en metylendioksygruppe, R2 is a methoxy group or Rx and R2 together form a methylenedioxy group,

m er tallet 2, 3 eller 4, m is the number 2, 3 or 4,

n er tallet 1 og n is the number 1 and

R betyr en naftyl-2-, 6-metoksy-naftyl-2-, 5-metyl-6-metoksy-naftyl-2-, tienyl-2-, benzo[b]furyl-2- eller benzo[b]tienyl-3-gruppe eller, når B utgjør -CH2- eller -CO-gruppen, en 4-metoksyfenyl- eller 3,4-dimetoksyfenylgruppe, samt deres fysiologisk akseptable syreaddisjonssalter. R means a naphthyl-2-, 6-methoxy-naphthyl-2-, 5-methyl-6-methoxy-naphthyl-2-, thienyl-2-, benzo[b]furyl-2- or benzo[b]thienyl- 3 group or, when B constitutes the -CH2 or -CO group, a 4-methoxyphenyl or 3,4-dimethoxyphenyl group, as well as their physiologically acceptable acid addition salts.

Særlig foretrukne forbindelser er de følgende: 3-[ (N-(2-(naftyl-2) -etyl) -piperidyl-3) -metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin, Particularly preferred compounds are the following: 3-[(N-(2-(naphthyl-2)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5 -tetrahydro-2H-3-benzazepine,

3- [ 2- (N-(2-(6-metoksy-naftyl-2)-etyl)-piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l ,3,4, 5-tetrahydro-2H-3-benzazepin, 3- [ 2- (N-(2-(6-methoxy-naphthyl-2)-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4, 5- tetrahydro-2H-3-benzazepine,

2 - [(N-(3-(4-metoksyfenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-1,2,3,4-tetrahydro-isokinolin, og 2 - [(N-(3-(4-methoxyphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, and

3-[(N-(4-(tienyl-2)-butyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin, 3-[(N-(4-(thienyl-2)-butyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzazepine,

og deres fysiologisk akseptable syreaddisjonssalter. and their physiologically acceptable acid addition salts.

I henhold til oppfinnelsen oppnås de nye forbindelsene med den generelle formel I etter følgende fremgangsmåter: According to the invention, the new compounds with the general formula I are obtained by the following methods:

a) Omsetning av en forbindelse med den generelle formel a) Reaction of a compound with the general formula

hvor where

Rlr R2, A, B, E, m og n er som tidligere definert, med en forbindelse med den generelle formel R1r R2, A, B, E, m and n are as previously defined, with a compound of the general formula

hvor where

R og G er som tidligere definert, og R and G are as previously defined, and

Zx er en nukleofil utgående gruppe, så som et halogenatom eller en sulfonyloksygruppe, f.eks. et klor-, brom- eller jodatom, en metansulfonyloksy-, p-toluensulfonyloksy- eller etoksysulfonyloksygruppe, eller en hydroksygruppe, eller 1X sammen med hydrogenatomet i den nabostilte metylengruppe utgjør et oksygenatom. Zx is a nucleophilic leaving group, such as a halogen atom or a sulfonyloxy group, e.g. a chlorine, bromine or iodine atom, a methanesulfonyloxy, p-toluenesulfonyloxy or ethoxysulfonyloxy group, or a hydroxy group, or 1X together with the hydrogen atom of the adjacent methylene group constitutes an oxygen atom.

Dersom Z: betyr en nukleofil utgående gruppe, foretas omsetningen hensiktsmessig i et oppløsningsmiddel eller en oppløsningsmiddelblanding som aceton, dietyleter, metylformamid, dimetylformamid, dimetylsulfoksyd, benzen, klorbenzen, tetrahydrofuran, benzen/tetrahydrofuran, dioksan eller i et overskudd av en av de benyttede forbindelser med den generelle formel II og/ellér III og eventuelt i nærvær av et syrebindende middel, f.eks. et alkoholat som kalium-tert- If Z: means a nucleophilic leaving group, the reaction is conveniently carried out in a solvent or a solvent mixture such as acetone, diethyl ether, methylformamide, dimethylformamide, dimethylsulfoxide, benzene, chlorobenzene, tetrahydrofuran, benzene/tetrahydrofuran, dioxane or in an excess of one of the compounds used with the general formula II and/or III and optionally in the presence of an acid binding agent, e.g. an alcoholate such as potassium tert-

i in

butylat, et alkalihydroksyd som natrium- eller kaliumhydroksyd, et alkalikarb<p>nat som kaliumkarbonat, et alkaliamid som natriumamid, et alkalihydrid som natriumhydrid, en tertiær organisk base som trietylamin eller pyridin, hvor de sistnevnte samtidig også kan tjene som oppløsningsmiddel, eller en katalysator som kaliumjodid, og alt etter reaktiviteten av den nukleofilt utskiftbare rest, hensiktsmessig ved temperaturer mellom 0 og 150°C, fortrinnsvis ved temperaturer mellom 50 og 120°C, f.eks. ved kokepunktet for det anvendte oppløsningsmiddel. Omsetningen kan imidlertid også foretas uten oppløsningsmiddel. Spesielt fordelaktig er det å foreta omsetningen i nærvær av en tertiær organisk base eller et overskudd av det anvendte amin med den generelle formel II. butylate, an alkali hydroxide such as sodium or potassium hydroxide, an alkali carbonate such as potassium carbonate, an alkali amide such as sodium amide, an alkali hydride such as sodium hydride, a tertiary organic base such as triethylamine or pyridine, where the latter can also serve as a solvent at the same time, or a catalyst such as potassium iodide, and depending on the reactivity of the nucleophilically replaceable residue, suitably at temperatures between 0 and 150°C, preferably at temperatures between 50 and 120°C, e.g. at the boiling point of the solvent used. However, the turnover can also be carried out without a solvent. It is particularly advantageous to carry out the reaction in the presence of a tertiary organic base or an excess of the amine used with the general formula II.

Dersom Z1 betyr en hydroksygruppe, foretas omsetningen fortrinnsvis i et egnet oppløsningsmiddel som metanol, etanol, tetrahydrofuran, dioksan, eddiksyreetylester eller iseddik, med hydrogen i nærvær av en hydreringskatalysator som platina, palladium/kull eller Raney-nikkel ved et hydrogentrykk på 2-10 bar, fortrinnsvis ved 5 bar, og ved temperaturer mellom 20 og 120°C, fortrinnsvis ved temperaturer mellom 50 og 100°C. If Z1 means a hydroxy group, the reaction is preferably carried out in a suitable solvent such as methanol, ethanol, tetrahydrofuran, dioxane, ethyl acetic acid ester or glacial acetic acid, with hydrogen in the presence of a hydrogenation catalyst such as platinum, palladium/charcoal or Raney nickel at a hydrogen pressure of 2-10 bar, preferably at 5 bar, and at temperatures between 20 and 120°C, preferably at temperatures between 50 and 100°C.

Dersom Z1 sammen med et hydrogenatom i den nabostilte metylengruppe betyr et oksygenatom, foretas omsetningen fortrinnsvis i et egnet oppløsningsmiddel som metanol, etanol, tetrahydrofuran, dioksan, eddiksyreetylester eller iseddik, med hydrogen i nærvær av en hydreringskatalysator som platina, palladium/kull eller Raney-nikkel ved et hydrogentrykk på 2-10 bar, fortrinnsvis 5 bar, og ved temperaturer mellom 20 og 12 0°C, fortrinnsvis ved temperaturer mellom 50 og 100°C, eller i nærvær av et egnet komplekst metallhydrid, som natriumcyan-borhydrid i et egnet oppløsningsmiddel som metanol, etanol, tetrahydrofuran, dioksan eller acetonitril, ved temperaturer mellom 0 og 50°C, fortrinnsvis ved romtemperatur. If Z1 together with a hydrogen atom in the adjacent methylene group means an oxygen atom, the reaction is preferably carried out in a suitable solvent such as methanol, ethanol, tetrahydrofuran, dioxane, ethyl acetate or glacial acetic acid, with hydrogen in the presence of a hydrogenation catalyst such as platinum, palladium/coal or Raney- nickel at a hydrogen pressure of 2-10 bar, preferably 5 bar, and at temperatures between 20 and 12 0°C, preferably at temperatures between 50 and 100°C, or in the presence of a suitable complex metal hydride, such as sodium cyanoborohydride in a suitable solvent such as methanol, ethanol, tetrahydrofuran, dioxane or acetonitrile, at temperatures between 0 and 50°C, preferably at room temperature.

b) Omsetning av en forbindelse med den generelle formel b) Reaction of a compound with the general formula

hvor where

Ri, R2, A og B er som innledningsvis definert, med en forbindelse med den generelle formel R 1 , R 2 , A and B are as initially defined, with a compound of the general formula

hvor where

R, E, G, m og n er som innledningsvis definert og R, E, G, m and n are as initially defined and

22 utgjør en nukleofil utgående gruppe så som et halogenatom eller en sulfonyloksygruppe, f.eks. et klor-, brom- eller jodatom, eller metansulfonyloksy-, p-toluensulfonyloksy- eller etoksysulfonyloksygruppen. 22 constitutes a nucleophilic leaving group such as a halogen atom or a sulfonyloxy group, e.g. a chlorine, bromine or iodine atom, or the methanesulfonyloxy, p-toluenesulfonyloxy or ethoxysulfonyloxy group.

Omsetningen foretas hensiktsmessig i et oppløsningsmiddel eller en oppløsningsmiddelblanding som metylformamid, dimetylformamid, dimetylsulfoksyd, benzen, klorbenzen, tetrahydrofuran, benzen/tetrahydrofuran eller dioksan, i nærvær av et syrebindende middel, f.eks. et alkoholat som kalium-tert-butylat, et alkalihydroksyd som natrium- eller kaliumhydroksyd, et alkalikarbonat som kaliumkarbonat, et alkaliamid som natriumamid eller et alkalihydrid som natriumhydrid, hensiktsmessig ved temperaturer mellom 0 og 150°C, fortrinnsvis ved temperaturer mellom 0 og 50°C. c) For fremstilling av forbindelser med den generelle formel I, hvor B utgjør en -CH2- eller -CH2CH2-gruppe: The reaction is conveniently carried out in a solvent or a solvent mixture such as methylformamide, dimethylformamide, dimethylsulfoxide, benzene, chlorobenzene, tetrahydrofuran, benzene/tetrahydrofuran or dioxane, in the presence of an acid-binding agent, e.g. an alcoholate such as potassium tert-butylate, an alkali hydroxide such as sodium or potassium hydroxide, an alkali carbonate such as potassium carbonate, an alkali amide such as sodium amide or an alkali hydride such as sodium hydride, suitably at temperatures between 0 and 150°C, preferably at temperatures between 0 and 50° C. c) For the preparation of compounds of the general formula I, where B constitutes a -CH2- or -CH2CH2 group:

reduksjon av en forbindelse med den generelle formel reduction of a compound with the general formula

hvor where

R, Rx, R2/ E, G, m og n er som innledningsvis definert, Ai utgjør en -CH2~, -CH2-CH2~, -CH=CH- eller -C0-gruppe, R, Rx, R2/ E, G, m and n are as initially defined, Ai constitutes a -CH2~, -CH2-CH2~, -CH=CH- or -C0 group,

og and

Bx utgjør en -CO- eller -CH2CO-gruppe, Bx constitutes a -CO- or -CH2CO group,

X X

hvor det karbonatom som er merket med X, er tilknyttet fenyl-k j ernen. where the carbon atom marked with X is attached to the phenyl nucleus.

Reduksjonen foretas fortrinnsvis med et metallhydrid som litiumaluminiumhydrid eller diboran eller med et kompleks av boran og en tioeter, f.eks. med boran-dimetylsulfid-kompleks, i et egnet oppløsningsmiddel så som dietyleter eller tetrahydrofuran, ved temperaturer mellom 0 og 80°C, fortrinnsvis ved temperaturer < mellom 10 og 45°C. The reduction is preferably carried out with a metal hydride such as lithium aluminum hydride or diborane or with a complex of borane and a thioether, e.g. with borane-dimethylsulphide complex, in a suitable solvent such as diethyl ether or tetrahydrofuran, at temperatures between 0 and 80°C, preferably at temperatures < between 10 and 45°C.

d) For fremstilling av forbindelser med den generelle formel I, hvor A utgjør en -CH2-gruppe og B en -CO- eller -CH2C0-gruppe: ' d) For the preparation of compounds of the general formula I, where A constitutes a -CH2 group and B a -CO or -CH2C0 group: '

reduksjon av en forbindelse med den generelle formel reduction of a compound with the general formula

hvor where

R, R1# R2, E, G, rn og n er som innledningsvis definert og R, R1# R2, E, G, rn and n are as initially defined and

B2 utgjør en -CO- eller -CH2CO-gruppe, B2 constitutes a -CO- or -CH2CO group,

X X

hvor karbonatomet som er merket med X, er tilknyttet fenylkjernen, med nascerende hydrogen. where the carbon atom marked with X is attached to the phenyl nucleus, with nascent hydrogen.

Reduksjonen utføres i et egnet oppløsningsmiddel som iseddik, iseddik/vann eller iseddik/etanol med nascerende hydrogen, f.eks. i nærvær av sink/iseddik, tinn/saltsyre eller tinndiklorid/saltsyre ved temperaturer mellom 20 og 150°C, fortrinnsvis ved reaksjonsblandingens kokepunkt, f.eks. ved temperaturer mellom 80 og 100°C. e) For fremstilling av forbindelser med den generelle formel I, hvor G, med unntak av rester som inneholder et svovelatom, en sulfinyl-eller sulfonylgruppe, har de for G innledningsvis nevnte betydninger og A utgjør -CH2-CH2-gruppen og B -CH2~, The reduction is carried out in a suitable solvent such as glacial acetic acid, glacial acetic acid/water or glacial acetic acid/ethanol with nascent hydrogen, e.g. in the presence of zinc/glacial acetic acid, tin/hydrochloric acid or tin dichloride/hydrochloric acid at temperatures between 20 and 150°C, preferably at the boiling point of the reaction mixture, e.g. at temperatures between 80 and 100°C. e) For the preparation of compounds of the general formula I, where G, with the exception of residues containing a sulfur atom, a sulfinyl or sulfonyl group, have the meanings mentioned for G at the beginning and A constitutes the -CH2-CH2 group and B -CH2 ~,

-CO- eller -CH2CO-gruppen: -CO or -CH2CO group:

hydrering av en forbindelse med den generelle formel hydration of a compound of the general formula

hvor where

R, Rlt R2, B, E, m og n er som innledningsvis definert, R, Rlt R2, B, E, m and n are as initially defined,

Gx med unntak av rester som inneholder et svovelatpm, en sulfinyl-eller sulfonylgruppe, har de for G innledningsvis nevnte betydninger og Gx, with the exception of residues containing a sulfur atom, a sulfinyl or sulfonyl group, have the meanings mentioned for G at the beginning and

B3 utgjør en -CH2-, -CO- eller -CH2CO-gruppe. B3 constitutes a -CH2-, -CO- or -CH2CO group.

Hydreringen utføres i et oppløsningsmiddel eller en oppløsningsmiddelblanding som metanol, etanol, eddiksyreetylester eller iseddik, med katalytisk aktivert hydrogen, f.eks. med hydrogen i nærvær av platina eller palladium/kull, ved et hydrogentrykk på 1-7 bar, fortrinnsvis 3-5 bar og ved temperaturer mellom 0 og 75°C, fortrinnsvis ved temperaturer mellom 20 og 50°C. The hydrogenation is carried out in a solvent or a solvent mixture such as methanol, ethanol, ethyl acetate or glacial acetic acid, with catalytically activated hydrogen, e.g. with hydrogen in the presence of platinum or palladium/carbon, at a hydrogen pressure of 1-7 bar, preferably 3-5 bar and at temperatures between 0 and 75°C, preferably at temperatures between 20 and 50°C.

Ved de ovenfor beskrevne omsetninger kan eventuelt forekommende reaktive grupper som hydroksy-, amino-, alkylamino-eller iminogrupper, beskyttes under omsetningen ved hjelp av vanlige beskyttelsesgrupper som avspaltes igjen etter omsetningen. In the reactions described above, possibly occurring reactive groups such as hydroxy, amino, alkylamino or imino groups can be protected during the reaction by means of common protective groups which are split off again after the reaction.

Eksempelvis kommer som beskyttelsesrest for en hydroksygruppe, trimetylsilyl-, acetyl-, benzoyl-, benzyl- eller tetrahydropyranylgruppen og som beskyttelsesrest for en amino-, alkylamino- eller iminogruppe, acetyl-, benzoyl-, etoksykarbonyl-eller benzylgruppen, i betraktning. For example, as protective residue for a hydroxy group, the trimethylsilyl, acetyl, benzoyl, benzyl or tetrahydropyranyl group and as protective residue for an amino, alkylamino or imino group, the acetyl, benzoyl, ethoxycarbonyl or benzyl group, come into consideration.

Den eventuelt påfølgende avspaltning av en anvendt beskyttelsesrest skjer fortrinnsvis hydrolytisk i et vandig oppløsningsmiddel, f.eks. i vann, isopropanol/vann, tetrahydrofuran/vann eller dioksan/vann, i nærvær av en syre som saltsyre eller svovelsyre eiler i nærvær av en alkalibase som natriumhydroksyd eller kaliumhydroksyd ved temperaturer mellom 0 og 100°C, fortrinnsvis ved reaksjonsblandingens kokepunkt. Avspaltningen av en benzylrest skjer imidlertid fortrinnsvis hydrogenolytisk, f [.eks. med hydrogen i nærvær av en katalysator som palladium/kull, i et oppløsningsmiddel som metanol, etanol, eddiksyreetylester eller iseddik, eventuelt under tilsetning av en syre som saltsyre, ved temperaturer mellom 0 og 50°C, fortrinnsvis ved romtemperatur, og ved et hydrogentrykk på 1-7 bar, fortrinnsvis 3-5 bar. The possibly subsequent cleavage of an applied protective residue preferably takes place hydrolytically in an aqueous solvent, e.g. in water, isopropanol/water, tetrahydrofuran/water or dioxane/water, in the presence of an acid such as hydrochloric acid or sulfuric acid or in the presence of an alkali base such as sodium hydroxide or potassium hydroxide at temperatures between 0 and 100°C, preferably at the boiling point of the reaction mixture. However, the removal of a benzyl residue preferably occurs hydrogenolytically, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal, in a solvent such as methanol, ethanol, ethyl acetate or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid, at temperatures between 0 and 50°C, preferably at room temperature, and at a hydrogen pressure of 1-7 bar, preferably 3-5 bar.

Oppnår man i henhold til oppfinnelsen en forbindelse med den generelle formel I, hvor R inneholder en nitrogruppe, så kan den reduseres til en tilsvarende aminoforbindelse med den generelle formel I, If, according to the invention, a compound with the general formula I is obtained, where R contains a nitro group, then it can be reduced to a corresponding amino compound with the general formula I,

mens en forbindelse med den generelle formel I, hvor R inneholder en aminogruppe, kan overføres i en tilsvarende alkanoylamino-forbindelse med den generelle formel I ved hjelp av acylering. while a compound of the general formula I, where R contains an amino group, can be transferred into a corresponding alkanoylamino compound of the general formula I by means of acylation.

Den etterfølgende reduksjon av nitro-forbindelsen utføres fortrinnsvis i et oppløsningsmiddel som vann, vann/etanol, metanol, iseddik, eddiksyreetylester eller dimetylformamid, hensiktsmessig med hydrogen i nærvær av en hydreringskatalysator som Raney-nikkel, platina eller palladium/kull, med metaller som jern, tinn eller sink i nærvær av en syre, med salter som jem(II)sulfat, tinn(II)klorid eller natriumditionitt, eller med hydrazin i nærvær av Raney-nikkel ved temperaturer mellom 0 og 50°C, fortrinnsvis ved romtemperatur. The subsequent reduction of the nitro compound is preferably carried out in a solvent such as water, water/ethanol, methanol, glacial acetic acid, ethyl acetate or dimethylformamide, suitably with hydrogen in the presence of a hydrogenation catalyst such as Raney nickel, platinum or palladium/charcoal, with metals such as iron , tin or zinc in the presence of an acid, with salts such as tin(II) sulfate, tin(II) chloride or sodium dithionite, or with hydrazine in the presence of Raney nickel at temperatures between 0 and 50°C, preferably at room temperature.

Den etterfølgende acylering utføres hensiktsmessig i et oppløsningsmiddel som metylenklorid, kloroform, tetraklormetan, eter, tetrahydrofuran, dioksan, benzen, toluen, acetonitril eller dimetylformamid, fortrinnsvis med et reaktivt derivat av syren, eksempelvis med acetylklorid, acetanhydrid eller propionsyreanhydrid, og eventuelt i nærvær av en uorganisk base, som natriumkarbonat, eller en tertiær organisk base, som trietylamin eller pyridin, som samtidig kan tjene som oppløsningsmiddel, ved temperaturer mellom -25°C og 100°C, fortrinnsvis ved temperaturer mellom -10°C og kokepunktet for den anvendte oppløsningsmiddel. The subsequent acylation is conveniently carried out in a solvent such as methylene chloride, chloroform, tetrachloromethane, ether, tetrahydrofuran, dioxane, benzene, toluene, acetonitrile or dimethylformamide, preferably with a reactive derivative of the acid, for example with acetyl chloride, acetic anhydride or propionic anhydride, and optionally in the presence of an inorganic base, such as sodium carbonate, or a tertiary organic base, such as triethylamine or pyridine, which can simultaneously serve as a solvent, at temperatures between -25°C and 100°C, preferably at temperatures between -10°C and the boiling point of the used solvent.

Da de oppnådde forbindelser med den generelle formel I har minst ett chiralt sentrum, kan de spaltes etter vanlige fremgangsmåter i deres diastereomerer, eksempelvis ved søyle-kromatografi, og i deres enantiomerer, eksempelvis ved søyle-kromatografi på en chiral fase eller ved krystallisasjon med optisk aktive syrer, f.eks. med D- eller L-monometylvinsyre, D-eller L-diacetylvinsyre, D- eller L-vinsyre, D- eller L-melkesyre eller D- eller L-kamfersyre. As the obtained compounds of the general formula I have at least one chiral center, they can be resolved by usual methods into their diastereomers, for example by column chromatography, and into their enantiomers, for example by column chromatography on a chiral phase or by crystallization with optical active acids, e.g. with D- or L-monomethyltartaric acid, D- or L-diacetyltartaric acid, D- or L-tartaric acid, D- or L-lactic acid or D- or L-camphoric acid.

De oppnådde forbindelser med den generelle formel I lar seg dessuten overføre i deres syreaddisjonssalter, spesielt for deres farmasøytiske anvendelse, i deres fysiologisk akseptable syreaddisjonssalter med uorganiske eller organiske syrer. Som syrer kommer herunder eksempelvis saltsyre, hydrogenbromidsyre, svovelsyre, fosforsyre, eddiksyre, melkesyre, sitronsyre, vinsyre, ravsyre, maleinsyre eller fumarsyre i betraktning. The obtained compounds of the general formula I can also be transferred in their acid addition salts, especially for their pharmaceutical use, in their physiologically acceptable acid addition salts with inorganic or organic acids. Acids include, for example, hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, acetic acid, lactic acid, citric acid, tartaric acid, succinic acid, maleic acid or fumaric acid.

Forbindelsene II til VIII som benyttes som utgangs-materialer, er tildels kjent fra litteraturen og kan tildels oppnås etter kjente fremgangsmåter. The compounds II to VIII which are used as starting materials are partly known from the literature and can partly be obtained by known methods.

Således oppnår man eksempelvis en utgangsforbindelse med den generelle formel II ved alkylering av en tilsvarende imino-forbindelse IV, med et i N-atomet beskyttet cyklisk amin som i karbonskjelettet er substituert med en alkylrest, som på sin side er terminalt substituert med en nukleofil utgående gruppe, og påfølgende avspaltning av den anvendte beskyttelsesrest. Det nødvendige cykliske amin oppnår man ved omdannelse av et tilsvarende hyidroks<y>alk<y>lsubstituer<t> cyklisk amin til den egnede halogen- eller sulfonsyreester, og den hertil nødvendige iminoforbindelse med den generelle formel IV ved cyklisering av en tilsvarende forbindelse, f.eks. ved cyklisering av en forbindelse med den generelle formel Thus, for example, a starting compound with the general formula II is obtained by alkylation of a corresponding imino compound IV, with a cyclic amine protected in the N atom which is substituted in the carbon skeleton with an alkyl residue, which in turn is terminally substituted with a nucleophilic leaving group, and subsequent cleavage of the protective residue used. The necessary cyclic amine is obtained by converting a corresponding hydroxyalk<y>lsubstituer<t> cyclic amine into the suitable halogen or sulfonic acid ester, and the required imino compound with the general formula IV by cyclization of a corresponding compound, e.g. by cyclization of a compound of the general formula

eller også med den generelle formel or also with the general formula

eventuelt med påfølgende katalytisk hydrering og/eller reduksjon av karbonylgruppen for eksempel med optionally with subsequent catalytic hydrogenation and/or reduction of the carbonyl group, for example with

natriumborhydrid/iseddik (se EP-A1 0.007.070, EP-A1 0.065.229 og EP-A1 0.109.639). sodium borohydride/glacial acetic acid (see EP-A1 0.007.070, EP-A1 0.065.229 and EP-A1 0.109.639).

En utgangsforbindelse med den generelle formel V oppnår man ved N-alkylering av et tilsvarende cyklisk amin som i karbonskjelettet er substituert med en hydroksyalkylrest, med en tilsvarende forbindelse eller med et tilsvarende 1, dihalogenalkan og påfølgende omsetning med en tilsvarende HO-, SH- eller HN-forbindelse og om nødvendig ved påfølgende oksydasjon, hvorved en således oppnådd hydroksyalkylforbindelse overføres i dens reaktive halogen-eller sulfonsyreester. A starting compound with the general formula V is obtained by N-alkylation of a corresponding cyclic amine which in the carbon skeleton is substituted with a hydroxyalkyl residue, with a corresponding compound or with a corresponding 1, dihaloalkane and subsequent reaction with a corresponding HO-, SH- or HN compound and, if necessary, by subsequent oxidation, whereby a hydroxyalkyl compound thus obtained is transferred into its reactive halogen or sulfonic acid ester.

Utgangsforbindelser med formel VI, VII og VIII oppnår man fortrinnsvis ved omsetning av en tilsvarende Starting compounds of formula VI, VII and VIII are preferably obtained by reacting an equivalent

halogenforbindelse med et tilsvarende amin, eventuelt etterfulgt av avspaltning av beskyttelsesrester som er benyttet for beskyttelse av aminogrupper. halogen compound with a corresponding amine, optionally followed by cleavage of protective residues which are used for the protection of amino groups.

Som allerede nevnt, oppviser de nye forbindelser med formel I og deres fysiologisk akseptable syreaddisjonssalter med uorganiske eller organiske syrer, verdifulle farmakologiske egenskaper, spesielt en blodtrykksenkende og en spesielt langvarig hjertefrekvens-senkende virkning samt en nedsettende virkning av hjertets Oz-behov, samtidig som de sentrale bivirkninger er svake. As already mentioned, the new compounds of formula I and their physiologically acceptable acid addition salts with inorganic or organic acids exhibit valuable pharmacological properties, in particular a blood pressure-lowering and a particularly long-lasting heart rate-lowering effect as well as a lowering effect on the heart's Oz demand, while central side effects are weak.

Følgende forbindelser: The following connections:

A = 3-[ (N-(2-(naftyl-2)-etyl)-piperidyl-3)-metyl]-7,8- dimetoksy-2-okso-l ,3,4, 5-tetrahydro-2H-3-benzazepin-hydroklorid, A = 3-[(N-(2-(naphthyl-2)-ethyl)-piperidyl-3)-methyl]-7,8- dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine hydrochloride,

B = 3-[ (N-(2-(5-metyl-6-metoksy-naftyl-2)-etyl)-piperidyl-3) - B = 3-[ (N-(2-(5-methyl-6-methoxy-naphthyl-2)-ethyl)-piperidyl-3)-

metyl ] -7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid, methyl ] -7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine hydrochloride,

C = 3-[2-(N-(2-(6-metoksy-naftyl-2)-etyl)-piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-1,3,4,, 5-tetrahydro-2H-3-benzazepin-hydroklorid, C = 3-[2-(N-(2-(6-methoxy-naphthyl-2)-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4, , 5-tetrahydro-2H-3-benzazepine hydrochloride,

D = 2-[ (N-(2-(6-metoksy-naftyl-2)-etyl)-heksahydro-azepinyl-3) -metyl ] -6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid, D = 2-[ (N-(2-(6-methoxy-naphthyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrochloride,

E = 2-[ (N-(2-(naftyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-l; 2,3,4-tetrahydro-isokinolin-hydrobromid, E = 2-[(N-(2-(naphthyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1; 2,3,4-tetrahydro-isoquinoline hydrobromide,

F = 2-[ (N- (2-(3,4-dimetoksyfenyl) -etyl) -piperidyl-3) -metyl]-6,7-dimetyl-l ,2,3,4-tetrahydro-isokinolin-dihydroklorid, F = 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline dihydrochloride,

i in

G = 2-[ (N-(2-(3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-1,2,3,4-rtetrahydro-isokinolin-hydroklorid, G = 2-[ (N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-rtetrahydro- isoquinoline hydrochloride,

H = 2-[ (N-(3-(4-metoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6.7- dimetyl-l-okso-1,2,3,4^tetrahydro-isokinolin, hydroklorid, H = 2-[ (N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4^tetrahydro-isoquinoline, hydrochloride,

I = 3-[ (N-(4-(tienyl-2)-butyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid, I = 3-[(N-(4-(thienyl-2-butyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine hydrochloride,

K = 3-[ (N-(2-(benzo[b]furyl-2)-etyl)-piperidyl-3)-metyl]-7.8- dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid og K = 3-[ (N-(2-(benzo[b]furyl-2-ethyl)-piperidyl-3)-methyl]-7,8- dimethoxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine hydrochloride and

L = 3-[ (N-(2-(benzo[b]tienyl-3)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid L = 3-[ (N-(2-(benzo[b]thienyl-3)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5- tetrahydro-2H-3-benzazepine hydrochloride

M = 2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3) -metyl]-1,3-dihydro-5,6-dimetoksy-isoindol, M = 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-1,3-dihydro-5,6-dimethoxy-isoindole,

N = 2-[(N-(3-(3-metyl-fenoksy)-propyl)-heksahydro-azepinyl-3 ) -metyl]-5,6-dimetoksy-l-okso-l,3-dihydro-isoindol-hydroklorid, N = 2-[(N-(3-(3-methyl-phenoxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole- hydrochloride,

0 = 2-[N-(2-(3,4-dimetoksy-fenyl)-etyl)-piperidyl-3)-metyl ]-5,6-dimetoksy-l-okso-l,3-dihydro-isoindol-hydroklorid, 0 = 2-[N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole hydrochloride ,

P = 2-[(N-(2-(4-metyl-fenyl)-etyl)-piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-l,3-dihydro-isoindol, P = 2-[(N-(2-(4-methyl-phenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole,

Q = 3-[(N-(2-(6-metyl-pyridyl-2-)-etyl)-pyrrolidyl-3)-metyl ]-7,8-dimetyl-l,3,4,5-tetrahydro-2H-3-benzazepin x 2,5 HC1 x H20 og Q = 3-[(N-(2-(6-methyl-pyridyl-2-)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-1,3,4,5-tetrahydro-2H -3-benzazepine x 2.5 HC1 x H20 and

R = 3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl ]-7,8-dimetyl-2-okso-l,3-dihydro-2H-3-benzazapin-dihydroklorid-semihydrat R = 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H- 3-benzazapine dihydrochloride hemihydrate

ble undersøkt på deres biologiske egenskaper på følgende måte: were examined for their biological properties as follows:

Virkning på hjertefrekvensen hos rotter: Effect on heart rate in rats:

Virkningen av testsubstansen på hjertefrekvensen ble for hver dose undersøkt på to rotter med en gj ennomsnittvekt på 250-300 g. Herunder ble rottene anestetisert med pentobarbital (50 mg/kg i.p. og 20 mg/kg s.c). Testsubstansen ble injisert 1 vandig oppløsning i vena jugularis (0,1 ml/100 g). The effect of the test substance on the heart rate was examined for each dose on two rats with an average weight of 250-300 g. During this, the rats were anesthetized with pentobarbital (50 mg/kg i.p. and 20 mg/kg s.c.). The test substance was injected 1 aqueous solution into the jugular vein (0.1 ml/100 g).

Blodtrykket ble målt via en kanyle i A. carotis, og hjertefrekvensen ble registrert ved EKG avledet med nål-elektroder (II. eller III. avledning). Dyrenes hjertefrekvens i kontrollperioden lå mellom 350 og 400 slag/minutt (S/min.). Blood pressure was measured via a cannula in the carotid artery, and heart rate was recorded by ECG derived with needle electrodes (II. or III. lead). The animals' heart rate during the control period was between 350 and 400 beats/minute (S/min.).

Den etterfølgende tabell inneholder de oppnådde verdier: The following table contains the obtained values:

Forbindelsene fremstillet i henhold til oppfinnelsen oppviser ingen som helst toksiske bivirkninger i terapeutiske doser. Ved en intravenøs tilførsel av substansene A og L kunne det således ved en høy dosering på 20 mg/kg i mus, ikke påvises toksiske bivirkninger utenom en svak sederende virkning. The compounds produced according to the invention show no toxic side effects whatsoever in therapeutic doses. With an intravenous supply of the substances A and L, no toxic side effects could be detected, apart from a weak sedative effect, at a high dosage of 20 mg/kg in mice.

På grunn av deres farmakologiske egenskaper er de nye forbindelsene egnet til behandling av sinus-tachykardier av ulik genese og til profylakse og terapi av ischemiske hjerte-lidelser. Due to their pharmacological properties, the new compounds are suitable for the treatment of sinus tachycardias of various genesis and for the prophylaxis and therapy of ischemic heart disorders.

Den nødvendige dose for å oppnå en passende virkning, utgjør hensiktsmessig 1 til 2 gangers daglig tilførsel av 0,01 til 0,2 mg/kg legemsvekt, fortrinnsvis 0,03-0,15 mg/kg legemsvekt. Til dette formål kan forbindelsene med den generelle formel I, samt deres fysiologisk akseptable syreaddisjonssalter, sammen med uorganiske eller organiske syrer, eventuelt i kombinasjon med andre virkestoff, innarbeides sammen med ett eller flere inerte vanlige bære-og/eller fortynningsmidler, som f.eks. maisstivelse, melkesukker, rørsukker, mikrokrystallinsk cellulose, magnesiumstearat, polyvinylpyrrolidon, sitronsyre, vinsyre, vann, vann/etanol, vann/glycerol, vann/sorbitol, vann/polyetylenglykol, propylenglykol, karboksymetylcellulose, eller fettholdige substanser som hårdfett og egnede blandinger derav, i vanlige galeniske tilberedninger som tabletter, drasjéer, kapsler, pulvere, suspensjoner, dråper, ampuller, siruper eller pastiller. The necessary dose to achieve an appropriate effect is suitably 1 to 2 times daily administration of 0.01 to 0.2 mg/kg body weight, preferably 0.03-0.15 mg/kg body weight. For this purpose, the compounds of the general formula I, as well as their physiologically acceptable acid addition salts, together with inorganic or organic acids, possibly in combination with other active ingredients, can be incorporated together with one or more inert usual carriers and/or diluents, such as e.g. . corn starch, milk sugar, cane sugar, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water/ethanol, water/glycerol, water/sorbitol, water/polyethylene glycol, propylene glycol, carboxymethyl cellulose, or fatty substances such as hard fat and suitable mixtures thereof, in common galenic preparations such as tablets, dragees, capsules, powders, suspensions, drops, ampoules, syrups or lozenges.

Eksempel A 2~[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro- isokinol in Example A 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline

a) N- benzyl- 3-( hydroksymetyl)- piperidin a) N-benzyl-3-(hydroxymethyl)-piperidine

En blanding av 40,3 g (0,35 mol) 3-(hydroksymetyl)-piperidin, 97,4 ml (0,70 mol) trietylamin og 40,3 ml A mixture of 40.3 g (0.35 mol) 3-(hydroxymethyl)-piperidine, 97.4 ml (0.70 mol) triethylamine and 40.3 ml

(0,35 mol) benzylklorid ble i løpet av 30 minutter oppvarmet til 95°C og holdt ved denne temperatur i 2 timer. Den avkjølte reaksjonsblanding ble oppløst i en blanding av 2 molar natronlut og eddiksyre. Den organiske fase ble vasket med vann, fraskilt, tørket over magnesiumsulfat og inndampet i vakuum. (0.35 mol) of benzyl chloride was heated to 95°C within 30 minutes and held at this temperature for 2 hours. The cooled reaction mixture was dissolved in a mixture of 2 molar caustic soda and acetic acid. The organic phase was washed with water, separated, dried over magnesium sulfate and evaporated in vacuo.

Utbytte: 57,2 g, (79,6% av det teoretiske) , Yield: 57.2 g, (79.6% of the theoretical) ,

Rf-verdi: 0,45 (aluminiumoksyd, nøytral, mobil fase: 3% etanol i metylenklorid) . Rf value: 0.45 (alumina, neutral, mobile phase: 3% ethanol in methylene chloride).

b) N- benzvl- 3- fbenzensulfonyloksvmetvl)- piperidin b) N-Benzyl-3-benzenesulfonyloxymethyl)-piperidine

En blanding av 6,8 g (0,033 mol) N-benzyl-3-(hydroksymetyl)-piperidin, 6,7 ml (0,052 mol) A mixture of 6.8 g (0.033 mol) N-benzyl-3-(hydroxymethyl)-piperidine, 6.7 ml (0.052 mol)

benzensulfonsyreklorid, 50 ml 20% vandig natronlut, 100 ml toluen og 1 spatelspiss tetrabutylammoniumbromid ble omrørt i 3 timer ved romtemperatur. Deretter ble blandingen fortynnet med 250 ml etylacetat og den organiske fase vasket med vann. Den organiske fase ble fraskilt, tørket over magnesiumsulfat og inndampet til tørrhet i vakuum. Rensingen av residuet ble foretatt over 200 g kiselgel (0,063 -0,2 mm) med metylenklorid og deretter med økende andeler etanol (til 5%). benzenesulfonic acid chloride, 50 ml of 20% aqueous sodium hydroxide solution, 100 ml of toluene and 1 spatula tip of tetrabutylammonium bromide were stirred for 3 hours at room temperature. The mixture was then diluted with 250 ml of ethyl acetate and the organic phase washed with water. The organic phase was separated, dried over magnesium sulfate and evaporated to dryness in vacuo. The purification of the residue was carried out over 200 g of silica gel (0.063-0.2 mm) with methylene chloride and then with increasing proportions of ethanol (to 5%).

Utbytte: 9,4 g (92% av det teoretiske), Yield: 9.4 g (92% of theoretical),

Rf-verdi: 0,5 (kiselgel, mobil fase: 5% etanol i metylenklorid) . Rf value: 0.5 (silica gel, mobile phase: 5% ethanol in methylene chloride).

c) 2-[(N-benzyl-piperidyl-3)^metyl]-6,7-dimetoksy-l-okso-1. 2. 3. 4- tetrahydro- isokinolin c) 2-[(N-benzyl-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1. 2. 3. 4- tetrahydro- isoquinoline

5,2 g (0,025 mol) 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin ble oppløst i 70 ml dimetylsulfoksyd og under omrøring tilsatt 3,1 g (0,025 mol) kalium-tert.butylat. Etter 1/2 time ble den oppnådde kaliumsaltsuspensjon tilsatt 5.2 g (0.025 mol) of 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline were dissolved in 70 ml of dimethyl sulfoxide and, with stirring, added 3.1 g (0.025 mol) of potassium tert .butylate. After 1/2 hour, the obtained potassium salt suspension was added

9,3 g (0,0275 mol) N-benzyl-3-(benzensulfonyloksymetyl)-piperidin i 20 ml dimetylsulfoksyd og omrørt i 2 timer ved 4 0°C. Blandingen ble helt på isvann og ekstrahert 3 x med 9.3 g (0.0275 mol) of N-benzyl-3-(benzenesulfonyloxymethyl)-piperidine in 20 ml of dimethylsulfoxide and stirred for 2 hours at 40°C. The mixture was poured onto ice water and extracted 3 times with

120 ml porsjoner etylacetat. De samlede organiske faser ble vasket med vann, tørket over magnesiumsulfat og inndampet i vakuum. Det oppnådde residuum ble renset over 200 g kiselgel (0,063-0,2 mm) med metylenklorid og påfølgende økende andeler etanol (til 2%). 120 ml portions of ethyl acetate. The combined organic phases were washed with water, dried over magnesium sulfate and evaporated in vacuo. The obtained residue was purified over 200 g of silica gel (0.063-0.2 mm) with methylene chloride and subsequent increasing proportions of ethanol (to 2%).

Utbytte: 7,7 g (78,5% av det teoretiske), Yield: 7.7 g (78.5% of the theoretical),

Rf-verdi: 0,5 (kiselgel, elueringsmiddel: 5% etanol i metylenklorid og 1 dråpe ammoniakk). Rf value: 0.5 (silica gel, eluent: 5% ethanol in methylene chloride and 1 drop of ammonia).

d) 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-1, 2. 3. 4- tetrahvdro- isokinolin d) 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1, 2. 3. 4- tetrahydroisoquinoline

9,4 g (0,0238 mol) 2-[(N-benzyl-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin i 200 ml metanol, ble i nærvær av 2 g 20% palladiumhydroksyd/kull hydrert i 3 timer ved romtemperatur og 5 bar hydrogen. Deretter ble katalysatoren suget av og filtratet inndampet til tørrhet i vakuum. 9.4 g (0.0238 mol) 2-[(N-benzyl-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline in 200 ml methanol, was hydrogenated in the presence of 2 g of 20% palladium hydroxide/charcoal for 3 hours at room temperature and 5 bar of hydrogen. The catalyst was then sucked off and the filtrate evaporated to dryness in vacuo.

Utbytte: 7,2 g (99% av det teoretiske), Yield: 7.2 g (99% of theoretical),

Rf-verdi: 0,15 (kiselgel, elueringsmiddel: 10% etanol i metylenklorid og 1 dråpe ammoniakk). Rf value: 0.15 (silica gel, eluent: 10% ethanol in methylene chloride and 1 drop of ammonia).

Eksempel B Example B

3- klormetvl- N- r 3- f naftyl- 2- oksv)- propyl]- piperidin 3- chloromethyl- N- r 3- f naphthyl- 2- oxy)- propyl]- piperidine

a) 3- fhydroksymetyl)- N-\ 3-( naftyl- 2- oksv)- propyl]- piperidin En blanding av 11,5 g (0,2 mol) 3-hydroksy-metyl-piperidin og 11 g 2-(3-klorpropoksy)-naftalen ble oppvarmet i 1 time til 120°C. Residuet ble renset over kiselgel (0,063-0,2 mm) med etylacetat/etanol/ammoniakk = 90:10:1. a) 3-hydroxymethyl)-N-\3-(naphthyl-2-oxv)-propyl]-piperidine A mixture of 11.5 g (0.2 mol) 3-hydroxy-methyl-piperidine and 11 g of 2-( 3-Chloropropoxy)-naphthalene was heated for 1 hour at 120°C. The residue was purified over silica gel (0.063-0.2 mm) with ethyl acetate/ethanol/ammonia = 90:10:1.

Utbytte: 11,5 g (76,6% av det teoretiske). Yield: 11.5 g (76.6% of the theoretical).

Smp.: 99-101°C. M.p.: 99-101°C.

b) 3- klormetvi- N- r 3-( naftyl- 2- oksy)- propyl1- piperidin b) 3-chloromethyl-N-r3-(naphthyl-2-oxy)-propyl-1-piperidine

En oppløsning av 1,5 g (5;mmol) 3-(hydroksymetyl)-N-[3-(naftyl-2-oksy)-propyl]-piperidin i 25 ml kloroform ble tilsatt 1,5 ml tionylklorid og kokt under tilbakeløpskjøling i 1,5 timer. Det ble foretatt inndampning i vakuum, hvorpå residuet ble tatt opp i metylenklorid, vasket med vann, 2 molar natronlut og deretter igjen med vann. Etter tørking over magnesiumsulfat ble metylenkloridfasen inndampet i vakuum. Utbytte: 1,4 g (87,5% av det teoretiske). A solution of 1.5 g (5 mmol) 3-(hydroxymethyl)-N-[3-(naphthyl-2-oxy)-propyl]-piperidine in 25 ml of chloroform was added with 1.5 ml of thionyl chloride and boiled under reflux for 1.5 hours. Evaporation was carried out in vacuo, after which the residue was taken up in methylene chloride, washed with water, 2 molar caustic soda and then again with water. After drying over magnesium sulfate, the methylene chloride phase was evaporated in vacuo. Yield: 1.4 g (87.5% of the theoretical).

Rf-verdi: 0,8 (kiselgel, elueringsmiddel: etylacetat/etanol/- Rf value: 0.8 (silica gel, eluent: ethyl acetate/ethanol/-

ammoniakk = 90:40:2) i ammonia = 90:40:2) i

Eksempel C Example C

2-[(heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-1. 2. 3. 4- tetrahydro- isokinolin 2-[(hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1. 2. 3. 4- tetrahydro- isoquinoline

a) N- benzyl- kaprolaktam a) N-benzylcaprolactam

33,9 g (0,3 mol) kaprolaktam ble oppløst i 250 ml 33.9 g (0.3 mol) caprolactam was dissolved in 250 ml

dimetylsulfoksyd og under omrøring tilsatt 37 g (0,33 mol) kalium-tert.butylat. Herved stég reaksjonstemperaturen til 60°C. Blandingen ble omrørt i 1/2 time ved 60°C og deretter dråpevis tilsatt 35 ml (0,3 mol) benzylbromid. Etter ytterligere 2,5 timer ved 60°C ble blandingen helt over i 1 liter isvann og utristet 3 ganger med etylacetat. De organiske fasene ble kombinert, vasket méd vann, tørket over magnesiumsulfat og inndampet i;vakuum. dimethyl sulfoxide and, with stirring, added 37 g (0.33 mol) of potassium tert.butylate. The reaction temperature thereby rose to 60°C. The mixture was stirred for 1/2 hour at 60°C and then 35 ml (0.3 mol) of benzyl bromide was added dropwise. After a further 2.5 hours at 60°C, the mixture was poured into 1 liter of ice water and decanted 3 times with ethyl acetate. The organic phases were combined, washed with water, dried over magnesium sulfate and evaporated in vacuo.

Utbytte: 60,3 g (99% av det teoretiske), Yield: 60.3 g (99% of the theoretical),

Rf-verdi: 0,6 (kiselgel, elueringsmiddel: 5% etanol i Rf value: 0.6 (silica gel, eluent: 5% ethanol in

metylenklorid). methylene chloride).

b) l- benzvl- kaprolaktam- 3- karboksylsyre b) 1-Benzyl-caprolactam-3-carboxylic acid

Til 33,9 g = 47,1 ml (0,33 mol) diisopropylamin i 450 ml To 33.9 g = 47.1 ml (0.33 mol) of diisopropylamine in 450 ml

absolutt eter ble det under omrøring under nitrogen tilsatt 180 ml 2,6 molar butyllitiumoppløsning i n-heksan ved -60°C. Deretter ble det under fortsatt kjøling dråpevis tilsatt absolute ether, 180 ml of 2.6 molar butyllithium solution in n-hexane at -60°C were added while stirring under nitrogen. It was then added dropwise while continuing to cool

48,8 g (0,24 mol) N-benzyl-kaprolaktam oppløst i 150 ml absolutt eter. Etter 10 minutters omrøring ble kjølebadet fjernet og karbondioksyd innledet i 15 minutter. 48.8 g (0.24 mol) of N-benzyl-caprolactam dissolved in 150 ml of absolute ether. After 10 minutes of stirring, the cooling bath was removed and carbon dioxide introduced for 15 minutes.

Reaksjonsblandingen ble helt på is, hvorpå eterfasen ble fraskilt og utristet 2 ganger med 2 molar natronlut. De vandige alkoholfasene ble kombinert, utristet med eter, surgjort med konsentrert saltsyre og utristet 2 ganger med metylenklorid. De kombinerte metylenklorid-fåsene ble tørket over magnesiumsulfat, og oppløsningsmidlet ble avdestillert i vakuum. The reaction mixture was poured onto ice, after which the ether phase was separated and decanted twice with 2 molar caustic soda. The aqueous alcohol phases were combined, decanted with ether, acidified with concentrated hydrochloric acid and decanted twice with methylene chloride. The combined methylene chloride phases were dried over magnesium sulfate, and the solvent was distilled off in vacuo.

Utbytte: 15,7 g (26,5% av det teoretiske), Yield: 15.7 g (26.5% of the theoretical),

IR-spektrum (metylenklorid): 1735 og 1600 cm"<1> (CO) . IR spectrum (methylene chloride): 1735 and 1600 cm"<1> (CO).

c. l- benzvl- 2- hydroksvmetvl- heksahydro- azepin c. 1-benzoyl-2-hydroxymethyl-hexahydro-azepine

Til 6,84 g (0,28 mol) litiumaluminiumhydrid i 300 ml absolutt tetrahydrofuran ble det dryppet inn 14,8 g (0,06 mol) l-benzyl-kaprolaktam-3-karboksylsyre, oppløst i 300 ml absolutt tetrahydrofuran. Blandingen ble kokt under tilbakeløpskjøling i 6 timer og deretter under kjøling med isvann tilsatt 6,8 ml vann, 6,8 ml 2 molar natronlut og 21 ml vann. Bunnfallet ble suget av, vasket med tetrahydrofuran og filtratet inndampet i vakuum. Residuet ble renset søylekromatografisk over aluminiumoksyd (aktivitet II, elueringsmiddel: metylenklorid). To 6.84 g (0.28 mol) of lithium aluminum hydride in 300 ml of absolute tetrahydrofuran, 14.8 g (0.06 mol) of 1-benzyl-caprolactam-3-carboxylic acid, dissolved in 300 ml of absolute tetrahydrofuran, were added dropwise. The mixture was boiled under reflux for 6 hours and then under cooling with ice water added 6.8 ml of water, 6.8 ml of 2 molar caustic soda and 21 ml of water. The precipitate was suctioned off, washed with tetrahydrofuran and the filtrate evaporated in vacuo. The residue was purified by column chromatography over alumina (activity II, eluent: methylene chloride).

Utbytte: 8,4 g (63,8% av det teoretiske). Yield: 8.4 g (63.8% of the theoretical).

IR-spektrum (metylenklorid) : 3620 cm"<1> (OH) . IR spectrum (methylene chloride) : 3620 cm"<1> (OH) .

d) l- benzyl- 3- ( 4- toluensulf onvloksvmetyl) - heksahvdro- azepin 15 g (0,0684 mol) l-benzyl-3-hydroksymetyl-heksahydro-azepin ble oppløst i 150 ml pyridin og under omrøring tilsatt 14,3 g (0,075 mol) p-toluensulfonsyreklorid og omrørt i 1 time ved romtemperatur. Blandingen ble inndampet i vakuum, residuet tatt opp i metylenklorid og vasket med 2 molar natronlut og med vann. Etter tørking over magnesiumsulfat ble den organiske fase inndampet i vakuum. d) l-benzyl-3-(4-toluenesulfonyloxymethyl)-hexahydro-azepine 15 g (0.0684 mol) l-benzyl-3-hydroxymethyl-hexahydro-azepine was dissolved in 150 ml of pyridine and, with stirring, added 14.3 g (0.075 mol) p-toluenesulfonic acid chloride and stirred for 1 hour at room temperature. The mixture was evaporated in vacuo, the residue taken up in methylene chloride and washed with 2 molar sodium hydroxide solution and with water. After drying over magnesium sulfate, the organic phase was evaporated in vacuo.

Utbytte: 23,3 g (91,3% av det teoretiske), Yield: 23.3 g (91.3% of the theoretical),

Rf-verdi: 0,45 (kiselgel, elueringsmiddel: 5% etanol i metylenklorid). Rf value: 0.45 (silica gel, eluent: 5% ethanol in methylene chloride).

e) 2-[(N-benzyl-heksahydro-azepinyl-3)-metyl]-6,7-metylen-dioksv- l- okso- 1. 2, 3. 4- tetrahvdro- isokinolin e) 2-[(N-benzyl-hexahydro-azepinyl-3)-methyl]-6,7-methylene-dioxv-l-oxo-1.2,3.4-tetrahydro- isoquinoline

7,4 g (0,0387 mol) 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin ble oppløst i 100 ml dimetylsulfoksyd, tilsatt 4,5 g (0,04 mol) kalium-tert.butylat og omrørt i 1/2 time ved romtemperatur. Blandingen ble deretter tilsatt 16,8 g (0,044 mol) l-benzyl-3-(4-toluénsulfonyloksymetyl)heksahydro-azepin og omrørt i 3 timer ved romtemperatur. 7.4 g (0.0387 mol) of 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline was dissolved in 100 ml of dimethylsulfoxide, to which was added 4.5 g (0.04 mol) of potassium -tert.butylate and stirred for 1/2 hour at room temperature. To the mixture was then added 16.8 g (0.044 mol) of 1-benzyl-3-(4-toluenesulfonyloxymethyl)hexahydro-azepine and stirred for 3 hours at room temperature.

Reaksjonsblandingen ble oppløst i etylacetat og utristet 2 ganger med vann. Den organiske fase ble tørket over magnesiumsulfat og inndampet i vakuum. Residuet ble renset over aluminiumoksyd N (aktivitet II, elueringsmiddel: metylenklorid, metylenklorid + 2% etanol). The reaction mixture was dissolved in ethyl acetate and shaken twice with water. The organic phase was dried over magnesium sulfate and evaporated in vacuo. The residue was purified over alumina N (activity II, eluent: methylene chloride, methylene chloride + 2% ethanol).

Utbytte: 3,0 g (19,6% av det teoretiske), Yield: 3.0 g (19.6% of the theoretical),

Rf-verdi: 0,6 (kiselgel, elueringsmiddel: 5% etanol i Rf value: 0.6 (silica gel, eluent: 5% ethanol in

metylenklorid). methylene chloride).

f) 2-[(heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso- 1. 2. 3, 4- tetrahvdro- isokinolin f) 2-[(hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1.2.3.4-tetrahydro-isoquinoline

6,7 g (0,017 mol) 2-[(N-benzyl-heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin i 250 ml metanol ble hydrert ii nærvær av 2 g 20% palladium-hydroksyd/kull i 4 timer ved romtemperatur under 5 bar hydrogen. Deretter ble katalysatoren suget av og filtratet inndampet i vakuum. Residuet'krystalliserte fra aceton. Utbytte: 4,9 g (95% av det teoretiske). 6.7 g (0.017 mol) 2-[(N-benzyl-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline in 250 ml methanol was hydrogenated in the presence of 2 g of 20% palladium hydroxide/charcoal for 4 hours at room temperature under 5 bar of hydrogen. The catalyst was then sucked off and the filtrate evaporated in vacuo. The residue was crystallized from acetone. Yield: 4.9 g (95% of theoretical).

Smp.: 267-269°C. M.p.: 267-269°C.

Eksempel D Example D

3- klormetvl- N-[ 3-( naftyl- 2- oksy)- propyl]- heksahvdro- azepin 3- chloromethyl- N-[ 3-( naphthyl- 2- oxy)- propyl]- hexahydro- azepine

a) 3- hydroksvmetvl- heksahydro- azepin a) 3-hydroxymethyl-hexahydro-azepine

16,6 g (0,0757 mol) l-benzyl-3-hydroksymetyl-heksahydro-azepin i 500 ml metanol, blé i nærvær av 16,6 g 20% palladium-hydroksyd/kull hydrert i 2 timer ved romtemperatur under 5 bar hydrogen. Deretter ble katalysatoren suget av og filtratet inndampet i vakuum. 16.6 g (0.0757 mol) 1-benzyl-3-hydroxymethyl-hexahydro-azepine in 500 ml of methanol, dissolved in the presence of 16.6 g of 20% palladium hydroxide/charcoal hydrated for 2 hours at room temperature below 5 bar hydrogen. The catalyst was then sucked off and the filtrate evaporated in vacuo.

Utbytte: 8 g (81,8% av det teoretiske). Yield: 8 g (81.8% of the theoretical).

Rf-verdi: 0,5 (kiselgel, elueringsmiddel: metylenklorid/- Rf value: 0.5 (silica gel, eluent: methylene chloride/-

etanol/ammoniakk = 5:4:1). ethanol/ammonia = 5:4:1).

b) 3-hydroksymetyl-N-[3-(naftyl-2-oksy)-propyl]-heksahvdro- azepin- hvdroklorid b) 3-hydroxymethyl-N-[3-(naphthyl-2-oxy)-propyl]-hexahydro-azepine-hydrochloride

En blanding av 7,8 g (0,06 mol) 3-hydroksymetyl-heksahydro-azepin og 6,7 g (0,03 mol) 2-(3-klorpropoksy)-naftalen ble oppvarmet i 1 time til 120°C. Reaksjonsblandingen ble renset over kiselgel (0,063-0,2 mm) med A mixture of 7.8 g (0.06 mol) of 3-hydroxymethyl-hexahydro-azepine and 6.7 g (0.03 mol) of 2-(3-chloropropoxy)-naphthalene was heated for 1 hour at 120°C. The reaction mixture was purified over silica gel (0.063-0.2 mm) with

etylacetat/etanol/ammoniakk = 90:10:1. ethyl acetate/ethanol/ammonia = 90:10:1.

Utbytte: 2,3 g (24,3% av det teoretiske). Yield: 2.3 g (24.3% of the theoretical).

Smp.: 127-129°C. M.p.: 127-129°C.

c) 3-klormetyl-N-[3-(naftyl-2-oksy)-propyl]-heksahydro- azepin c) 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-hexahydroazepine

2,4 g (6,86 mmol) 3-hydroksymetyl-N-[3-(naftyl-2-oksy)-propyl]heksahydro-azepin-hydroklorid oppløst i 30 ml kloroform, ble tilsatt 5 ml tionylklorid og kokt under tilbakeløpskjøling i 1 time. Blandingen ble inndampet til tørrhet i vakuum. Residuet ble oppløst i metylenklorid, utristet med vann, 2 molar natronlut og deretter igjen med vann. Metylenklorid-fasen ble tørket over magnesiumsulfat og inndampet i vakuum. 2.4 g (6.86 mmol) of 3-hydroxymethyl-N-[3-(naphthyl-2-oxy)-propyl]hexahydro-azepine hydrochloride dissolved in 30 ml of chloroform, 5 ml of thionyl chloride was added and boiled under reflux in 1 hour. The mixture was evaporated to dryness in vacuo. The residue was dissolved in methylene chloride, shaken out with water, 2 molar caustic soda and then again with water. The methylene chloride phase was dried over magnesium sulfate and evaporated in vacuo.

Utbytte: 1,1 g (48,5% av det teoretiske), Yield: 1.1 g (48.5% of the theoretical),

Rf-verdi: 0,55 (kiselgel, elueringsmiddel: 5% etanol i metylenklorid). Rf value: 0.55 (silica gel, eluent: 5% ethanol in methylene chloride).

Eksempel E Example E

2~t(pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahvdro- isokinolin 2~t(pyrrolidyl-3)methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydroisoquinoline

a) N- benzyl- 2- pyrrolidon a) N-benzyl-2-pyrrolidone

Til 25,5 g (0,3 mol) 2-pyrrolidon i 300 ml absolutt To 25.5 g (0.3 mol) of 2-pyrrolidone in 300 ml of absolute

dimetylsulfoksyd, ble det porsjonsvis tilsatt 14,4 g dimethyl sulfoxide, 14.4 g were added in portions

(0,33 mol) 50% natriumhydrid-dispersjon i olje. Deretter ble blandingen omrørt i 5 timer ved 40-50°C og så ved 25-30°C dryppet inn 56,4 g = 39,2 ml (0,33 mol) benzylbromid. Etter omrøring i 10 timer ved romtemperatur ble reaksjonsblandingen (0.33 mol) 50% sodium hydride dispersion in oil. The mixture was then stirred for 5 hours at 40-50°C and then at 25-30°C 56.4 g = 39.2 ml (0.33 mol) of benzyl bromide were added dropwise. After stirring for 10 hours at room temperature, the reaction mixture was

oppløst i 500 ml etylacetat og utristet flere ganger med vann. Den organiske fase ble fraskilt, tørket over magnesiumsulfat, hvorpå oppløsningsmidlet ble fjernet i vakuum. Det oppnådde residuum ble renset over 900 g aluminiumoksyd (nøytral, aktivitet II) med metylenklorid og 0,1% etanol. dissolved in 500 ml ethyl acetate and shaken several times with water. The organic phase was separated, dried over magnesium sulfate, whereupon the solvent was removed in vacuo. The obtained residue was purified over 900 g of alumina (neutral, activity II) with methylene chloride and 0.1% ethanol.

Utbytte: 35,6 g (67,7% av det teoretiske), Yield: 35.6 g (67.7% of the theoretical),

Rf-verdi: 0,77 (aluminiumoksyd, nøytral, elueringsmiddel: 5% etanol i metylenklorid). Rf value: 0.77 (alumina, neutral, eluent: 5% ethanol in methylene chloride).

b) N- benzvl- 2- pyrrolidon- 3- karboksylsyre b) N-Benzyl-2-pyrrolidone-3-carboxylic acid

Til 28,3 g = 39,3 ml (0,28 mol) diisopropylamin i 400 ml To 28.3 g = 39.3 ml (0.28 mol) diisopropylamine in 400 ml

absolutt eter ble det under omrøring og under nitrogen ved -60°C tilsatt 150 ml 1,6 molar butyllitiumoppløsning i n-heksan. Til dette ble det ved -60°C dryppet inn 35,1 g (0,2 mol) N-benzyl-2-pyrrolidon oppløst i 150 ml absolutt eter. Kjølebadet ble fjernet, hvorpå det i 15 minutter ble ledet inn tørr karbondioksyd. Etter omrøring i 10 minutter ble blandingen helt over på is og den organiske fase fraskilt og utristet 2 ganger med 2 molar natronlut. De samlede vandige faser ble utristet 1 gang med eter og deretter under avkjøling surgjort med konsentrert saltsyre. Den vandige fase ble utristet 2 ganger med metylenklorid og etter tørking av den organiske fase over magnesiumsulfat, inndampet i vakuum. Utbytte; 35 g (79,8% av det teoretiske), absolute ether, 150 ml of 1.6 molar butyllithium solution in n-hexane was added with stirring and under nitrogen at -60°C. To this, 35.1 g (0.2 mol) of N-benzyl-2-pyrrolidone dissolved in 150 ml of absolute ether were added dropwise at -60°C. The cooling bath was removed, after which dry carbon dioxide was introduced for 15 minutes. After stirring for 10 minutes, the mixture was poured onto ice and the organic phase separated and decanted twice with 2 molar caustic soda. The combined aqueous phases were shaken once with ether and then acidified with concentrated hydrochloric acid while cooling. The aqueous phase was decanted twice with methylene chloride and, after drying the organic phase over magnesium sulphate, evaporated in vacuo. Dividend; 35 g (79.8% of the theoretical),

Rf-verdi: 0,42 (kiselgel, elueringsmiddel: 5% etanol i Rf value: 0.42 (silica gel, eluent: 5% ethanol in

metylenklorid). methylene chloride).

c) N- benzvl- 3- hvdroksvmetyl- pvrrolidin c) N-Benzyl-3-hydroxymethyl-pyrrolidine

Til 12,2 g (0,32 mol) litiumaluminiumhydrid i 350 ml To 12.2 g (0.32 mol) lithium aluminum hydride in 350 ml

absolutt tetrahydrofuran ble det under omrøring dryppet inn 35 g (0,16 mol) N-benzyl-2-pyrrolidon-3-karboksylsyre oppløst i 250 ml absolutt tetrahydrofuran. Etter koking under tilbakeløpskjøling i 6 timer ble det under kjøling med isvann tilsatt 18,2 ml vann, 12,2 ml 15% vandig natronlut og 3 6,6 ml vann. Det resulterende bunnfall ble suget av og vasket med tetrahydrofuran. De kombinerte filtratene ble inndampet i vakuum, hvoretter det oppnådde residuum ble renset over 900 g absolute tetrahydrofuran, 35 g (0.16 mol) of N-benzyl-2-pyrrolidone-3-carboxylic acid dissolved in 250 ml of absolute tetrahydrofuran were added dropwise while stirring. After boiling under reflux for 6 hours, 18.2 ml of water, 12.2 ml of 15% aqueous caustic soda and 36.6 ml of water were added while cooling with ice water. The resulting precipitate was suctioned off and washed with tetrahydrofuran. The combined filtrates were evaporated in vacuo, after which the residue obtained was purified over 900 g

aluminiumoksyd (nøytral, aktivitet II) med metylenklorid og deretter med økende andeler etanol (til 2%) . aluminum oxide (neutral, activity II) with methylene chloride and then with increasing proportions of ethanol (to 2%).

Utbytte: 16 g (52,3% av det teoretiske), Yield: 16 g (52.3% of the theoretical),

Rf-verdi: 0,42 (aluminiumoksyd, nøytral, elueringsmiddel: 5% Rf value: 0.42 (alumina, neutral, eluent: 5%

etanol i metylenklorid). ethanol in methylene chloride).

d. 3- ( ben2ensulfonyloksymetyl)- 1- benzyl- pvrrolidin d. 3-(benzenesulfonyloxymethyl)-1-benzylpyrrolidine

Til en blanding av 3,8 g (20 mmol) N-benzyl-3-hydroksymetyl-pyrrolidin og 3,7 ml (24 mmol) To a mixture of 3.8 g (20 mmol) N-benzyl-3-hydroxymethyl-pyrrolidine and 3.7 ml (24 mmol)

benzensulfonsyreklorid ble 40 ml 20% natronlut dråpevis tilsatt i løpet av 1 time. Blandingen ble tilsatt 150 ml toluen, den organiske fase vasket med vann, tørket over magnesiumsulfat og inndampet i vakuum til tørrhet. benzenesulfonic acid chloride, 40 ml of 20% caustic soda was added dropwise over the course of 1 hour. To the mixture was added 150 ml of toluene, the organic phase washed with water, dried over magnesium sulphate and evaporated in vacuo to dryness.

Utbytte: 5,9 g (89,4% av det teoretiske), Yield: 5.9 g (89.4% of the theoretical),

Rf-verdi: 0,4 (kiselgel, elueringsmiddel: 5% etanol i Rf value: 0.4 (silica gel, eluent: 5% ethanol in

metylenklorid). methylene chloride).

e. 2-[N- (benzyl-pyrrolidyl-3) -metyl]-6,7-dimetoksy-l-okso-1. 2, 3. 4- tetrahydro- isokinolin e. 2-[N-(benzyl-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1. 2, 3. 4-tetrahydro- isoquinoline

3,3 g (15,9 mmol) 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin ble oppløst i 50 ml dimetylsulfoksyd og under omrøring ved romtemperatur tilsatt 2 g (17,5 mmol) kalium-tert-butylat. Etter 1/2 time ble det til den resulterende kaliumsaltsuspensjon tilsatt 5,8 g (17,5 mmol) 3-benzensulfonyloksymetyl) -1-benzylpyrrolidin i 10 ml dimetylsulfoksyd og omrørt i 3 timer ved 60°C. Blandingen ble helt på isvann og ekstrahert med etylacetat. De samlede organiske faser ble vasket med vann og tørket over magnesiumsulfat. Den organiske fase ble inndampet i vakuum og det oppnådde residuum renset over 350 g aluminiumoksyd N (aktivitet II) med metylenklorid og deretter med økende andeler etanol (til 1%). 3.3 g (15.9 mmol) of 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline were dissolved in 50 ml of dimethyl sulfoxide and, with stirring at room temperature, added 2 g (17.5 mmol ) potassium tert-butylate. After 1/2 hour, 5.8 g (17.5 mmol) of 3-benzenesulfonyloxymethyl)-1-benzylpyrrolidine in 10 ml of dimethylsulfoxide was added to the resulting potassium salt suspension and stirred for 3 hours at 60°C. The mixture was poured into ice water and extracted with ethyl acetate. The combined organic phases were washed with water and dried over magnesium sulfate. The organic phase was evaporated in vacuo and the residue obtained purified over 350 g of alumina N (activity II) with methylene chloride and then with increasing proportions of ethanol (to 1%).

Utbytte: 3,3 g (54,4% av det teoretiske), Yield: 3.3 g (54.4% of the theoretical),

Rf-verdi: 0,74 (aluminiumoksyd N, elueringsmiddel: 5% etanol i metylenklorid). Rf value: 0.74 (alumina N, eluent: 5% ethanol in methylene chloride).

f. 2-[(pyrrolid-3-yl)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro- isokinolin f. 2-[(pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline

3,2 g (8,4 mmol) 2-[(N-benzyl-pyrrolid-3-yl)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin ble oppløst i 250 ml metanol og hydrert i nærvær av 1 g 20% palladium-hydroksyd/kull i 3 timer ved romtemperatur under 5 bar hydrogen. Katalysatoren ble deretter suget av og filtratet inndampet i vakuum til tørrhet. Residuet ble renset med 150 g kiselgel (0,063-0,2 mm) med metylenklorid/etanol/ammoniakk = 6:1:0,5). 3.2 g (8.4 mmol) of 2-[(N-benzyl-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline was dissolved in 250 ml of methanol and hydrated in the presence of 1 g of 20% palladium hydroxide/charcoal for 3 hours at room temperature under 5 bar hydrogen. The catalyst was then sucked off and the filtrate evaporated in vacuo to dryness. The residue was purified with 150 g of silica gel (0.063-0.2 mm) with methylene chloride/ethanol/ammonia = 6:1:0.5).

Utbytte: 0,9 g (37,5% av det teoretiske), Yield: 0.9 g (37.5% of the theoretical),

Rf-verdi: 0,6 (kiselgel, elueringsmiddel: metylenklorid/- Rf value: 0.6 (silica gel, eluent: methylene chloride/-

etanol/ammoniakk = 5:4:1). ethanol/ammonia = 5:4:1).

Eksempel F Example F

3- (p-toluensulfonyloksymetyl) -N-f [2- (6-metoksy-naftyl-2) -etyl] - pyrrol idin 3-(p-toluenesulfonyloxymethyl)-N-f[2-(6-methoxy-naphthyl-2)-ethyl]-pyrrolidine

a) 3- hydroksymetyl- pyrrolidin a) 3-hydroxymethyl-pyrrolidine

14 g (0,073 mol) N-benzyl-3-hydroksymetyl-pyrrolidin ble 14 g (0.073 mol) of N-benzyl-3-hydroxymethyl-pyrrolidine were

hydrert i 7 timer ved 50°C og 5 bar i 300 ml metanol i nærvær av 1,5 g 20% palladiumhydroksyd/aktivkull. Deretter ble katalysatoren suget av og filtratet inndampet i vakuum. Utbytte: 7,3 g (99% av det teoretiske). hydrated for 7 hours at 50°C and 5 bar in 300 ml of methanol in the presence of 1.5 g of 20% palladium hydroxide/activated carbon. The catalyst was then sucked off and the filtrate evaporated in vacuo. Yield: 7.3 g (99% of theoretical).

Massespektrum: Moltopp 101. Mass spectrum: Mole top 101.

i in

b. 3- hydroksymetyl- N- r 2-( 6- metoksynaftvl- 2) etyl]- pyrrolidin b. 3-hydroxymethyl-N-r2-(6-methoxynaphthyl-2)ethyl]-pyrrolidine

En blanding av 3,6 g (29,4 mmol) 3-hydroksymetyl-pyrrolidin og 4,7 g (14,7 mmol) 2-(2-brometyl)-6-metoksy-naf talen ble oppvarmet i 2 timer til 120°C. Reaksjonsblandingen ble renset over 200 g kiselgel (0,063-0,2 mm) med metylenklorid og deretter med økende andeler etanol (til 5%). Utbytte: 3,48 g (82,5% av det teoretiske), A mixture of 3.6 g (29.4 mmol) of 3-hydroxymethyl-pyrrolidine and 4.7 g (14.7 mmol) of 2-(2-bromomethyl)-6-methoxy-naphthalene was heated for 2 hours at 120 °C. The reaction mixture was purified over 200 g of silica gel (0.063-0.2 mm) with methylene chloride and then with increasing proportions of ethanol (to 5%). Yield: 3.48 g (82.5% of the theoretical),

Smp.: 121-123°C. M.p.: 121-123°C.

c) 3-(p-toluensulfonyloksymetyl)-N-[2-(6-metoksy-naftalen-2)- etyl1- pyrrolidin c) 3-(p-toluenesulfonyloxymethyl)-N-[2-(6-methoxy-naphthalene-2)-ethyl1-pyrrolidine

0,8 g (2,8 mmol) 3-hydroksymetyl-N-[2-(6-metoksy-naft-2-yl)-etyl]-pyrrolidin ble oppløst i 10 ml pyridin og under omrøring tilsatt 1,2 g (6,3 mmol) p-toluensulfonsyreklorid. Etter 2 timer ved romtemperatur ble blandingen inndampet til tørrhet i vakuum. Residuet ble oppløst i metylenklorid, vasket med 2 molar natronlut og vann. Den organiske fase ble deretter tørket over magnesiumsulfat og inndampet i vakuum. Residuet ble renset over 150 g kiselgel (0,063-0,2 mm) med etylacetat og deretter med økende andeler etanol. 0.8 g (2.8 mmol) of 3-hydroxymethyl-N-[2-(6-methoxy-naphth-2-yl)-ethyl]-pyrrolidine was dissolved in 10 ml of pyridine and, with stirring, added 1.2 g ( 6.3 mmol) p-toluenesulfonic acid chloride. After 2 hours at room temperature, the mixture was evaporated to dryness in vacuo. The residue was dissolved in methylene chloride, washed with 2 molar caustic soda and water. The organic phase was then dried over magnesium sulfate and evaporated in vacuo. The residue was purified over 150 g of silica gel (0.063-0.2 mm) with ethyl acetate and then with increasing proportions of ethanol.

Utbytte: 0,6 g (48,8% av det teoretiske), Yield: 0.6 g (48.8% of the theoretical),

Rf-verdi: 0,45 (kiselgel, elueringsmiddel: 5% etanol i metylenklorid). Rf value: 0.45 (silica gel, eluent: 5% ethanol in methylene chloride).

Eksempel G Example G

2-[(azacyklooktyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro- isokinolin 2-[(azacyclooctyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline

a) l- benzyl- 2- okso- azacyklooktan a) 1-benzyl-2-oxo-azacyclooctane

25 g (0,196 mol) 2-azacyklooktanon ble oppløst i 150 ml 25 g (0.196 mol) of 2-azacyclooctanone was dissolved in 150 ml

dimetylsulfoksyd og under omrøring tilsatt 24,2 g (0,216 mol) kalium-tert-butylat og omrørt i 1/2 time ved 40°C. Deretter ble 24 ml (0,2 mol) benzylbromid tilsatt dråpevis i løpet av 1/4 time, hvorved temperaturen steg til 80°C. Blandingen ble omrørt i 2 timer, hvorved reaksjonstemperaturen igjen sank til romtemperatur. Reaksjonsblandingen ble helt over i 1 liter isvann og utristet fire ganger med 150 ml porsjoner etylacetat. De samlede organiske fasene ble vasket med vann, tørket over magnesiumsulfat og inndampet i vakuum. dimethyl sulfoxide and, with stirring, added 24.2 g (0.216 mol) of potassium tert-butylate and stirred for 1/2 hour at 40°C. Then 24 ml (0.2 mol) of benzyl bromide were added dropwise over 1/4 hour, whereby the temperature rose to 80°C. The mixture was stirred for 2 hours, whereby the reaction temperature again dropped to room temperature. The reaction mixture was poured into 1 liter of ice water and shaken four times with 150 ml portions of ethyl acetate. The combined organic phases were washed with water, dried over magnesium sulfate and evaporated in vacuo.

Utbytte: 42,7 g (100% av det teoretiske), Yield: 42.7 g (100% of the theoretical),

Rf-verdi: 0,55 (kiselgel, elueringsmiddel: 5% etanol i Rf value: 0.55 (silica gel, eluent: 5% ethanol in

metylenklorid). methylene chloride).

b) l- benzvl- azacyklooktan- 2- okso- 3- karboksylsyre b) 1-Benzyl-azacyclooctane-2-oxo-3-carboxylic acid

Til-26,7 g = 38,4 ml (0,26 mol) diisopropylamin i 250 ml To-26.7 g = 38.4 ml (0.26 mol) diisopropylamine in 250 ml

absolutt eter ble det under omrøring under nitrogen dryppet inn 147 ml 1,6 molar bytyllitiumoppløsning i n-heksan ved -60°C. Deretter ble det ved -60°C dråpevis tilsatt 42,7 g (0,196 mol) l-benzyl-2-okso-azacyklooktan i 100 ml absolutt eter. Etter 10 minutter ble tørr karbondioksyd ledet inn i 20 minutter. Reaksjonsblandingen ble helt over på is, eterfasen fraskilt og utristet to ganger med 2 molar natronlut. De samlede vandige faser ble utristet én gang med eter og deretter under kjøling surgjort med konsentrert saltsyre. De ble utristet tre ganger med metylenklorid, hvoretter metylenkloridfasen ble tørket over magnesiumsulfat og inndampet i vakuum. absolute ether, 147 ml of 1.6 molar butyllithium solution in n-hexane at -60°C were added dropwise while stirring under nitrogen. Then, at -60°C, 42.7 g (0.196 mol) of 1-benzyl-2-oxo-azacyclooctane in 100 ml of absolute ether were added dropwise. After 10 minutes, dry carbon dioxide was introduced for 20 minutes. The reaction mixture was poured onto ice, the ether phase separated and decanted twice with 2 molar caustic soda. The combined aqueous phases were decanted once with ether and then, under cooling, acidified with concentrated hydrochloric acid. They were shaken three times with methylene chloride, after which the methylene chloride phase was dried over magnesium sulfate and evaporated in vacuo.

Utbytte: 25,9 g (50,6% av det teoretiske), Yield: 25.9 g (50.6% of the theoretical),

Rf-verdi: 0,15 (aluminiumoksyd, elueringsmiddel: 5% etanol i Rf value: 0.15 (alumina, eluent: 5% ethanol in

metylenklorid). methylene chloride).

c) l- benzyl- 3- hvdroksymetyl- azacvklooktan c) 1- benzyl- 3- hydroxymethyl- azacvcloctane

Til 22,7 g (0,6 mol) litiumaluminiumhydrid i 800 ml To 22.7 g (0.6 mol) lithium aluminum hydride in 800 ml

absolutt eter ble det under omrøring dryppet inn 53,6 g (0,205 mol) l-benzyl-2-okso-azacyklooktan-3-karboksylsyre oppløst i 100 ml absolutt tetrahydrofuran. Etter 1/2 times koking under tilbakeløpskjøling ble det under kjøling med isvann, tilsatt 28,4 ml vann, 19 ml 15% natronlut og 57 ml vann. Det resulterende bunnfall ble suget av og vasket med tetrahydrofuran. De samlede filtrater ble inndampet i vakuum og det oppnådde residuum renset over 700 g aluminiumoksyd (nøytral, aktivitet II) med 1% etanol i metylenklorid: Utbytte: 9,3 g (19,6% av det teoretiske), absolute ether, 53.6 g (0.205 mol) of 1-benzyl-2-oxo-azacyclooctane-3-carboxylic acid dissolved in 100 ml of absolute tetrahydrofuran were added dropwise while stirring. After 1/2 hour of boiling under reflux cooling, 28.4 ml of water, 19 ml of 15% caustic soda and 57 ml of water were added while cooling with ice water. The resulting precipitate was suctioned off and washed with tetrahydrofuran. The combined filtrates were evaporated in vacuo and the obtained residue purified over 700 g of alumina (neutral, activity II) with 1% ethanol in methylene chloride: Yield: 9.3 g (19.6% of the theoretical),

Rf-verdi: 0,5 (kiselgel, elueringsmiddel: 5% etanol i Rf value: 0.5 (silica gel, eluent: 5% ethanol in

metylenklorid). methylene chloride).

d) 1- benzvi- 3- klormety1- azacyklooktan d) 1- benzzi- 3- chloromethyl-azacyclooctane

9,3 g (39,8 mmol) l-benzyl-3-hydroksymetyl-azacyklooktan 9.3 g (39.8 mmol) of 1-benzyl-3-hydroxymethyl-azacyclooctane

i 30 ml pyridin ble tilsatt 10 ml (79,6 mmol) in 30 ml of pyridine was added 10 ml (79.6 mmol)

benzensulfonsyreklorid og omrørt ved romtemperatur i 2,5 timer. Reaksjonsblandingen ble inndampet i vakuum. Det gjenværende residuum ble oppløst i 150 ml metylenklorid, vasket med 2N natronlut og deretter med vann. Den organiske fase ble tørket over magnesiumsulfat, inndampet til tørrhet og benzenesulfonic acid chloride and stirred at room temperature for 2.5 hours. The reaction mixture was evaporated in vacuo. The remaining residue was dissolved in 150 ml of methylene chloride, washed with 2N caustic soda and then with water. The organic phase was dried over magnesium sulfate, evaporated to dryness and

renset over 150 g kiselgel (0,063-0,2 mm) med metylenklorid. Utbytte: 3,5 g (35% av det teoretiske), purified over 150 g of silica gel (0.063-0.2 mm) with methylene chloride. Yield: 3.5 g (35% of the theoretical),

Rf-verdi: 0,75 (kiselgel, elueringsmiddel: 5% etanol i Rf value: 0.75 (silica gel, eluent: 5% ethanol in

metylenklorid). methylene chloride).

e) 2-[(N-benzyl-azacyklooktyl-3)-metyl]-6,7-dimetoksy-l-okso- 1. 2, 3, 4- tetrahvdro- isokinolin e) 2-[(N-benzyl-azacyclooctyl-3)-methyl]-6,7-dimethoxy-1-oxo-1.2,3,4-tetrahydro-isoquinoline

2,3 g (11,1 mmol) 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin ble oppløst i 40 ml dimetylsulfoksyd og under omrøring tilsatt 1,33 g (12,2 mmol) kalium-tert-butylat. Etter 1/2 time ble den oppnådde kaliumsaltsuspensjon tilsatt 3,5 g (9,4 mmol) l-benzyl-3-klormetyl-azacyklooktan i 40 ml dimetylsulfoksyd og omrørt i 2,5 timer ved 120°C. Blandingen ble helt over i isvann og ekstrahert tre ganger med 50 ml porsjoner etylacetat. De samlede organiske faser ble vasket med vann, tørket over magnesiumsulfat og inndampet i vakuum. Det oppnådde residuum ble renset over 150 g kiselgel (0,063-0,2 mm) med 1% etanol i metylenklorid. 2.3 g (11.1 mmol) of 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline were dissolved in 40 ml of dimethyl sulfoxide and, with stirring, added 1.33 g (12.2 mmol ) potassium tert-butylate. After 1/2 hour, the obtained potassium salt suspension was added with 3.5 g (9.4 mmol) of 1-benzyl-3-chloromethyl-azacyclooctane in 40 ml of dimethylsulfoxide and stirred for 2.5 hours at 120°C. The mixture was poured into ice water and extracted three times with 50 ml portions of ethyl acetate. The combined organic phases were washed with water, dried over magnesium sulfate and evaporated in vacuo. The obtained residue was purified over 150 g of silica gel (0.063-0.2 mm) with 1% ethanol in methylene chloride.

Utbytte: 1 g (25,1% av det teoretiske), Yield: 1 g (25.1% of the theoretical),

Rf-verdi: 0,5 (kiselgel, elueringsmiddel: 2% etanol i Rf value: 0.5 (silica gel, eluent: 2% ethanol in

metylenklorid). methylene chloride).

f) 2-[(azacyklooktyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahvdro- isokinolin f) 2-[(azacyclooctyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydroisoquinoline

0,85 g (2 mmol) 2-[(N-benzyl-azacyklooktyl-3)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin i 50 ml metanol, ble hydrert i nærvær av 0,85 g 20% 0.85 g (2 mmol) 2-[(N-benzyl-azacyclooctyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline in 50 ml methanol, was hydrated in the presence of 0.85 g of 20%

palladiumhydroksyd/kull i 4,5 timer ved romtemperatur og 5 bar hydrogen. Katalysatoren ble deretter suget av og filtratet inndampet til tørrhet. palladium hydroxide/charcoal for 4.5 hours at room temperature and 5 bar hydrogen. The catalyst was then sucked off and the filtrate evaporated to dryness.

Utbytte: 0,5 g (74,6% av det teoretiske), Yield: 0.5 g (74.6% of the theoretical),

Rf-verdi: 0,45 (kiselgel, elueringsmiddel: 25% etanol i metylenklorid og 1 dråpe ammoniakk). Rf value: 0.45 (silica gel, eluent: 25% ethanol in methylene chloride and 1 drop of ammonia).

Eksempel H Example H

1- klor-3-TN-( 4- metoksv- fenyl)- metylaminol- propan 1- chloro-3-TN-(4- methoxyphenyl)- methylaminol- propane

10 g (0,073 mol) N-metyl-4-metoksy-anilin ble oppløst i 50 ml dimetylsulfoksyd og under omrøring tilsatt 9 g (0,08 mol) kalium-tert-butylat. Etter 1/2 time ble 10 ml l-brom-3-klorpropan tilsatt og omrøringen fortsatt i 3 timer ved romtemperatur. Blandingen ble helt i isvann, utristet med etylacetat, hvorpå den organiske fase ble vasket med vann, tørket over natriumsulfat og inndampet til tørrhet. Residuet ble renset over kiselgel (0,063-0,2 mm) med metylenklorid. Utbytte: 9,1 g (58,3% av det teoretiske), 10 g (0.073 mol) of N-methyl-4-methoxy-aniline were dissolved in 50 ml of dimethylsulfoxide and 9 g (0.08 mol) of potassium tert-butylate were added while stirring. After 1/2 hour, 10 ml of 1-bromo-3-chloropropane was added and stirring continued for 3 hours at room temperature. The mixture was poured into ice water, decanted with ethyl acetate, after which the organic phase was washed with water, dried over sodium sulfate and evaporated to dryness. The residue was purified over silica gel (0.063-0.2 mm) with methylene chloride. Yield: 9.1 g (58.3% of the theoretical),

Rf-verdi: 0,55 (kiselgel, elueringsmiddel: Rf value: 0.55 (silica gel, eluent:

metyletylketon/xylen =1:6). methyl ethyl ketone/xylene =1:6).

Beregnet: C, 61,82; H, 7,55; N, 6,55; Cl, 16,59 Funnet: C, 61,71; H, 7,88; N, 6,69; Cl, 16,24 Calculated: C, 61.82; H, 7.55; N, 6.55; Cl, 16.59 Found: C, 61.71; H, 7.88; N, 6.69; Cl, 16.24

Eksempel I Example I

2- [(N-3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-5,6-metylendioksy- f tal imid 2-[(N-3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-5,6-methylenedioxy-phthalimide

2,1 g (0,011 mol) 5,6-metylendioksy-ftalimid ble oppløst i 100 ml dimetylsulfoksyd og under omrøring tilsatt 1,25 g (0,012 mol) kalium-tert-butylat. Kaliumsaltet falt derved ut. Omrøringen ble fortsatt i 1/2 time ved romtemperatur, og en oppløsning av 2,5 g (0,01 mol) 3-klormety1-N-(3-(pyridyl-3)-propyl)-piperidin i 20 ml dimetylsulfoksyd ble tilsatt og blandingen oppvarmet til 120°C i 8 timer. Blandingen ble helt over i isvann, utristet tre ganger med 150 ml porsjoner etylacetat og den organiske fase etter tørking over magnesiumsulfat, inndampet i vakuum. Residuet ble renset over 200 g kiselgel (0,063-0,2 mm) med etylacetat/etanol/ammoniakk = 80:10:0,5). 2.1 g (0.011 mol) of 5,6-methylenedioxyphthalimide was dissolved in 100 ml of dimethylsulfoxide and, with stirring, 1.25 g (0.012 mol) of potassium tert-butylate was added. The potassium salt thereby precipitated out. Stirring was continued for 1/2 hour at room temperature, and a solution of 2.5 g (0.01 mol) of 3-chloromethyl-N-(3-(pyridyl-3)-propyl)-piperidine in 20 ml of dimethylsulfoxide was added and the mixture heated to 120°C for 8 hours. The mixture was poured into ice water, shaken three times with 150 ml portions of ethyl acetate and the organic phase, after drying over magnesium sulfate, evaporated in vacuo. The residue was purified over 200 g of silica gel (0.063-0.2 mm) with ethyl acetate/ethanol/ammonia = 80:10:0.5).

Utbytte: 3 g (74% av det teoretiske). Yield: 3 g (74% of the theoretical).

Beregnet (2 x HC1): C, 55,42; H, 5,86; N, 8,43; Cl, 14,22 Funnet: C, 55,28; H, 6,06; N, 8,26; Cl, 14,64 Calcd (2 x HCl): C, 55.42; H, 5.86; N, 8.43; Cl, 14.22 Found: C, 55.28; H, 6.06; N, 8.26; Cl, 14.64

Eksempel K 2- [ (N-3-klorpropyl)-3-piperidyl-metyl]-6,7-dimetoksy-l-okso-1, 2, 3, 4- tetrahydro- isokinolin 3 g (0,01 mol) 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l , 2 , 3 , 4-tetrahydro-isokinolin ble oppløst i 50 ml dimetylsulfoksyd og under omrøring tilsatt 1,3 g (0,011 mol) kalium-tert-butylat. Etter 1/2 time ble 3 ml l-brom-3-klorpropan tilsatt og omrøring ved romtemperatur foretatt i 1 time. Blandingen ble helt over i isvann, ekstrahert med etylacetat, hvoretter den organiske fase ble vasket med vann, tørket over natriumsulfat og inndampet i vakuum til tørrhet. Utbytte: 2,7 g (71% av det teoretiske), Example K 2-[(N-3-chloropropyl)-3-piperidyl-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline 3 g (0.01 mol) 2 -[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline was dissolved in 50 ml of dimethylsulfoxide and, with stirring, added 1.3 g (0.011 mol) potassium tert-butylate. After 1/2 hour, 3 ml of 1-bromo-3-chloropropane was added and stirring at room temperature was carried out for 1 hour. The mixture was poured into ice water, extracted with ethyl acetate, after which the organic phase was washed with water, dried over sodium sulfate and evaporated in vacuo to dryness. Yield: 2.7 g (71% of theoretical),

Rf-verdi: 0,65 (kiselgel, elueringsmiddel: etylacetat/etanol/- Rf value: 0.65 (silica gel, eluent: ethyl acetate/ethanol/-

ammoniakk = 50:45:5). ammonia = 50:45:5).

Eksempel 1 Example 1

2 -[ (N- (3-(2-naftyl)-propyl)-3-piperidyl)-metyl]-6,7-dimetoksy-1- okso- l. 2, 3. 4- tetrahydro- isokinolin- hydroklorid 2 -[ (N-(3-(2-naphthyl)-propyl)-3-piperidyl)-methyl]-6,7-dimethoxy-1-oxo- l. 2, 3. 4- tetrahydro- isoquinoline- hydrochloride

En blanding av 1 g (3,2 mmol) 2-(piperidyl-3-metyl)-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin, 5 ml dimetylsulfoksyd, 0,5 g (0,36 mmol) kaliumkarbonat og 0,75 g (3,66 mmol) 2-(3-klorpropyl)-naftalen ble oppvarmet i 3 timer til 120°C. Reaksjonsblandingen ble helt over i isvann og utristet tre ganger med 50 ml porsjoner etylacetat. De samlede organiske fasene ble vasket med 2 molar natronlut og deretter med vann, tørket over magnesiumsulfat og inndampet i vakuum, hvoretter det oppnådde residuum ble renset over kiselgel (0,063-0,2 mm) med 1% etanol i metylenklorid. Fra en acetonoppløsning ble hydrokloridet utfelt med eterisk saltsyre og krystallisert fra aceton. A mixture of 1 g (3.2 mmol) 2-(piperidyl-3-methyl)-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 5 ml dimethylsulfoxide, 0.5 g (0.36 mmol) of potassium carbonate and 0.75 g (3.66 mmol) of 2-(3-chloropropyl)-naphthalene were heated for 3 hours at 120°C. The reaction mixture was poured into ice water and shaken three times with 50 ml portions of ethyl acetate. The combined organic phases were washed with 2 molar caustic soda and then with water, dried over magnesium sulfate and evaporated in vacuo, after which the residue obtained was purified over silica gel (0.063-0.2 mm) with 1% ethanol in methylene chloride. From an acetone solution, the hydrochloride was precipitated with ethereal hydrochloric acid and crystallized from acetone.

Utbytte: 0,74 g (44% av det teoretiske). Yield: 0.74 g (44% of theoretical).

Smp.: 179-181°C. M.p.: 179-181°C.

Beregnet: C, 70,77; H, 7,37; N, 5,50; Cl, 6,96 Calculated: C, 70.77; H, 7.37; N, 5.50; Cl, 6.96

Funnet: C, 70,47; H, 7,40; N, 5,47; Cl, 7,06. Found: C, 70.47; H, 7.40; N, 5.47; Cl, 7.06.

Eksempel 2 2-[(N-3-(naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-1,2,3,4-tetrahydro-isokinolin-hydroklorid-hydrat Example 2 2-[(N-3-(naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline -hydrochloride hydrate

1,58 g (9 mmol) 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin ble oppløst i 30 ml dimetylsulfoksyd og under omrøring tilsatt 1,1 g (9,9 mmol) kalium-tert-butylat. Etter 1 time ble en oppløsning av 2,9 g (9,1 mmol) 3-klormetyl-N-[3-(naftyl-2-oksy)-propyl]-piperidin i 10 ml dimetylsulfoksyd tilsatt og reaksjonsblandingen omrørt i 16 timer ved 80°C. Blandingen ble derpå helt over i isvann, utristet tre ganger med 50 ml etylacetat og den organiske fase vasket med vann, tørket over magnesiumsulfat og etter inndampning, renset over kiselgel (0,063-0,2 mm) med etylacetat/etanol/ammoniakk = 95:5:0,5). Fra en acetonoppløsning ble hydrokloridet oppnådd som hydrat med eterisk saltsyre. 1.58 g (9 mmol) of 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline was dissolved in 30 ml of dimethylsulfoxide and, while stirring, 1.1 g (9.9 mmol) of potassium was added -tert-butylate. After 1 hour, a solution of 2.9 g (9.1 mmol) of 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-piperidine in 10 ml of dimethyl sulfoxide was added and the reaction mixture was stirred for 16 hours at 80°C. The mixture was then poured into ice water, shaken three times with 50 ml of ethyl acetate and the organic phase washed with water, dried over magnesium sulfate and, after evaporation, purified over silica gel (0.063-0.2 mm) with ethyl acetate/ethanol/ammonia = 95: 5:0.5). From an acetone solution, the hydrochloride was obtained as a hydrate with ethereal hydrochloric acid.

i in

Utbytte: 2 g (45,1% av det teoretiske). Yield: 2 g (45.1% of the theoretical).

Smp.: 152-154°C. M.p.: 152-154°C.

Beregnet: C, 70,50; H, 7,69; N, 5,49; Cl, 6,93 Calculated: C, 70.50; H, 7.69; N, 5.49; Cl, 6.93

Funnet: C, 70,31; H, 7,52; N, 5,49; Cl, 7,10 Found: C, 70.31; H, 7.52; N, 5.49; Cl, 7.10

Eksempel 3 Example 3

2-[(N-(3-(naftyl-2)-propyl)-piperidyl-3) -metyl]-6,7-dimetyl-1. 2. 3, 4- tetrahydro- isokinolin- dihvdroklorid 2-[(N-(3-(naphthyl-2)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1. 2. 3, 4- tetrahydro- isoquinoline- dihydrochloride

0,8 g (18 mmol) 2-[(N-(3-(naftyl-2)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin ble oppløst i 10 ml absolutt tetrahydrofuran og 20 ml absolutt eter, tilsatt 70 mg (18 mmol) litiumaluminiumhydrid og kokt under tilbakeløpskjøling i 1 time. Reaksjonsblandingen ble tilsatt 5 ml mettet vandig natriumsulfatoppløsning, det utfelte natriumsulfat frafiltrert og vasket med tetrahydrofuran. Filtratet ble tørket over magnesiumsulfat og etter inndampning, renset over 150 g kiselgel (0,063-0,2 mm) med etylacetat/etanol/ammoniakk =90:10:0,05). Fra en acetonoppløsning ble hydrokloridet utfelt med eterisk saltsyre. 0.8 g (18 mmol) 2-[(N-(3-(naphthyl-2)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3, 4-tetrahydro-isoquinoline was dissolved in 10 ml absolute tetrahydrofuran and 20 ml absolute ether, added 70 mg (18 mmol) lithium aluminum hydride and refluxed for 1 hour. 5 ml of saturated aqueous sodium sulfate solution was added to the reaction mixture, the precipitated sodium sulfate was filtered off and washed with tetrahydrofuran. The filtrate was dried over magnesium sulfate and, after evaporation, purified over 150 g of silica gel (0.063-0.2 mm) with ethyl acetate/ethanol/ammonia =90:10:0.05). From an acetone solution, the hydrochloride was precipitated with ethereal hydrochloric acid.

Utbytte: 0,49 g (54,4% av det teoretiske). Yield: 0.49 g (54.4% of theoretical).

Smp.: 148-150°C. Melting point: 148-150°C.

Beregnet: C, 69,61; H, 8,18; N, 5,41; Cl, 13,70 Calculated: C, 69.61; H, 8.18; N, 5.41; Cl, 13.70

Funnet: C, 69,46; H, 8,32; N, 5,26; Cl, 14,17 Found: C, 69.46; H, 8.32; N, 5.26; Cl, 14,17

Eksempel 4 Example 4

2- [(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-5,6-metvlendioksv- l- okso- 1, 3- dihvdro- isoindol- dihvdroklorid 2- [(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-5,6-methylenedioxy- l- oxo- 1, 3- dihydro-isoindole- dihydrochloride

2,4 g (5,9 mmol) 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-5,6-metylendioksy-ftalimid ble oppløst i 50 ml iseddik og kokt under tilbakeløpskjøling i 5 timer. Med 1 times mellomrom ble det tilsatt 1 g sinkstøv. Etter endt reaksjonstid ble det foretatt avsugning og inndamping med etanol. Residuet ble oppløst i metylenklorid, utristet med konsentrert ammoniakk, tørket over magnesiumsulfat og etter inndampning i vakuum, renset over 150 g kiselgel (0,063- 2.4 g (5.9 mmol) of 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-5,6-methylenedioxyphthalimide was dissolved in 50 ml of glacial acetic acid and boiled under reflux for 5 hours. At 1-hour intervals, 1 g of zinc dust was added. After the end of the reaction time, aspiration and evaporation with ethanol was carried out. The residue was dissolved in methylene chloride, shaken out with concentrated ammonia, dried over magnesium sulfate and, after evaporation in a vacuum, purified over 150 g of silica gel (0.063-

0,2 mm) med etylacetat/etanol/ammoniakk = 90:10:0,2). Fra en acetonoppløsning ble hydrokloridet utfelt. 0.2 mm) with ethyl acetate/ethanol/ammonia = 90:10:0.2). From an acetone solution the hydrochloride was precipitated.

Utbytte: 2,05 g (75% av det teoretiske). Yield: 2.05 g (75% of the theoretical).

Smp.: 165-167°C. M.p.: 165-167°C.

Beregnet: C, 59,22; H, 6,27; N, 9,00; Cl, 15,20 Calculated: C, 59.22; H, 6.27; N, 9.00; Cl, 15,20

Funnet: C, 59,03; H, 6,45; N, 8,85; Cl, 15,06 Found: C, 59.03; H, 6.45; N, 8.85; Cl, 15.06

Eksempel 5 Example 5

3- [(N-(3-(pyridyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzoazepin-dihydroklorid 3- [(N-(3-(pyridyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzoazepine dihydrochloride

1,1 g (2,6 mmol) 3-[(N-(3-(pyridyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzoazepin, oppløst i 50 ml etanol, ble hydrert i 2 timer i nærvær av 1 g 10% palladium på aktivkull ved 80°C og 5 bar hydrogen. Deretter ble katalysatoren suget av og filtratet etter inndampning i vakuum, renset over 100 g kiselgel (0,063-0,2 mm) med etylacetat/etanol/ammoniakk = 80:40:1). Fra en acetonoppløsning ble hydrokloridet utfelt. 1.1 g (2.6 mmol) 3-[(N-(3-(pyridyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3- dihydro-2H-3-benzoazepine, dissolved in 50 ml of ethanol, was hydrogenated for 2 hours in the presence of 1 g of 10% palladium on activated carbon at 80°C and 5 bar of hydrogen. The catalyst was then sucked off and the filtrate, after evaporation in vacuum, purified over 100 g of silica gel (0.063-0.2 mm) with ethyl acetate/ethanol/ammonia = 80:40:1). From an acetone solution the hydrochloride was precipitated.

Utbytte: 0,37 g (33% av det teoretiske). Yield: 0.37 g (33% of theoretical).

Smp.: 96-98°C. M.p.: 96-98°C.

Beregnet: C, 60,42; H, 7,11; N, 8,46; Cl, 14,28 Calculated: C, 60.42; H, 7.11; N, 8.46; Cl, 14.28

Funnet: C, 60,35; H, 7,46; N, 8,43; Cl, 14,58 Found: C, 60.35; H, 7.46; N, 8.43; Cl, 14.58

Eksempel 6 Example 6

2-[(N-(2-(4-amino-fenyl)-etyl)-piperidyl-3) -metyl]-5,6-dimetoksv- l- okso- 1. 3- dihydro- isoindol- dihydroklorid 2-[(N-(2-(4-amino-phenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy- l - oxo- 1. 3- dihydro- isoindole- dihydrochloride

2,1 g (4,78 mmol) 2-[(N-(2-(4-nitro-fenyl)-etyl)-piperidyl-3) -metyl ] -5,6-dimetoksy-l-okso-l, 3-dihydro-isoindol ble oppløst i 50 ml iseddik og under omrøring tilsatt 0,4 ml (8,22 mmol) hydrazin-hydrat og 1 spatelspiss Raney-nikkel. Tilsetningen av 0,2 ml hydrazin-hydrat og en spatelspiss Raney-nikkel ble gjentatt tre ganger med 1 times mellomrom. Katalysatoren ble suget av og vasket med metanol, hvorpå filtratet ble tørket med magnesiumsulfat og inndampet i vakuum og det oppnådde residuum renset over aluminiumoksyd (nøytral, aktivitet II) med metylenklorid og deretter med økende andeler etanol. 2.1 g (4.78 mmol) 2-[(N-(2-(4-nitro-phenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1, 3-dihydro-isoindole was dissolved in 50 ml of glacial acetic acid and, with stirring, added 0.4 ml (8.22 mmol) of hydrazine hydrate and 1 spatula tip of Raney nickel. The addition of 0.2 ml of hydrazine hydrate and a Raney nickel spatula tip was repeated three times at 1 hour intervals. The catalyst was sucked off and washed with methanol, after which the filtrate was dried with magnesium sulfate and evaporated in vacuo and the residue obtained purified over aluminum oxide (neutral, activity II) with methylene chloride and then with increasing proportions of ethanol.

Utbytte: 1,8 g (91,8% av det teoretiske). Yield: 1.8 g (91.8% of the theoretical).

1 g ble oppløst i aceton og dihydrokloridet ble utfelt med eterisk saltsyre. 1 g was dissolved in acetone and the dihydrochloride was precipitated with ethereal hydrochloric acid.

Utbytte: 1,02 g (86,4% av det teoretiske med henblikk på basen). Yield: 1.02 g (86.4% of theoretical with respect to the base).

Smp.: 232-235°C. M.p.: 232-235°C.

Beregnet: C, 59,72; H, 6,89; N, 8,71; Cl, 14,69 Calcd: C, 59.72; H, 6.89; N, 8.71; Cl, 14.69

Funnet: C, 59,54; H, 7,08; N, 8,56; Cl, 14,45 Found: C, 59.54; H, 7.08; N, 8.56; Cl, 14.45

Eksempel 7 Example 7

2-[(N-(2-(4-acetamino-fenyl)-etyl)-piperidyl-3)-metyl]-5,6-dimetoksv- l- okso- l. 3- dihvdro- isoindol 2-[(N-(2-(4-acetamino-phenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-l-oxo-l. 3-dihydro-isoindole

819 mg (2 mmol) 2-[(N-(2-(4-amino-fenyl)-etyl)-piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-l,3-dihydro-isoindol i 10 ml metylenklorid ble, etter tilsetning av 0,3 ml (2,2 mmol) trietylamin, dråpevis tilsatt 0,16 ml (2,2 mmol) acetylklorid. Herved steg reaksjonstemperaturen til 30°C. Blandingen ble omrørt i 1/2 time ved romtemperatur, utristet to ganger med vann og den organiske fase tørket over magnesiumsulfat og 819 mg (2 mmol) 2-[(N-(2-(4-amino-phenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro- isoindole in 10 ml of methylene chloride, after the addition of 0.3 ml (2.2 mmol) of triethylamine, 0.16 ml (2.2 mmol) of acetyl chloride was added dropwise. This raised the reaction temperature to 30°C. The mixture was stirred for 1/2 hour at room temperature, shaken out twice with water and the organic phase dried over magnesium sulfate and

inndampet i vakuum. Residuet ble krystallisert fra aceton. Utbytte: 660 mg (73,2% av det teoretiske). evaporated in vacuum. The residue was crystallized from acetone. Yield: 660 mg (73.2% of the theoretical).

Smp.: 195-196°C. M.p.: 195-196°C.

Beregnet: C, 69,16; H, 7,37; N, 9,31 Calculated: C, 69.16; H, 7.37; N, 9.31

Funnet: C, 69,33; H, 7,11; N, 9,16 Found: C, 69.33; H, 7.11; N, 9.16

Eksempel 8 Example 8

3-[ (N- (3- (furyl-2) -propyl) -piperidyl-3) -metyl]-7,8-dimetoksy-2- okso- l , 3, 4, 5- tetrahvdro- 2H- 3- benzazepin- hydroklorid 3-[ (N-(3-(furyl-2)-propyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzazepine hydrochloride

3,2 g (0,010 mol) 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin i 100 ml absolutt etanol ble hydrert i 2 dager i nærvær av 1,3 g (0,010 mol) 3-(furyl-2)-propanal og 1 g Raney-nikkel ved 80°C ved 5 bar. Katalysatoren ble suget av, filtratet inndampet og renset over en kiselgelsøyle med metylenklorid/metanol som eluent. Hydrokloridet ble utfelt med eterisk saltsyre og krystallisert fra aceton. 3.2 g (0.010 mol) 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine in 100 ml absolute ethanol was hydrated for 2 days in the presence of 1.3 g (0.010 mol) 3-(furyl-2)-propanal and 1 g Raney nickel at 80°C at 5 bar. The catalyst was sucked off, the filtrate evaporated and purified over a silica gel column with methylene chloride/methanol as eluent. The hydrochloride was precipitated with ethereal hydrochloric acid and crystallized from acetone.

Utbytte: 0,50 g (11% av det teoretiske). Yield: 0.50 g (11% of the theoretical).

Smp.: 204-206°C. M.p.: 204-206°C.

Beregnet: C, 64,85; H, 7,62; N, 6,05, Cl, 7,66 Calcd: C, 64.85; H, 7.62; N, 6.05, Cl, 7.66

Funnet: C, 64,88; H, 7,76; N, 5,93; Cl, 7,55 Found: C, 64.88; H, 7.76; N, 5.93; Cl, 7.55

Rf-verdi: 0,69 (kiselgel; metylenklorid/metanol = 10:1; Rf value: 0.69 (silica gel; methylene chloride/methanol = 10:1;

ammoniakk/atmosfære). ammonia/atmosphere).

Eksempel 9 Example 9

2- [ (N- (3- (3-metylf enoksy) -propyl) -piperidyl-3) -metyl ] -6, 7-dimetoksv- 1. 2. 3, 4- tetrahvdro- isokinolin- dihydroklorid 2- [ (N-(3-(3-methylphenoxy)-propyl)-piperidyl-3)-methyl]-6, 7-dimethoxy- 1. 2. 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremst i11et fra 2-[(N-(3-(3-metylfenoksy)-propyl) - piperidyl-3) -metyl ] -6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Mainly from 2-[(N-(3-(3-methylphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3.

Utbytte: 92,9 % av det teoretiske. Yield: 92.9% of the theoretical.

Smp.: 100-103°C. M.p.: 100-103°C.

Beregnet: C, 61,23; H, 7,99; N, 5,29; Cl, 13,39 Calculated: C, 61.23; H, 7.99; N, 5.29; Cl, 13.39

Funnet: C, 61,21; H, 8,13; N, 5,10; Cl, 13,15 Found: C, 61.21; H, 8.13; N, 5.10; Cl, 13,15

Eksempel 10 Example 10

2 - [ (N- (3 - (na f ty 1 - 2 -oksy) -propyl) -pyrrol idy 1 - 3) -metyl ] - 6,7 - dimetoksv- l- okso- l , 2, 3, 4- tetrahydro- isokinolin- hvdroklorid 2 - [ (N- (3 - (na f ty 1 - 2 -oxy) -propyl) -pyrr ol id 1 - 3) -methyl ] - 6,7 - dimethoxy- l - oxo- l , 2, 3, 4 - tetrahydroisoquinoline hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormety1-N-[3-(naftyl-2-oksy)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-pyrrolidine, analogous to Example 2 .

Utbytte: 22 % av det teoretiske. Yield: 22% of the theoretical.

Smp.: 78-80°C. Melting point: 78-80°C.

Beregnet (x H20): C, 65,83; H, 7,04; N, 5,29; Cl, 6,70 Funnet: C, 65,79; H, 7,00; N, 5,03; Cl, 6,99 Calcd (x H 2 O): C, 65.83; H, 7.04; N, 5.29; Cl, 6.70 Found: C, 65.79; H, 7.00; N, 5.03; Cl, 6.99

Eksempel 11 Example 11

2-[(N-(3-(naftyl-2-oksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[(N-(3-(naphthyl-2-oxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline- hydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormetyl-N-[3-(naftyl-2-oksy)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-pyrrolidine, analogous to Example 2 .

Utbytte: 53 % av det teoretiske. Yield: 53% of the theoretical.

Smp.: 78-80°C. Melting point: 78-80°C.

Beregnet (x H20): C, 65,56; H, 6,48; N, 5,46; Cl, 6,91 Funnet: C, 65,44; H, 6,32; N, 5,38; Cl, 7,13 Calcd (x H 2 O): C, 65.56; H, 6.48; N, 5.46; Cl, 6.91 Found: C, 65.44; H, 6.32; N, 5.38; Cl, 7.13

Eksempel 12 Example 12

2- [ (N- (2- (naftyl-2) -etyl) -pyrrolidyl-3) -metyl] -6,7-dimetoksy-1, 2. 3. 4- tetrahvdro- isokinolin- hydroklorid 2- [ (N-(2-(naphthyl-2)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1, 2. 3. 4- tetrahdro- isoquinoline- hydrochloride

Fremstillet fra 2-[(N-(2-(iraftyl-2)-etyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran og eter, analogt med Eksempel 3. Prepared from 2-[(N-(2-(iraphthyl-2-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran and ether, analogously to Example 3.

Utbytte: 66,2% av det teoretiske. Yield: 66.2% of the theoretical.

Smp.: 239-241°C. M.p.: 239-241°C.

Beregnet (x H20) : C, 64,48; H, 7,44; N, 5,37; Cl, 13,91 Funnet: C, 64,30; H, 7,34; N, 5,52; Cl, 13,69 Calcd (x H 2 O) : C, 64.48; H, 7.44; N, 5.37; Cl, 13.91 Found: C, 64.30; H, 7.34; N, 5.52; Cl, 13.69

Eksempel 13 Example 13

2-[(N-((2-metylnaftyl-l)-metyl)-heksahydro-azepinyl-3)-metyl]-6, 7- dimetoksv- l, 2, 3, 4- tetrahvdro- isokinolin- hvdroklorid 2-[(N-((2-methylnaphthyl-1)-methyl)-hexahydro-azepinyl-3)-methyl]-6, 7- dimethoxy-1, 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(N-((2-metylnaftyl-l)-metyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran og eter, analogt med Eksempel 3. Prepared from 2-[(N-((2-methylnaphthyl-1)-methyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran and ether, analogously to Example 3.

Utbytte: 73,8 % av det teoretiske. Yield: 73.8% of the theoretical.

Smp.: 182-184°C. M.p.: 182-184°C.

Beregnet (x H20): C, 65,56; H, 7,70; N, 5,09; Cl, 12,90 Funnet: C, 65,52; H, 7,57; N, 5,32; Cl, 12,72 Calcd (x H 2 O): C, 65.56; H, 7.70; N, 5.09; Cl, 12.90 Found: C, 65.52; H, 7.57; N, 5.32; Cl, 12.72

Eksempel 14 Example 14

2-[(N-(4-(naftyl-2-oksy)-butyl)-pyrrolidyl-3)-metyl]-6,7-dimetvl- l- okso- l, 2, 3, 4- tetrahydro- isokinolin- hvdroklorid 2-[(N-(4-(naphthyl-2-oxy)-butyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1, 2, 3, 4- tetrahydro-isoquinoline- hydrochloride

Fremstillet fra 2-(pyrrolidyl-3-metyl)-6,7-dimetyl-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og 2-(4-brom-butyloksy)-naftalen, analogt med Eksempel 1. Prepared from 2-(pyrrolidyl-3-methyl)-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(4-bromo-butyloxy)-naphthalene, analogously to Example 1 .

Utbytte: 30 % av det teoretiske. Yield: 30% of the theoretical.

Smp.: 133-136°C. M.p.: 133-136°C.

Beregnet: C, 67,02; H, 6,92; N, 5,21; Cl, 14,86 Calculated: C, 67.02; H, 6.92; N, 5.21; Cl, 14.86

Funnet: C, 67,26; H, 7,03; N, 5,36; Cl, 14,89 Found: C, 67.26; H, 7.03; N, 5.36; Cl, 14.89

Eksempel 15 Example 15

2-[(N-(2-metyl-naftyl-l)-metyl)-pyrrolidyl-3)-metyl]-6,7-dimetyl- l- okso- 1. 2. 3, 4- tetrahvdro- isokinolin- hvdroklorid 2-[(N-(2-methyl-naphthyl-1)-methyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl- 1- oxo- 1. 2. 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-(pyrrolidyl-3-metyl)-6,7-dimetyl-l-okso-l, 2,3,4-tetrahydro-isokinolin og l-klormetyl-2-metyl-naftalen, analogt med Eksempel 1. Prepared from 2-(pyrrolidyl-3-methyl)-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloromethyl-2-methyl-naphthalene, analogously to Example 1.

Utbytte: 32,5% av det teoretiske. Yield: 32.5% of the theoretical.

Smp.: 142-144°C. M.p.: 142-144°C.

Beregnet: C, 69,34; H, 7,69; N, 5,77; Cl, 7,37 Calcd: C, 69.34; H, 7.69; N, 5.77; Cl, 7.37

Funnet: C, 69,59; H, 7,63; N, 5,72; Cl, 7,89 Found: C, 69.59; H, 7.63; N, 5.72; Cl, 7.89

Eksempel 16 Example 16

2 - [ (N- (2 - (5-metyl-6-metoksy-naftyl-2) -etyl) -pyrrolidyl-3) - metyl ] -6,7-dimetyl-l-okso-l ,2,3,4-tetrahydro-isokinolin-hvdrobromid 2 - [ (N-(2 - (5-methyl-6-methoxy-naphthyl-2)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrobromide

Fremstillet fra 2-[(N-(pyrrolidyl-3-metyl)]-6,7-dimetyl-l-okso-l ,2,3,4-tetrahydro-isokinolin og 2-(2-brometyl)-5-metyl-6-metoksy-naftalen, analogt med Eksempel 1. Prepared from 2-[(N-(pyrrolidyl-3-methyl)]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-5-methyl -6-methoxy-naphthalene, analogous to Example 1.

Utbytte: 19% av det teoretiske. Yield: 19% of the theoretical.

Smp.: 230-232°C. M.p.: 230-232°C.

Beregnet: C, 67,02; H, 6,93; N, 5,21; Br, 14,86 Calculated: C, 67.02; H, 6.93; N, 5.21; Br, 14.86

Funnet: C, 67,10; H, 7,12; N, 5,33; Br, 15,01 Found: C, 67.10; H, 7.12; N, 5.33; Br, 15.01

Eksempel 17 Example 17

2-[ (N-(2-(naftyl-2)-etyl) -pyrrolidyl-3) -6,7-dimetoksy-l-okso-1. 2. 3. 4- tetrahvdro- isokinolin- hvdroklorid 2-[ (N-(2-(naphthyl-2)-ethyl)-pyrrolidyl-3)-6,7-dimethoxy-1-oxo-1. 2. 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-(pyrrolidyl-3-metyl)-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og 2-(2-brometyl)-naftalen, analogt med Eksempel 1. Prepared from 2-(pyrrolidyl-3-methyl)-6,7-dimethoxy-1-oxo-1, 2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-naphthalene, analogously to Example 1.

Utbytte: 7,8% av det teoretiske. Yield: 7.8% of the theoretical.

Smp.: 219-221°C. M.p.: 219-221°C.

Beregnet (x H20): C, 67,39; H, 7,07; N, 5,61; Cl, 7,10 Funnet: C, 67,21; H, 7,23; N, 5,57; Cl, 7,63 Calcd (x H 2 O): C, 67.39; H, 7.07; N, 5.61; Cl, 7.10 Found: C, 67.21; H, 7.23; N, 5.57; Cl, 7.63

Eksempel 18 Example 18

2- [ (N- (2 - (6-metoksy-naf tyl-2) -etyl) -pyrrolidyl-3) -metyl ]-6,7-dimetoksy- l- okso- 1. 2. 3, 4- tetrahvdro- isokinolin- hvdroklorid 2- [ (N- (2 - (6-Methoxy-naphthyl-2)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy- l - oxo- 1. 2. 3, 4- tetrahydro - isoquinoline hydrochloride

Fremstillet fra 2-(pyrrolidyl-3)-metyl)-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og 2-(2-brometyl)-6-metoksy-naftalen, analogt med Eksempel 1. Prepared from 2-(pyrrolidyl-3-methyl)-6,7-dimethoxy-1-oxo-1, 2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-6-methoxy-naphthalene, analog with Example 1.

Utbytte: 39,2% av det teoretiske. Yield: 39.2% of the theoretical.

Smp.: 224-226°C. M.p.: 224-226°C.

Beregnet (x H20): C, 65,84; H, 7,05; N, 5,29; Cl, 7,05 Funnet: C, 66,08; H, 7,13; N, 5,39; Cl, 6,77 Calcd (x H 2 O): C, 65.84; H, 7.05; N, 5.29; Cl, 7.05 Found: C, 66.08; H, 7.13; N, 5.39; Cl, 6.77

Eksempel 19 Example 19

2- [ (N- (3 - (naftyl-2) -propyl) -piperidyl-3) -metyl]-6,7-dimetyl-1- okso- l. 2. 3. 4- tetrahvdro- isokinolin- hvdroklorid 2- [ (N- (3 - (naphthyl-2)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1- oxo- l. 2. 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormetyl-N-[3-(naftyl-2)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2)-propyl]-piperidine, analogously to Example 2.

Utbytte: 40,4% av det teoretiske. Yield: 40.4% of the theoretical.

Smp.: 185-187°C. M.p.: 185-187°C.

Beregnet: C, 75,52; H, 7,82; N, 5,87; Cl, 7,43 Calculated: C, 75.52; H, 7.82; N, 5.87; Cl, 7.43

Funnet: C, 75,39; H, 7,85; N, 5,82; Cl, 7,52 Found: C, 75.39; H, 7.85; N, 5.82; Cl, 7.52

Eksempel 20 Example 20

2- [2-(N-(3-(nafty1-2-oksy)-propyl)-piperidy1-2)-etyl ] -6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin-hvdroklorid 2- [2-(N-(3-(naphthy1-2-oxy)-propyl)-piperidy1-2)-ethyl] -6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-(piperidyl-2)-etyl)-6,7-metylendioksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og 2-(3-klorpropoksy)naftalen, analogt med Eksempel 1. Prepared from 2-(piperidyl-2)-ethyl)-6,7-methylenedioxy-1-oxo-1, 2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)naphthalene, analogously to Example 1.

Utbytte: 21,2% av det teoretiske. Yield: 21.2% of the theoretical.

Smp.: 85-87°C. M.p.: 85-87°C.

Beregnet (x H20): C, 66,59; H, 6,89; N, 5,17; Cl, 6,53 Funnet: C, 66,77; H, 6,98; N, 4,95; Cl, 6,74 Calcd (x H 2 O): C, 66.59; H, 6.89; N, 5.17; Cl, 6.53 Found: C, 66.77; H, 6.98; N, 4.95; Cl, 6.74

v Eksempel 21 v Example 21

2-[(N-(3-(naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetvl- 1. 2. 3. 4- tetrahvdro- isokinolin- dihydroklorid 2-[(N-(3-(naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl- 1. 2. 3. 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(naftyl-2-oksy)-propyl)-piperidyl-3) -metyl ] -6,7-dimetyl-l-okso-l ,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 53% av det teoretiske. Yield: 53% of the theoretical.

Smp.: 133-135°C. M.p.: 133-135°C.

Beregnet (x H20): C, 68,30; H, 6,87; N, 5,31; Cl, 13,44 Funnet: C, 68,05; H, 6,85; N, 5,23; Cl, 13,03 Calcd (x H 2 O): C, 68.30; H, 6.87; N, 5.31; Cl, 13.44 Found: C, 68.05; H, 6.85; N, 5.23; Cl, 13.03

Eksempel 22 Example 22

2-[(N-(3-(naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-metylendioksv- 1. 2, 3, 4- tetrahvdro- isokinolin- dihvdroklorid 2-[(N-(3-(naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy- 1. 2, 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiiumhydrid i tetrahydrofuran/eter, analogt méd Eksempel 3. Prepared from 2-[(N-(3-(naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 44,7% av det teoretiske. Yield: 44.7% of the theoretical.

Smp.: 130-132°C. M.p.: 130-132°C.

Beregnet (x HzO): C, 63,62; H, 6,62; N, 5,11; Cl, 12,95 Funnet: C, 63,49; H, 6,86; N, 4,97; Cl, 12,64 Calcd (x HzO): C, 63.62; H, 6.62; N, 5.11; Cl, 12.95 Found: C, 63.49; H, 6.86; N, 4.97; Cl, 12.64

Eksempel 23 Example 23

2-[(N-((2-metyl-naftyl-l)-metyl)-piperidyl-3)-metyl]-6,7-dimetoksv- 1. 2. 3. 4- tetrahvdro- isokinolin- dihvdroklorid 2-[(N-((2-methyl-naphthyl-1)-methyl)-piperidyl-3)-methyl]-6,7-dimethoxy- 1. 2. 3. 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-((2-metyl-naftyl-l)-metyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-((2-methyl-naphthyl-1)-methyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 80,5% av det teoretiske. Yield: 80.5% of the theoretical.

Smp.: 210-212°C. M.p.: 210-212°C.

Beregnet (x H20): C, 65,05; H, 7,53; N, 5,23 Calcd (x H 2 O): C, 65.05; H, 7.53; N, 5.23

Funnet: C, 65,23; H, 7,78; N, 5,03 Found: C, 65.23; H, 7.78; N, 5.03

Eksempel 24 Example 24

2-[2-(N-(2-(6-metoksy-naftyl-2)-etyl)-piperidyl-2)-etyl]-6,7-metylendioksv- l- okso- 1. 2, 3, 4- tetrahvdro- isokinolin- hydroklorid 2-[2-(N-(2-(6-methoxy-naphthyl-2)-ethyl)-piperidyl-2)-ethyl]-6,7-methylenediox- l- oxo- 1. 2, 3, 4- tetrahydroisoquinoline hydrochloride

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(2-brometyl)-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 27,6% av det teoretiske. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-6-methoxy- naphthalene, analogously to Example 1. Yield: 27.6% of the theoretical.

Smp.: 112-117°C. M.p.: 112-117°C.

Beregnet (x 1/2 H20): C, 67,74; H, 6,82; N, 5,26; Cl, 6,65 Calcd (x 1/2 H 2 O): C, 67.74; H, 6.82; N, 5.26; Cl, 6.65

Funnet: '■ C, 67,54; H, 6,73; N, 5,47; Cl, 6,86 Found: '■ C, 67.54; H, 6.73; N, 5.47; Cl, 6.86

Eksempel 25 Example 25

2- [ (N- (2- (naftyl-1) -etyl) -piperidyl-3) -metyl] -6,7-dimetoksy-1- okso- l, 2. 3, 4- tetrahvdro- isokinolin- hvdroklorid 2- [ (N-(2-(naphthyl-1)-ethyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-l, 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og benzensulfonsyre-2-etyl(naftyl-1)-ester, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and benzenesulfonic acid 2-ethyl(naphthyl-1)-ester, analog with Example 1.

Utbytte: 26,9% av det teoretiske. Yield: 26.9% of the theoretical.

Smp.: 220-225°C. Melting point: 220-225°C.

Beregnet: C, 67,89; H, 7,27; N, 5,46; Cl, 6,91 Calcd: C, 67.89; H, 7.27; N, 5.46; Cl, 6.91

Funnet: C, 67,75; H, 6,92; N, 5,56; Cl, 7,00 Found: C, 67.75; H, 6.92; N, 5.56; Cl, 7.00

Eksempel 2 6 Example 2 6

2- [(N-(2-(naftyl-2)-etyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinoiin-hydroklorid . Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og benzensulfonsyre-2-etyl-(naftyl-2)-ester, analogt med Eksempel 1. 2-[(N-(2-(naphthyl-2)-ethyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline hydrochloride. Prepared from 2-[(piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and benzenesulfonic acid 2-ethyl-(naphthyl-2)-ester, analogous to Example 1.

Utbytte: 27,9% av det teoretiske. Yield: 27.9% of the theoretical.

Smp.: 128-130°C. Melting point: 128-130°C.

Beregnet (x H20) : C, 67,66; H, 6,69; N, 5,63; Cl, 7,13 Funnet: C, 67,64; H, 6,70; N, 5,76; Cl, 7,35 Calcd (x H 2 O) : C, 67.66; H, 6.69; N, 5.63; Cl, 7.13 Found: C, 67.64; H, 6.70; N, 5.76; Cl, 7.35

Eksempel 27 Example 27

2 - [ (N- (2 - (5 -me ty 1 -6 -metoksy-na f ty 1 -2) -etyl) -p iper idy 1 - 3) - metyl ] -6,7-metylendioksy-l-okso-l ,2,3,4-tetrahydro-isokinolin-hvdroklorid 2 - [ (N-(2 - (5 -methyl 1 -6 -methoxynaphthy 1 -2) -ethyl) -piperidy 1 - 3) - methyl ] -6,7-methylenedioxy-l- oxo-1,2,3,4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2, 3,4-tetrahydro-isokinolin og 2-(2-brometyl)-5-metyl-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 51,2% av det teoretiske. Prepared from 2-[(piperidyl-3-methyl)-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-5-methyl-6- methoxy-naphthalene, analogous to Example 1. Yield: 51.2% of the theoretical.

Smp.: 128-131°C. M.p.: 128-131°C.

Beregnet: C, 68,88; H, 6,74; N, 5,34; Cl, 6,77 Calcd: C, 68.88; H, 6.74; N, 5.34; Cl, 6.77

Funnet: C, 68,90; H, 6,61; N, 5,30; Cl, 7,05 Found: C, 68.90; H, 6.61; N, 5.30; Cl, 7.05

Eksempel 28 Example 28

2-[(N-((2-metyl-naftyl-l)-metylj-piperidyl-3)-metyl]-6,7-dimetoksy- l- okso- 1. 2, 3. 4- tetrahvdro- isokinolin- hvdroklorid 2-[(N-((2-methyl-naphthyl-1)-methylj-piperidyl-3)-methyl]-6,7-dimethoxy- l- oxo- 1. 2, 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l ,2,3,4-tetrahydro-isokinoiin og l-klormetyl-2-metyl-naftalen, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoin and 1-chloromethyl-2-methyl-naphthalene, analogously to Example 1 .

Utbytte: 57,9% av det teoretiske. Yield: 57.9% of the theoretical.

Smp. : 212-214°C. Temp. : 212-214°C.

Beregnet (x 2 H20): C, 67,63; H, 7,63; N, 5,44; Cl, 6,88 Calcd (x 2 H 2 O): C, 67.63; H, 7.63; N, 5.44; Cl, 6.88

Funnet: C, 67,46; H, 7,56; N, 5,54; Cl, 6,67 Found: C, 67.46; H, 7.56; N, 5.54; Cl, 6.67

Eksempel 29 Example 29

2-[ (N-(4-(naftyl-2.-oksy) -butyl) -piperidyl-3) -metyl]-6,7-dimetoksy- l- okso- 1, 2, 3. 4- tetrahvdro- isokinolin- hvdroklorid 2-[ (N-(4-(naphthyl-2.-oxy)-butyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3.4-tetrahydro- isoquinoline - Hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og 2-(4-brom-butoksy)naftalen, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1, 2,3,4-tetrahydro-isoquinoline and 2-(4-bromo-butoxy)naphthalene, analogously to Example 1.

Utbytte: 46,3% av det teoretiske. Yield: 46.3% of the theoretical.

Smp.: 80-84°C. M.p.: 80-84°C.

Beregnet (x H20): C, 66,83; H, 7,41; N, 5,03; Cl, 6,36 Funnet: C, 66,79; H, 7,22; N, 4,90; Cl, 6,64 Calcd (x H 2 O): C, 66.83; H, 7.41; N, 5.03; Cl, 6.36 Found: C, 66.79; H, 7.22; N, 4.90; Cl, 6.64

Eksempel 30 Example 30

2-[(N-(2-(6-metoksy-naftyl-2)-etyl)-piperidyl-3)-metyl]-6,7-dimetoksv- l- okso- 1. 2. 3. 4- tetrahvdro- isokinolin- hydroklorid 2-[(N-(2-(6-methoxy-naphthyl-2)-ethyl)-piperidyl-3)-methyl]-6,7-dimethoxy- l - oxo- 1. 2. 3. 4- tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og 2-(2-brom-etyl)-6-metoksy-naftalen, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1, 2,3,4-tetrahydro-isoquinoline and 2-(2-bromo-ethyl)-6-methoxy- naphthalene, analogous to Example 1.

Utbytte: 22,8% av det teoretiske. Yield: 22.8% of the theoretical.

Smp.: 80-85°C. Melting point: 80-85°C.

Beregnet (x H20 x HC1 x CH3COCH3) : Calculated (x H20 x HC1 x CH3COCH3) :

C, 64,01; H, 7,65; N, 4,52; Cl, 5,72 C, 64.01; H, 7.65; N, 4.52; Cl, 5.72

Funnet: C, 64,26; H, 7,70; N, 4,62; Cl, 5,49 Found: C, 64.26; H, 7.70; N, 4.62; Cl, 5.49

Eksempel 31 Example 31

2-[3-(N-(2-(6-metoksy-nafty1-2)-etyl)-piperidyl-3)-propyl]-6, 7- metylendioksy- l- okso- l, 2, 3. 4- tetrahvdro- isokinolin 2-[3-(N-(2-(6-methoxy-naphthy1-2-ethyl)-piperidyl-3)-propyl]-6, 7- methylenedioxy-l-oxo-l, 2, 3. 4- tetrahydroisoquinoline

Fremstillet fra 2-[3-(piperidyl-3)-propyl]-6,7-metylendioksy-l-okso-l, 2, 3, 4-tetrahydro-isokinolin og 2-(2-brometyl)-6-metoksy-naftalen, analogt med Eksempel 1. Prepared from 2-[3-(piperidyl-3)-propyl]-6,7-methylenedioxy-1-oxo-1, 2, 3, 4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-6-methoxy- naphthalene, analogous to Example 1.

Utbytte: 36,8% av det teoretiske. Yield: 36.8% of the theoretical.

Smp.: 118-121°C. M.p.: 118-121°C.

Beregnet: C, 74,37; H, 7,25; N, 5,60 Calculated: C, 74.37; H, 7.25; N, 5.60

Funnet: C, 74,60; H, 7,43; N, 5,65 Found: C, 74.60; H, 7.43; N, 5.65

Eksempel 32 Example 32

2-[3-(N-(2-(naftyl-1)-etyl)-piperidyl-3)-propyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin-hvdroklorid . 2-[3-(N-(2-(naphthyl-1)-ethyl)-piperidyl-3)-propyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline- hydrogen chloride.

Fremstillet fra 2-[3-(piperidyl-3)-propyl]-6,7-metylendioksy-l-okso-l ,2,3,4-tetrahydro-isokinolin og benzensulfonsyre-2-etyl-(naftyl-1)-ester, analogt med Eksempel 1. Prepared from 2-[3-(piperidyl-3)-propyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and benzenesulfonic acid 2-ethyl-(naphthyl-1)- ester, analogous to Example 1.

Utbytte: 20,8% av det teoretiske. Yield: 20.8% of the theoretical.

Smp.: 195-197°C. M.p.: 195-197°C.

Beregnet: C, 71,07; H, 6,95; N, 5,53; Cl, 6,99 Calculated: C, 71.07; H, 6.95; N, 5.53; Cl, 6.99

Funnet: C, 71,30; H, 6,95; N, 5,65; Cl, 6,80 Found: C, 71.30; H, 6.95; N, 5.65; Cl, 6.80

Eksempel 33 Example 33

2-[2-(N-(2-(5-metyl-6-metoksy-nafty1-2)-etyl)-piperidy1-2)-etyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[2-(N-(2-(5-methyl-6-methoxy-naphthyl-2-ethyl)-piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2, 3,4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og 2-(2-brometyl)-5-metyl-6-metoksy-naftalen, analogt med Eksempel 1. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-5-methyl- 6-methoxy-naphthalene, analogous to Example 1.

Utbytte: 33,6% av det teoretiske. Yield: 33.6% of the theoretical.

Smp.: 95-100°C. Melting point: 95-100°C.

Beregnet (x 1/2 H20): C, 68,38; H, 7,52; N, 4,98; Cl, 6,30 Calcd (x 1/2 H 2 O): C, 68.38; H, 7.52; N, 4.98; Cl, 6.30

Funnet: C, 68,14; H, 7,43; N, 4,92; Cl, 6,77 Found: C, 68.14; H, 7.43; N, 4.92; Cl, 6.77

Eksempel 34 Example 34

2-[(N-(3-(naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline- hydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormety1-N-[3-(naftyl-2-oksy) - propyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-piperidine, analogous to Example 2 .

Utbytte: 27,3% av det teoretiske. Yield: 27.3% of the theoretical.

Smp.: 104-106°C. M.p.: 104-106°C.

Beregnet (x H20): C, 66,09; H, 6,69; N, 5,31; Cl, 6,72 Funnet: C, 66,19; H, 6,34; N, 5,24; Cl, 7,22 Calcd (x H 2 O): C, 66.09; H, 6.69; N, 5.31; Cl, 6.72 Found: C, 66.19; H, 6.34; N, 5.24; Cl, 7.22

Eksempel 35 Example 35

2-[(N-(3-(naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksv- l- okso- 1. 2, 3. 4- tetrahvdro- isokinolin- hvdroklorid 2-[(N-(3-(naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy- l - oxo- 1. 2, 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormetyl-N-[3-(naftyl-2-oksy)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-piperidine, analogously to Example 2 .

Utbytte: 28,6% av det teoretiské. Yield: 28.6% of the theoretical amount.

Smp.: 191-193°C. M.p.: 191-193°C.

Beregnet (x H20): C, 66,34; H, 7,23; N, 5,15; Cl, 6,53 Funnet: C, 66,59; H, 7,19; N, 5,03; Cl, 6,65 Calcd (x H 2 O): C, 66.34; H, 7.23; N, 5.15; Cl, 6.53 Found: C, 66.59; H, 7.19; N, 5.03; Cl, 6.65

Eksempel 3 6 Example 3 6

2-[(N-(3-(naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 2-(3-klor-propoksy)naftalen, analogt med Eksempel 1. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloro-propoxy)naphthalene, analog with Example 1.

Utbytte: 16,1% av det teoretiske. Yield: 16.1% of the theoretical.

Smp.: 86^88°C. M.p.: 86^88°C.

Beregnet (x H20) : C, 66,83; H, 7,42; N, 5,03; Cl, 6,36 Funnet: C, 66,90; H, 7,40; N, 5,26; Cl, 6,87 Calcd (x H 2 O) : C, 66.83; H, 7.42; N, 5.03; Cl, 6.36 Found: C, 66.90; H, 7.40; N, 5.26; Cl, 6.87

Eksempel 3 7 Example 3 7

2-[(N-(3-(naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormetyl-N-[3-(naftyl-2-oksy)-propyl]-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-hexahydro-azepine, analogous to Example 2.

Utbytte: 22,5% av det teoretiske. Yield: 22.5% of the theoretical.

Smp.: 191-193°C. M.p.: 191-193°C.

Beregnet: C, 73,42; H, 7,75; N, 5,52; Cl, 6,99 Calculated: C, 73.42; H, 7.75; N, 5.52; Cl, 6.99

Funnet: C, 73,37; H, 7,67; N, 5,52; Cl, 7,12 Found: C, 73.37; H, 7.67; N, 5.52; Cl, 7.12

Eksempel 3 8 Example 3 8

2-[(N-(2-(5-metyl-6-metoksy-naftyl-2)-etyl)-heksahydro-azepinyl-3 )-metyl]-6,7-dimetoksy-l,2,3,4-tetrahydro-isokinolin- dihydroklorid 2-[(N-(2-(5-methyl-6-methoxy-naphthyl-2)-ethyl)-hexahydro-azepinyl-3 )-methyl]-6,7-dimethoxy-1,2,3,4- tetrahydroisoquinoline dihydrochloride

Fremstillet fra 2-[(N-(2-(5-metyl-6-metoksy-naftyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4~tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(2-(5-methyl-6-methoxy-naphthyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1, 2,3,4~tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 77,6% av det teoretiske. Yield: 77.6% of the theoretical.

Smp.: 170-172°C. M.p.: 170-172°C.

Beregnet (x H20): C, 64,96; H, 7,49; N, 4,73; Cl, 11,98 Funnet: C, 65,11: H, 7,62; N, 4,95; Cl, 11,84 Calcd (x H 2 O): C, 64.96; H, 7.49; N, 4.73; Cl, 11.98 Found: C, 65.11: H, 7.62; N, 4.95; Cl, 11.84

Eksempel 39 Example 39

2-[(N-(2-(5-metyl-6-metoksy-nafty1-2)-etyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin 2-[(N-(2-(5-methyl-6-methoxy-naphthy1-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2, 3,4-tetrahydro-isoquinoline

Fremstillet fra 2-[heksahydro-azepinyl-3)metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(2-brometyl)-5-metyl-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 43,5% av det teoretiske. Prepared from 2-[hexahydro-azepinyl-3)methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl)-5-methyl-6- methoxy-naphthalene, analogous to Example 1. Yield: 43.5% of the theoretical.

Smp.: 125-127°C. M.p.: 125-127°C.

Beregnet: C, 74,39; H, 7,80; N, 5,42 Calculated: C, 74.39; H, 7.80; N, 5.42

Funnet: C, 74,31; H, 7,82; N, 5,35 Found: C, 74.31; H, 7.82; N, 5.35

Eksempel 40 2- [ (N- (2-metyl-naftyl-l) -metyl) -heksahydro-azepinyl-3) -metyl]-6. 7- dimetoksy- l- okso- l . 2, 3. 4- tetrahydro- isokinolin- hydroklorid Example 40 2-[ (N-(2-methyl-naphthyl-1)-methyl)-hexahydro-azepinyl-3)-methyl]-6. 7-dimethoxy-l-oxo-l. 2, 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 1-klormetyl-2-metyl-naftalen, analogt med Eksempel 1. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloromethyl-2-methyl-naphthalene, analogous to Example 1.

Utbytte: 67,5% av det teoretiske. Yield: 67.5% of the theoretical.

Smp.: 128-130°C. Melting point: 128-130°C.

Beregnet (x 2 H20): C, 66,10; H, 7,58; N, 5,13; Cl, 6,50 Funnet: C, 66,24; H, 7,44; N, 5,23; Cl, 6,85 Calcd (x 2 H 2 O): C, 66.10; H, 7.58; N, 5.13; Cl, 6.50 Found: C, 66.24; H, 7.44; N, 5.23; Cl, 6.85

Eksempel 41 Example 41

2- [ (N- (4- (naftyl-2-oksy) -butyl) -iheksahydro-azepinyl-3) -metyl] - 6. 7- dimetoksy- l- okso- l . 2. 3. 4- tetrahvdro- isokinolin- hydroklorid 2- [ (N-(4-(naphthyl-2-oxy)-butyl)-hexahydro-azepinyl-3)-methyl] - 6. 7- dimethoxy-l-oxo-l. 2. 3. 4- tetrahvdro- isoquinoline- hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(4-brom-butyloksy)naftalen, analogt med\Eksempel 1. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(4-bromo-butyloxy)naphthalene, analog with\Example 1.

Utbytte: 26% av det teoretiske. Yield: 26% of the theoretical.

Smp.: 192-194°C. M.p.: 192-194°C.

Beregnet: C, 69,22; H, 7,80; N, 5,04; Cl, 6,38 Calculated: C, 69.22; H, 7.80; N, 5.04; Cl, 6.38

Funnet: C, 70,01; H, 7,70; N, 5,15; Cl, 6,48 Found: C, 70.01; H, 7.70; N, 5.15; Cl, 6.48

Eksempel 42 Example 42

2- [ (N- (2- (naftyl-1) -etyl) -heksahydro-azepinyl-3) -metyl]-6,7-metvlendioksy- l- okso- 1. 2. 3. 4- tetrahvdro- isokinolin- hydroklorid 2- [ (N-(2-(naphthyl-1)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy- l- oxo- 1. 2. 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(2-benzensulfonyloksy-etyl)-naftalen, analogt med Eksempel 1. Utbytte: 15,4% av det teoretiske. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-benzenesulfonyloxy-ethyl)-naphthalene, analogous to Example 1. Yield: 15.4% of the theoretical.

Smp.: 236-238°C. M.p.: 236-238°C.

Beregnet (x 1/2 H20) : C, 69,40; H, 6,82; N, 5,58; Cl, 7,06 Calcd (x 1/2 H 2 O) : C, 69.40; H, 6.82; N, 5.58; Cl, 7.06

Funnet: C, 69,07; H, 6,74; N, 6,13; Cl, 7,29 Found: C, 69.07; H, 6.74; N, 6.13; Cl, 7.29

Eksempel 43 2-[(N-(2-(naftyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy- l- okso- 1, 2, 3, 4- tetrahydro- isokinolin- hydrobromid Example 43 2-[(N-(2-(naphthyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro- isoquinoline hydrobromide

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(2-brometyl]-naftalen, analogt med Eksempel 1. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl]-naphthalene, analogous to Example 1.

Smp.: 100-102°C. M.p.: 100-102°C.

Utbytte: 31,6% av det teoretiske. Yield: 31.6% of the theoretical.

Beregnet: C, 64,80; H, 6,18; N, 5,21; Br, 14,86 Calculated: C, 64.80; H, 6.18; N, 5.21; Br, 14.86

Funnet: C, 65,02; H, 6,07; N, 5,39; Br, 14,78 Found: C, 65.02; H, 6.07; N, 5.39; Br, 14.78

Eksempel 44 Example 44

2-[(N-(2-(6-metoksy-naftyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(2-(6-methoxy-naphthyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4- tetrahydroisoquinoline hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(2-brometyl]-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 34,1% av det teoretiske. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl]-6-methoxy- naphthalene, analogous to Example 1. Yield: 34.1% of the theoretical.

Smp.: 147-149°C. M.p.: 147-149°C.

Beregnet (x H20): C, 68,62; H, 7,10; N, 5,33; Cl, 6,75 Funnet: C, 68,88; H, 6,98; N, 5,41; Cl, 6,78 Calcd (x H 2 O): C, 68.62; H, 7.10; N, 5.33; Cl, 6.75 Found: C, 68.88; H, 6.98; N, 5.41; Cl, 6.78

Eksempel 45 Example 45

2-[(N-(2-(5-metyl-6-metoksy-naftyl-2)-etyl)-heksahydro-azepinyl-3 )-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(2-(5-methyl-6-methoxy-naphthyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2, 3,4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(2-brometyl]-5-metyl-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 3 6,1% av det teoretiske. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromomethyl]-5-methyl- 6-methoxy-naphthalene, analogous to Example 1. Yield: 3 6.1% of the theoretical.

Smp.: 112-114°C. M.p.: 112-114°C.

Beregnet (x H20): C, 67,07; H, 7,08; N, 5,04; Cl, 6,38 Funnet: C, 67,13; H, 7,15; N, 4,97; Cl, 6,56 Calcd (x H 2 O): C, 67.07; H, 7.08; N, 5.04; Cl, 6.38 Found: C, 67.13; H, 7.15; N, 4.97; Cl, 6.56

Eksempel 4 6 Example 4 6

2 - [(N-(3-(4-metoksy-fenoksy)-propyl)-piperidy1-3)-metyl]-6,7-dimetoksy- 1, 2, 3. 4- tetrahvdro- is6kinolin- dihvdroklorid 2 - [(N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy- 1, 2, 3. 4- tetrahydro- is6quinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(4-metoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 88,5% av det teoretiske. Yield: 88.5% of the theoretical.

Smp.: 189-191°C. M.p.: 189-191°C.

Beregnet: C, 59,44; H, 7,76; N, 5,13; Cl, 12,99 Calcd: C, 59.44; H, 7.76; N, 5.13; Cl, 12.99

Funnet: C, 59,55; H, 7,99; N, 5,12; Cl, 12,61 Found: C, 59.55; H, 7.99; N, 5.12; Cl, 12.61

Eksempel 47 Example 47

2-[(N-(2-(3,4-dimetoksyfeny1)-etyl)-piperidy1-3)-metyl]-6,7-dimetoksy- 1, 2. 3, 4- tetrahvdro- isokinolin- dihydroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-dimethoxy- 1, 2, 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 92,8% av det teoretiske. Yield: 92.8% of the theoretical.

Smp.: 175-176°C. M.p.: 175-176°C.

Beregnet: C, 60,66; H, 7,35; N, 5,33; Cl, 13,49 Calculated: C, 60.66; H, 7.35; N, 5.33; Cl, 13.49

Funnet: C, 60,58; H, 7,56; N, 5,32; Cl, 13,22 Found: C, 60.58; H, 7.56; N, 5.32; Cl, 13.22

Eksempel 48 Example 48

2-[(N-(3-(3-metoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6. 7- metylendioksv- l. 2. 3. 4- tetrahvdro- isokinolin- dihvdroklorid 2-[(N-(3-(3-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6. 7- methylenedioxy- l. 2. 3. 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(3-metoksyfenoksy)-propyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiuma<i>luminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(3-methoxyphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 94,5% av det teoretiske. Yield: 94.5% of the theoretical.

Smp.: 169-171°C. M.p.: 169-171°C.

Beregnet: C, 57,03; H, 7,36; N, 5,11; Cl, 13,86 Calculated: C, 57.03; H, 7.36; N, 5.11; Cl, 13.86

Funnet: C, 56,91; H, 7,26; N, 5,15; Cl, 13,68 Found: C, 56.91; H, 7.26; N, 5.15; Cl, 13.68

i in

Eksempel 49 Example 49

2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-metyl]-6,7-dimetyl- 1. 2, 3, 4- tetrahvdro- isokinolin- dihvdroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-dimethyl- 1. 2, 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 91,3% av det teoretiske. Yield: 91.3% of the theoretical.

Smp.: 140-142°C. M.p.: 140-142°C.

Beregnet: C, 62,00; H, 8,34; N, 5,27; Cl, 13,44 Calculated: C, 62.00; H, 8.34; N, 5.27; Cl, 13.44

Funnet: C, 61,85; H, 8,27; N, 5,31; Cl, 13,33 Found: C, 61.85; H, 8.27; N, 5.31; Cl, 13.33

Eksempel 50 Example 50

2-[(N-(3-(4-metoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetvl- l. 2. 3, 4- tetrahydro- isokinolin- dihvdroklorid 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1.2, 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(4-metoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 88,3% av det teoretiske. Yield: 88.3% of the theoretical.

Smp.: 170-172°C. M.p.: 170-172°C.

Beregnet: C, 63,14; H, 8,24; N, 5,65; Cl, 14,31 Calculated: C, 63.14; H, 8.24; N, 5.65; Cl, 14.31

Funnet: C, 63,09; H, 8,33; N, 5,82; Cl, 14,02 Found: C, 63.09; H, 8.33; N, 5.82; Cl, 14.02

Eksempel 51 Example 51

2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-metyl]-6,7-metvlendioksv- 1. 2. 3. 4- tetrahydro- isokinolin- dihvdroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-methylenedioxy- 1. 2. 3. 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 93,3% av det teoretiske. Yield: 93.3% of the theoretical.

Smp.: 150-154°C. M.p.: 150-154°C.

Beregnet: C, 60,01; H, 7,34; N, 5,39; Cl, 13,64 Calculated: C, 60.01; H, 7.34; N, 5.39; Cl, 13.64

Funnet: C, 59,96; H, 7,41; N, 5,25; Cl, 13,43 Found: C, 59.96; H, 7.41; N, 5.25; Cl, 13.43

Eksempel 52 2-[ (N-(3-(4-metoksy-fenoksy) -propyl)-piperidyl-3)-metyl]-6,7-dimetoksy- 1, 2, 3, 4- tetrahydro- isokinolin- dihydroklorid Example 52 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride

Fremst illet fra 2-[(N-(3-(4-metoksy-fenoksy)-propyl)-piperidyl-3) -metyl ] -6,7-dimetoksy-l-okso-l ,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro -isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 95,3% av det teoretiske. Yield: 95.3% of the theoretical.

Smp.: 182-185°C. M.p.: 182-185°C.

Beregnet: C, 61,05; H, 7,09; N, 5,48; Cl, 13,86 Calculated: C, 61.05; H, 7.09; N, 5.48; Cl, 13.86

Funnet: C, 61,10; H, 6,95; N, 5,68; Cl, 13,55 Found: C, 61.10; H, 6.95; N, 5.68; Cl, 13.55

Eksempel 53 Example 53

2-[2- (N- (3- (3,4-metylendioksy-f enoksy) -propyl) -piperidyl-3) - etyl ] -6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[2-(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-piperidyl-3)-ethyl]-6,7-dimethoxy-1-oxo-1, 2,3,4 -tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-etyl]-6,7-dimetoksy-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og l-klor-3-(3,4-metylendioksy-f enoksy) propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-methylenedioxy-f enoxy) propane, analogously to Example 1.

Utbytte: 35,5% av det teoretiske. Yield: 35.5% of the theoretical.

Smp.: 97-100°C. M.p.: 97-100°C.

Beregnet: C, 59,09; H, 7,28; N, 4,62; Cl, 6,65 Calculated: C, 59.09; H, 7.28; N, 4.62; Cl, 6.65

Funnet: C, 58,97; H, 7,36; N, 4,66; Cl, 6,52 Found: C, 58.97; H, 7.36; N, 4.66; Cl, 6.52

Eksempel 54 Example 54

2-[2-(N-(2-(3,4 -dimetoksy f enyl) ^etyl) -piper idyl -3) -etyl ] -6,7 - dimetoksv- l- okso- 1. 2, 3, 4- tetrahvdro- isokinolin- hvdroklorid 2-[2-(N-(2-(3,4-dimethoxyphenyl)^ethyl)-piperidyl-3)-ethyl]-6,7-dimethoxy-l-oxo- 1. 2, 3, 4 - tetrahydroisoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3-)-etyl]-6,7-dimetoksy-l-okso-l, 2 , 3,4-tetrahydro-isokinolin og l-brom-2-(3,4-dimetoksy-fenyl)-etan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3-)ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-2-(3,4-dimethoxy- phenyl)-ethane, analogously to Example 1.

Utbytte: 35,9% av det teoretiske. Yield: 35.9% of the theoretical.

Smp.: 103-105°C. M.p.: 103-105°C.

Beregnet: C, 62,60; H, 7,79; N, 5,21; Cl, 6,83 Calculated: C, 62.60; H, 7.79; N, 5.21; Cl, 6.83

Funnet: C, 62,41; H, 7,82; N, 5,09; Cl, 7,19 Found: C, 62.41; H, 7.82; N, 5.09; Cl, 7.19

Eksempel 55 Example 55

2-[3-(N-(2-(3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-propyl]-6,7-dimetoksy-l-okso-l ,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[3-(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[3-(piperidyl-3)-propyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin og l-brom-2-(3,4-dimetoksyfenyl)-etan, analogt med Eksempel 1. Prepared from 2-[3-(piperidyl-3)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-2-(3,4-dimethoxyphenyl )-ethane, analogous to Example 1.

Utbytte: 32,6% av det teoretiske. Yield: 32.6% of the theoretical.

Smp. : 102-106°C. Temp. : 102-106°C.

Beregnet: C, 63,20; H, 7,86; N, 5,08; Cl, 6,43 Calculated: C, 63.20; H, 7.86; N, 5.08; Cl, 6.43

Funnet: C, 63,39; H, 7,90; N, 4,86; Cl, 6,13 Found: C, 63.39; H, 7.90; N, 4.86; Cl, 6.13

Eksempel 56 Example 56

2-[3 - (N- (3-(3,4-metylendioksy-fenoksy)-propyl)-piperidyl-3)-propyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[3 - (N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-piperidyl-3)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4- tetrahydroisoquinoline hydrochloride

Fremstillet fra 2-[3-(piperidyl-3)-propyl]-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og l-klor-3-(3,4-metylendioksy-f enoksy) -propan, analogt med Eksempel 1. Prepared from 2-[3-(piperidyl-3)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3,4-methylenedioxy -phenoxy)-propane, analogously to Example 1.

Utbytte: 29,7% av det teoretiske. Yield: 29.7% of the theoretical.

Smp.: 97-100°C. M.p.: 97-100°C.

Beregnet: C, 61,63; H, 7,31; N, 4,96; Cl, 6,47 Calculated: C, 61.63; H, 7.31; N, 4.96; Cl, 6.47

Funnet: C, 61,94; H, 7,46; N, 5,16; Cl, 6,48 Found: C, 61.94; H, 7.46; N, 5.16; Cl, 6.48

Eksempel 57 Example 57

2- [ (N- (3,4-dimetoksybenzyl) -piperidyl-3) -metyl] -6,7-dimetoksy-1- okso- l. 2, 3, 4- tetrahvdro- isokinolin- hvdroklorid 2- [ (N-(3,4-dimethoxybenzyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1- oxo- l. 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-(piperidyl-3-metyl)-6,7-dimetoksy-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og 3,4-dimetoksy-benzylbromid, analogt med Eksempel 1. Prepared from 2-(piperidyl-3-methyl)-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3,4-dimethoxy-benzyl bromide, analogously to Example 1.

Utbytte: 53,3% av det teoretiske. Yield: 53.3% of the theoretical.

Smp.: 127-132°C. M.p.: 127-132°C.

Beregnet: C, 63,58; H, 7,18; N, 5,70; Cl, 7,22 Calculated: C, 63.58; H, 7.18; N, 5.70; Cl, 7.22

Funnet: C, 63,30; H, 7,22; N, 5,52; Cl, 7,14 Found: C, 63.30; H, 7.22; N, 5.52; Cl, 7.14

Eksempel 58 Example 58

2-[ (N-(3-(4-metoksyfenyl) -propyl) -piperidyl-3)-metyl]-6,7-dimetoksv- l- okso- 1. 2, 3. 4- tetrahydro- isokinolin- hvdroklorid 2-[ (N-(3-(4-Methoxyphenyl)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy- l - oxo- 1. 2, 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-(piperidyl-3-metyl)-6,7-dimetoksy-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og l-brom-3-(4-metoksyfenyl)-propan, analogt med Eksempel 1. Prepared from 2-(piperidyl-3-methyl)-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-3-(4-methoxyphenyl)-propane, analogous to Example 1.

Utbytte: 42% av det teoretiske. Yield: 42% of the theoretical.

Smp.: 229-231°C. M.p.: 229-231°C.

Beregnet: C, 66,31; H, 7,63; N, 5,73; Cl, 7,25 Calculated: C, 66.31; H, 7.63; N, 5.73; Cl, 7.25

Funnet: C, 66,27; H, 7,64; N, 5,65; Cl, 7,33 Found: C, 66.27; H, 7.64; N, 5.65; Cl, 7.33

Eksempel 59 Example 59

2- [2- (N- (3 - (3-metyl-f enoksy) -propyl) -piperidyl-2) -etyl]-6,7-dimetoksv- l- okso- 1, 2. 3. 4- tetrahydro- isokinolin- hvdroklorid 2- [2- (N- (3- (3-methyl-phenoxy)-propyl)-piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1, 2, 3, 4- tetrahydro - isoquinoline hydrochloride

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og l-klor-3-(3-metyl-fenoksy)-propan, analogt med Eksempel 1. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3-methyl-phenoxy) )-propane, analogous to Example 1.

Utbytte: 52,4% av det teoretiske. Yield: 52.4% of the theoretical.

Smp.: 142-144°C. M.p.: 142-144°C.

Beregnet: C, 66,85; H, 7,81; N, 5,57; Cl, 7,05 Calcd: C, 66.85; H, 7.81; N, 5.57; Cl, 7.05

Funnet: C, 66,73; H, 7,68; N, 5,53; Cl, 6,94 Found: C, 66.73; H, 7.68; N, 5.53; Cl, 6.94

Eksempel 60 Example 60

2-[2-(N-(2-(3,4-dimetoksyfenyl) -etyl)-piperidyl-2)-etyl]-6,7-dimetoksv- l- okso- 1, 2, 3, 4- tetrahvdro- isokinolin- hydroklorid 2-[2-(N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-2)-ethyl]-6,7-dimethoxy- l - oxo- 1, 2, 3, 4- tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l, 2, 3,4-tetrahydro-isokinolin og l-brom-2-(3,4-dimetoksy-fenyl) -etan, analogt med Eksempel 1. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-2-(3,4-dimethoxy -phenyl)-ethane, analogously to Example 1.

Utbytte: 47,3% av det teoretiske. Yield: 47.3% of the theoretical.

Smp.: 150-155°C. Melting point: 150-155°C.

Beregnet: C, 64,72; H, 7,68; N, 5,39; Cl, 6,82 Calculated: C, 64.72; H, 7.68; N, 5.39; Cl, 6.82

Funnet: C, 64,40; H, 7,83; N, 5,27; Cl, 6,90 Found: C, 64.40; H, 7.83; N, 5.27; Cl, 6.90

Eksempel 61 Example 61

2-[2-(N-(3-benzyloksy-propy1)-piperidyl-2)-etyl]-6,7-dimetoksv- l- okso- 1, 2, 3, 4- tetrahydro- isokinolin- hvdroklorid 2-[2-(N-(3-benzyloxy-propyl)-piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1, 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l ,2,3,4-tetrahydro-isokinolin og l-klor-3-benzyloksypropan, analogt med Eksempel 1. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-benzyloxypropane, analogously to Example 1 .

Utbytte: 56,3% av det teoretiske. Yield: 56.3% of the theoretical.

Smp.: 116-120°C. M.p.: 116-120°C.

Beregnet: C, 66,85; H, 7,81; N, 5,57; Cl, 7,05 Calcd: C, 66.85; H, 7.81; N, 5.57; Cl, 7.05

Funnet: C, 66,60; H, 7,75; N, 5,25; Cl, 7,25 Found: C, 66.60; H, 7.75; N, 5.25; Cl, 7.25

Eksempel 62 Example 62

2-[2-(N-(4-(4-metoksyfenyl)-butyl)-piperidyl-2)-etyl]-6,7-dimetoksv- l- okso- 1. 2. 3, 4- tetrahvdro- isokinolin- hvdroklorid 2-[2-(N-(4-(4-methoxyphenyl)-butyl)-piperidyl-2)-ethyl]-6,7-dimethoxy- l- oxo- 1. 2. 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og l-brom-4-(4-metoksyfenyl)-butan, analogt med Eksempel 1. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-4-(4-methoxyphenyl)- butane, analogous to Example 1.

Utbytte: 42,8% av det teoretiske. Yield: 42.8% of the theoretical.

Smp.: 107-112°C. M.p.: 107-112°C.

Beregnet: C, 67,36; H, 7,99; N, 5,42; Cl, 6,86 Calculated: C, 67.36; H, 7.99; N, 5.42; Cl, 6.86

Funnet: C, 67,16; H, 8,05; N, 5,35; Cl, 7,34 Found: C, 67.16; H, 8.05; N, 5.35; Cl, 7.34

Eksempel 63 Example 63

2-[2-(N-(3-(3,5-dimetoksy-fenoksy)-propyl)-piperidyl-2)-etyl]-6. 7- dimetoksy- l- okso- l. 2, 3. 4- tetrahvdro- isokinolin- hydroklorid 2-[2-(N-(3-(3,5-dimethoxy-phenoxy)-propyl)-piperidyl-2)-ethyl]-6. 7- dimethoxy- l- oxo- l. 2, 3. 4- tetrahdro- isoquinoline- hydrochloride

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l ,2,3,4-tetrahydro-isokinolin og l-klor-3-(3,5-dimetoksy-fenoksy)-propan, analogt med Eksempel 1. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3,5-dimethoxy -phenoxy)-propane, analogous to Example 1.

Utbytte: 56,3% av det teoretiske. Yield: 56.3% of the theoretical.

Smp.: 127-132°C. M.p.: 127-132°C.

Beregnet: C, 61,41; H, 7,64; N, 5,10; Cl, 6,46 Calculated: C, 61.41; H, 7.64; N, 5.10; Cl, 6.46

Funnet: C, 61,56; H, 7,65; N, 5,28; Cl, 6,89 Found: C, 61.56; H, 7.65; N, 5.28; Cl, 6.89

Eksempel 64 Example 64

2-[2-(N-(3-(3,4-metylendioksy-fenoksy)-propyl)-piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid [2-[2-(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4- tetrahydro-isoquinoline hydrochloride [

Fremstillet fra 2-[2-(piperidyl-2)-etyl]-6,7-dimetoksy-l-okso-l ,2,3,4-tetrahydro-isokinolin og l-klor-3-(3,4-metylendioksy-f enoksy) -propan, analogt med Eksempel l. Prepared from 2-[2-(piperidyl-2)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3,4-methylenedioxy -phenoxy)-propane, analogously to Example 1.

Utbytte: 49% av det teoretiske. Yield: 49% of the theoretical.

Smp.: 118-120°C. M.p.: 118-120°C.

Beregnet: C, 63,09; H, 7,00; N, 5,26; Cl, 6,65 Calculated: C, 63.09; H, 7.00; N, 5.26; Cl, 6.65

Funnet: C, 62,90; H, 7,04; N, 5,46; Cl, 6,79 Found: C, 62.90; H, 7.04; N, 5.46; Cl, 6.79

Eksempel 65 Example 65

2-[(N-(3-(3,5-dimetoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6. 7- dimetoksv- l- okso- l. 2. 3, 4- tetrahydro- isokinolin- hvdroklorid 2-[(N-(3-(3,5-dimethoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6. 7- dimethoxy-l- oxol- l. 2. 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l , 2 , 3 , 4-tetrahydro-isokinolin og l-klor-3-(3,5-dimetoksy-fenoksy)-propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3,5-dimethoxy-phenoxy )-propane, analogous to Example 1.

Utbytte: 37,5% av det teoretiske. Yield: 37.5% of the theoretical.

Smp.: 98-102°C. M.p.: 98-102°C.

Beregnet: C, 62,85; H, 7,35; N, 5,24; Cl, 6,63 Calcd: C, 62.85; H, 7.35; N, 5.24; Cl, 6.63

Funnet: C, 62,81; H, 7,41; N, 5,10; Cl, 6,75 Found: C, 62.81; H, 7.41; N, 5.10; Cl, 6.75

Eksempel 66 Example 66

2-[(N-(3-(3,4-metylendioksy-fenyl)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(3,4-methylenedioxy-phenyl)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-2)-metyl]-6,7-dimetoksy-l-okso-l, 2, 3, 4 -tetrahydro-isokinolin og l-klor-3-(3,4-metylen-dioksyfenyl)-propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-2)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-methylenedioxyphenyl) )-propane, analogous to Example 1.

Utbytte: 50% av det teoretiske. Yield: 50% of the theoretical.

Smp.: 236-238°C. M.p.: 236-238°C.

Beregnet: C, 64,46; H, 7,01; N, 5,57; Cl, 7,04 Calcd: C, 64.46; H, 7.01; N, 5.57; Cl, 7.04

Funnet: C, 64,30; H, 6,97; N, 5,59; Cl, 7,08 Found: C, 64.30; H, 6.97; N, 5.59; Cl, 7.08

Eksempel 67 Example 67

2-[(N-(3-(3,4-metylendioksy-fenoksy)-propyl)-piperidyl-3)-metyl] -6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-2)-metyl]-6,7-dimetoksy-l-okso-l, 2, 3, 4-tetrahydro-isokinolin og l-klor-3-(3,4-metylendioksy-f enoksy) -propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-2)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-methylenedioxy-f enoxy)-propane, analogously to Example 1.

Utbytte: 46,2% av det teoretiske. Yield: 46.2% of the theoretical.

Smp.: 149-153°C. M.p.: 149-153°C.

Beregnet: C, 60,38; H, 6,94; N, 5,21; Cl, 6,60 Calculated: C, 60.38; H, 6.94; N, 5.21; Cl, 6.60

Funnet: C, 60,30; H, 6,93; N, 5,29; Cl, 6,37 Found: C, 60.30; H, 6.93; N, 5.29; Cl, 6.37

Eksempel 68 Example 68

2-[(N-(3-(2,6-dimetyl-fenoksy)-propyl)-piperidyl-3)-metyl]-6. 7- dimetoksv- l- okso- l. 2, 3, 4- tetrahvdro- isokinolin- hydroklorid 2-[(N-(3-(2,6-dimethyl-phenoxy)-propyl)-piperidyl-3)-methyl]-6. 7- dimethoxy-l-oxo- l. 2, 3, 4- tetrahdro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l, 2, 3, 4 -tetrahydro-isokinolin og l-klor-3-(2,6-dimetyl-fenoksy)-propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(2,6-dimethyl-phenoxy )-propane, analogous to Example 1.

Utbytte: 53,3% av det teoretiske. Yield: 53.3% of the theoretical.

Smp.: 131-135°C. M.p.: 131-135°C.

Beregnet: C, 66,85; H, 7,81; N, 5,57; Cl, 7,05 Calcd: C, 66.85; H, 7.81; N, 5.57; Cl, 7.05

Funnet: C, 66,88; H, 7,95; N, 5,59; Cl, 6,85 Found: C, 66.88; H, 7.95; N, 5.59; Cl, 6.85

Eksempel 69 Example 69

2-[(N-(4-(2,4-diklor-fenoksy)-butyl)-piperidyl-3)-metyl]-6,7-dimetoksv- l- okso- l. 2. 3. 4- tetrahvdro- isokinolin- hvdroklorid 2-[(N-(4-(2,4-dichloro-phenoxy)-butyl)-piperidyl-3)-methyl]-6,7-dimethoxy- l - oxo- l. 2. 3. 4- tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og l-klor-4-(2,4-diklor-fenoksy)-butan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-4-(2,4-dichloro-phenoxy )-butane, analogous to Example 1.

Utbytte: 54,1% av det teoretiske. Yield: 54.1% of the theoretical.

Smp.: 125-128°C. M.p.: 125-128°C.

Beregnet: C, 58,12; H, 6,32; N, 5,02; Cl, 19,06 Calculated: C, 58.12; H, 6.32; N, 5.02; Cl, 19.06

Funnet: C, 58,21; H, 6,38; N, 5,08; Cl, 18,85 Found: C, 58.21; H, 6.38; N, 5.08; Cl, 18.85

Eksempel 70 Example 70

2-[(N-(2-(3,4-dimetoksyfenyl)etyl)piperidyl-3)-metyl]-6,7-dimetoksv- l- okso- 1, 2, 3. 4- tetrahydro- isokinolin- hvdroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)ethyl)piperidyl-3)-methyl]-6,7-dimethoxy- l - oxo- 1, 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin og l-brom-2(3,4-dimetoksy-fenyl) -etan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-2-(3,4-dimethoxy-phenyl) -ethane, analogous to Example 1.

Utbytte: 57,5% av det teoretiske. Yield: 57.5% of the theoretical.

Smp.: 118-121°C. M.p.: 118-121°C.

Beregnet: C, 64,21; H, 7,38; N, 5,55 Calculated: C, 64.21; H, 7.38; N, 5.55

Funnet: C, 64,18; H, 7,36; N, 5,19 Found: C, 64.18; H, 7.36; N, 5.19

Eksempel 71 Example 71

2- [ (N- (3 - (3,4-dimetoksy-f enoksy );-propyl) -piperidyl-3) -metyl] - 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[ (N-(3-(3,4-dimethoxy-phenoxy);-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4- tetrahydroisoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l, 2, 3, 4-tetrahydro-isokinolin og l-klor-3-(3,4-dimetoksy-fenoksy)-propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1, 2, 3, 4-tetrahydro-isoquinoline and 1-chloro-3-(3,4-dimethoxy-phenoxy )-propane, analogous to Example 1.

Utbytte: 62,5% av det teoretiske. Yield: 62.5% of the theoretical.

Smp.: 112-115°C. M.p.: 112-115°C.

Beregnet: C, 60,80; H, 7,47; N, 5,24 Calculated: C, 60.80; H, 7.47; N, 5.24

Funnet: C, 60,65; H, 7,69; N, 5,27 Found: C, 60.65; H, 7.69; N, 5.27

Eksempel 72 Example 72

2- [(N-(3-(3,4-dimetoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2- [(N-(3-(3,4-dimethoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 1-klor-3- (3,4-dimetoksy-fenoksy)-propan, analogt med Eksempel 1. Utbytte: 60% av det teoretiske. Prepared from 2-[(piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3,4-dimethoxy-phenoxy )-propane, analogous to Example 1. Yield: 60% of the theoretical.

Smp.: 97-100°C. M.p.: 97-100°C.

Beregnet: C, 60,38; H, 6,94; N, 5,40; Cl, 6,60 Calculated: C, 60.38; H, 6.94; N, 5.40; Cl, 6.60

Funnet: C, 60,20; H, 6,97; N, 5,21; Cl, 6,83 Found: C, 60.20; H, 6.97; N, 5.21; Cl, 6.83

Eksempel 73 Example 73

2- [ (N- (2- (4-metoksy-fenyl) -etyl) -piperidyl-3) -metyl] -6,7-metylendioksy- l- okso- 1, 2, 3, 4- tetrahvdro- isokinolin- hvdroklorid 2- [ (N-(2-(4-methoxy-phenyl)-ethyl)-piperidyl-3)-methyl]-6,7-methylenedioxy- l- oxo- 1, 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 1-klor-2-(4-metoksyfenyl)-etan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-2-(4-methoxyphenyl)-ethane, analogous to Example 1.

Utbytte: 71,4% av det teoretiske. Yield: 71.4% of the theoretical.

Smp.: 195-197°C. M.p.: 195-197°C.

Beregnet: C, 62,94; H, 6,97; N, 5,87; Cl, 7,73 Calcd: C, 62.94; H, 6.97; N, 5.87; Cl, 7.73

Funnet: C, 62,90; H, 6,98; N, 5,68; Cl, 8,04 Found: C, 62.90; H, 6.98; N, 5.68; Cl, 8.04

Eksempel 74 Example 74

2 -[ (N- (2- (3,4-dimetoksyfenyl)-etyl)-piperidyl-3)-metyl]-6, 7- dimetvl- l- okso- l . 2. 3, 4- tetrahvdro- isokinolin- hvdroklorid 2-[ (N-(2-(3,4-dimethoxyphenyl)-ethyl)-piperidyl-3)-methyl]-6, 7- dimethyl-1-oxo-l. 2. 3, 4- tetrahydro-isoquinoline-hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og l-brom-2-(3,4-dimetoksy-fenyl) -etan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-2-(3,4-dimethoxy-phenyl) ) -ethane, analogously to Example 1.

Utbytte: 41,9% av det teoretiske. Yield: 41.9% of the theoretical.

Smp.: 132-134°C. M.p.: 132-134°C.

Beregnet: C, 63,57; H, 8,10; N, 5,49; Cl, 6,95 Calculated: C, 63.57; H, 8.10; N, 5.49; Cl, 6.95

Funnet: C, 63,70; H, 8,26; N, 5,45; Cl, 7,13 Found: C, 63.70; H, 8.26; N, 5.45; Cl, 7.13

Eksempel 75 Example 75

2-[ (N-(3-(4-metoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl- l- okso- 1, 2, 3. 4- tetrahydro- isokinolin- hydroklorid 2-[ (N-(3-(4-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl- 1- oxo- 1, 2, 3. 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l ,2,3,4-tetrahydro-isokinolin og l-klor-3-(4-metoksy-fenoksy)-propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(4-methoxy-phenoxy)- propane, analogous to Example 1.

Utbytte: 57,8% av det teoretiske. Yield: 57.8% of the theoretical.

Smp.: 144-146°C. M.p.: 144-146°C.

Beregnet: C, 68,55; H, 7,88; N, 5,92; Cl, 7,49 Calcd: C, 68.55; H, 7.88; N, 5.92; Cl, 7.49

Funnet: C, 68,45; H, 7,80; N, 6,11; Cl, 7,33 Found: C, 68.45; H, 7.80; N, 6.11; Cl, 7.33

Eksempel 76 2- [(N-(3-(3-metoksy-fenoksy)-propyl)-piperidyl-3)-metyl]-6,7-metvlendioksy- l- okso- 1. 2. 3, 4- tetrahvdro- isokinolin- hvdroklorid Example 76 2-[(N-(3-(3-methoxy-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1.2.3.4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 1-klor-3- (3-metoksy-fenoksy)-propan, analogt med Eksempel 1. Utbytte: 32,5% av det teoretiske. Prepared from 2-[(piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3-methoxy-phenoxy)- propane, analogous to Example 1. Yield: 32.5% of the theoretical.

Smp.: 142-145°C. M.p.: 142-145°C.

Beregnet: C, 60,58; H, 6,95; N, 5,52; Cl, 6,99 Calculated: C, 60.58; H, 6.95; N, 5.52; Cl, 6.99

Funnet: C, 60,42; H, 6,92; N, 5,50; Cl, 7,18 Found: C, 60.42; H, 6.92; N, 5.50; Cl, 7.18

Eksempel 77 Example 77

2-[(N-(3-(3-metyl-fenoksy)-propyl)-piperidyl-3)-metyl]-6,7-metvlendioksv- l- okso- 1. 2, 3, 4- tetrahvdro- isokinolin- hvdroklorid 2-[(N-(3-(3-methyl-phenoxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy- l- oxo- 1. 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 3-(3-metyl-fenoksy)-1-klor-propan, analogt med Eksempel 1. Utbytte: 31,6% av det teoretiske. Prepared from 2-[(piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(3-methyl-phenoxy)-1-chloro- propane, analogously to Example 1. Yield: 31.6% of the theoretical.

Smp.: 178-180°C. Melting point: 178-180°C.

Beregnet: C, 63,59; H, 6,97; N, 5,70; Cl, 7,22 Calcd: C, 63.59; H, 6.97; N, 5.70; Cl, 7.22

Funnet: C, 63,59; H, 6,92; N, 5,86; Cl, 7,50 Found: C, 63.59; H, 6.92; N, 5.86; Cl, 7.50

Eksempel 78 Example 78

2-[(N-(3-(4-metoksy-N-metyl-fenylamino)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-dihvdroklorid 2-[(N-(3-(4-methoxy-N-methyl-phenylamino)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4- tetrahydroisoquinoline dihydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l, 2,3,4-tetrahydro-isokinolin og l-klor-3-(4-metoksy-N-metyl-fenylamino) -propan, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(4-methoxy-N-methyl -phenylamino)-propane, analogous to Example 1.

Utbytte: 52,5% av det teoretiske. Yield: 52.5% of the theoretical.

Smp.: 180-183°C. M.p.: 180-183°C.

Beregnet: C, 60,64; H, 7,45; N, 7,58; Cl, 12,79 Calculated: C, 60.64; H, 7.45; N, 7.58; Cl, 12.79

Funnet: C, 60,50; H, 7,35; N, 7,56; Cl, 12,87 Found: C, 60.50; H, 7.35; N, 7.56; Cl, 12.87

Eksempel 79 Example 79

2 - [ (N- (3 - (4-metoksy-f enoksy) -propyl) -pyrrolidyl-3) -metyl ] - 6, 7- dimetoksy- l- okso- l, 2. 3, 4- tetrahvdro- isokinolin- hvdroklorid 2 - [ (N-(3 - (4-Methoxy-phenoxy)-propyl)-pyrrolidyl-3)-methyl ] - 6, 7- dimethoxy- l - oxo- l, 2, 3, 4- tetrahydro- isoquinoline - Hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-(3-(4-metoksy-fenoksy)-propyl)-3-benzen-sulfonyloksymetyl-pyrrolidin, analogt med Eksempel 2. Utbytte: 84,4% av det teoretiske. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-(3-(4-methoxy-phenoxy)-propyl)-3-benzene-sulfonyloxymethyl-pyrrolidine, analogous to Example 2. Yield: 84.4% of the theoretical.

Smp.: 142-144°C. M.p.: 142-144°C.

Beregnet: C, 63,60; H, 7,18; N, 5,71; Cl, 7,22 Calculated: C, 63.60; H, 7.18; N, 5.71; Cl, 7.22

Funnet: C, 63,75; H, 7,12; N, 5,64; Cl, 7,32 Found: C, 63.75; H, 7.12; N, 5.64; Cl, 7.32

Eksempel 80 Example 80

2- [(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin 2- [(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4- tetrahydroisoquinoline

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(p-toluensulfonyloksymetyl)-N-(6-metoksy-naf tyl-2-oksy) -pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulfonyloxymethyl)-N-(6-methoxy-naphthyl-2-oxy)-pyrrolidine, analog with Example 2.

Utbytte: 47% av det teoretiske. Yield: 47% of the theoretical.

Smp.: 142-144°C. M.p.: 142-144°C.

Beregnet: C, 71,41; H, 7,19; N, 5,55 Calculated: C, 71.41; H, 7.19; N, 5.55

Funnet: C, 71,14; H, 7,16; N, 5,53 Found: C, 71.14; H, 7.16; N, 5.53

Eksempel 81 Example 81

2-[(N-(3-(4-metoksy-fenoksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksv- 1. 2. 3, 4- tetrahvdro- isokinolin- dihvdroklorid 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy- 1. 2. 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(4-metoksy-fenoksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 90,9% av det teoretiske. Yield: 90.9% of the theoretical.

Smp.: 248-250°C. Melting point: 248-250°C.

Beregnet: C, 60,81; H, 7,46; N, 5,46; Cl, 13,81 Calculated: C, 60.81; H, 7.46; N, 5.46; Cl, 13.81

Funnet: C, 60,79; H, 7,61; N, 5,48; Cl, 13,84 Found: C, 60.79; H, 7.61; N, 5.48; Cl, 13.84

Eksempel 82 Example 82

2-[(N-(3-(4-metoksy-fenoksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetvl- l- okso- 1, 2, 3. 4- tetrahydro- isokinolin- hvdroklorid 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1- oxo- 1, 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(4-metoksy-fenoksy)-propyl]-3-benzen-sulfonyloksymetyl-pyrrolidin, analogt med Eksempel 2. Utbytte: 60,6% av det teoretiske. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxy-phenoxy)-propyl]-3-benzene-sulfonyloxymethyl-pyrrolidine, analogous to Example 2. Yield: 60.6% of the theoretical.

Smp.: 118-121°C. M.p.: 118-121°C.

Beregnet: C, 68,03; H, 7,69; N, 6,10; Cl, 7,72 Calculated: C, 68.03; H, 7.69; N, 6.10; Cl, 7.72

Funnet: C, 67,90; H, 7,71; N, 6,04; Cl, 7,90 Found: C, 67.90; H, 7.71; N, 6.04; Cl, 7.90

Eksempel 83 Example 83

2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy- l- okso- 1, 2, 3. 4- tetrahydro'- isokinolin- hvdroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro'-isoquinoline - Hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[2-(3,4-dimetoksy-fenoksy)-etyl]-3-benzen-sulfonyloksymetyl-pyrrolidin, analogt med Eksempel 2. Utbytte: 56,7% av det teoretiske. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(3,4-dimethoxy-phenoxy)-ethyl]-3-benzenesulfonyloxymethyl-pyrrolidine, analogous to Example 2. Yield: 56.7% of the theoretical.

Smp.: 116-118°C. M.p.: 116-118°C.

Beregnet: C, 63,60; H, 7,19; N, 5,71; Cl, 7,22 Calculated: C, 63.60; H, 7.19; N, 5.71; Cl, 7.22

Funnet: C, 63,82; H, 7,32; N, 5,60; Cl, 7,66 Found: C, 63.82; H, 7.32; N, 5.60; Cl, 7.66

Eksempel 84 Example 84

2-[(N-(3-(4-metoksy-fenoksy)-propyl)-pyrrolidyl-3)-metyl]-6. 7- dimetyl- l. 2, 3, 4- tetrahydro- isokinolin- dihvdroklorid 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-pyrrolidyl-3)-methyl]-6. 7- dimethyl- l. 2, 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[N-(3-(4-metoksy-fenoksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[N-(3-(4-methoxy-phenoxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 90,9% av det teoretiske. Yield: 90.9% of the theoretical.

Smp.: 243-246°C. M.p.: 243-246°C.

Beregnet: C, 64,85; H, 7,95; N, 5,82; Cl, 14,73 Calcd: C, 64.85; H, 7.95; N, 5.82; Cl, 14.73

Funnet: C, 64,88; H, 7,92; N, 5,63; Cl, 14,80 Found: C, 64.88; H, 7.92; N, 5.63; Cl, 14.80

Eksempel 85 Example 85

2 - [(N-(2-(3,4-dimetoksyfenyl)-etyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy- 1. 2, 3, 4- tetrahydro- isokinolin- dihydroklorid 2 - [(N-(2-(3,4-dimethoxyphenyl)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy- 1. 2, 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 92,9% av det teoretiske. Yield: 92.9% of the theoretical.

Smp.: 240-242°C. M.p.: 240-242°C.

Beregnet: C, 60,81; H, 7,46; N, 5,46; Cl, 13,81 Calculated: C, 60.81; H, 7.46; N, 5.46; Cl, 13.81

Funnet: C, 60,64; H, 7,61; N, 5,31; Cl, 13,50 Found: C, 60.64; H, 7.61; N, 5.31; Cl, 13.50

Eksempel 86 Example 86

2 - [ (N- (3-pyridy 1-4) -propyl) -pyrrolidyl-3) -metyl] -5,6-dimetyl- l- okso- 1. 3- dihydro- isoindol- dihydroklorid- semihydrat 2 - [ (N-(3-pyridy 1-4)-propyl)-pyrrolidyl-3)-methyl]-5,6-dimethyl- l- oxo- 1. 3- dihydro- isoindole- dihydrochloride- hemihydrate

Fremstillet fra 2-[(N-(3-pyridyl-4)-propyl)-pyrrolidyl-3)-metyl]-5,6-dimetyl-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-5,6-dimethyl-phthalimide and zinc/glacial acetic acid, analogously to Example 4.

Utbytte: 65% av det teoretiske. Yield: 65% of the theoretical.

Smp.: 119-122°C. M.p.: 119-122°C.

Beregnet: C, 62,02; H, 7,24; N, 9,43; Cl, 15,92 Calculated: C, 62.02; H, 7.24; N, 9.43; Cl, 15.92

Funnet: C, 62,25; H, 7,47; N, 9,39; Cl, 15,90 Found: C, 62.25; H, 7.47; N, 9.39; Cl, 15.90

Eksempel 87 Example 87

2-[3-(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-propyl]-5,6-dimetoksv- l- okso- 1. 3- dihydro- isoindol- dihydroklorid- monohvdrat 2-[3-(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-propyl]-5,6-dimethoxy- l - oxo- 1. 3- dihydro- isoindole- dihydrochloride- monohydrate

Fremstillet fra 2-[3-(N-(3-pyridyl-3)-propyl)-piperidyl-3)-propyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[3-(N-(3-pyridyl-3)-propyl)-piperidyl-3)-propyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4.

Utbytte: 72% av det teoretiske. Yield: 72% of the theoretical.

Smp.: 118-121°C. M.p.: 118-121°C.

Beregnet: C, 59,08; H, 7,43; N, 7,95; Cl, 13,41 Calculated: C, 59.08; H, 7.43; N, 7.95; Cl, 13.41

Funnet: C, 59,02; H, 7,23; N, 7,12; Cl, 13,27 Found: C, 59.02; H, 7.23; N, 7.12; Cl, 13.27

Eksempel 8 8 2 - [ (N- (3 - (pyridyl-3) -propyl) -piperidyl-3) -metyl ]-5,6-dimetoksy-l-okso-1,3-dihydro-isoindol-dihydroklorid-monohydrat Example 8 8 2-[ (N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole-dihydrochloride monohydrate

Fremstillet fra 2-[(N-(3-pyridyl-3)-propyl)-piperidyl-3)-metyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-pyridyl-3)-propyl)-piperidyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4.

Utbytte: 42% av det teoretiske. Yield: 42% of the theoretical.

Smp.: 91-96°C. M.p.: 91-96°C.

Beregnet: C, 59,08; H, 7,43; N, 7,95; Cl, 13,41 Calculated: C, 59.08; H, 7.43; N, 7.95; Cl, 13.41

Funnet: C, 59,02; H, 7,23; N, 7,12; Cl, 13,27 Found: C, 59.02; H, 7.23; N, 7.12; Cl, 13.27

Eksempel 89 Example 89

2-[ (N-( 2-(6,7-dimetoksy-isokinplyl-4)-etyl)-piperidyl-3)-metyl 1 - 5. 6- dimetoksv- l- okso- l. 3- dihydro- isoindol 2-[ (N-(2-(6,7-dimethoxy-isoquinoyl-4)-ethyl)-piperidyl-3)-methyl 1 - 5. 6- dimethoxy- l - oxo- l. 3- dihydro- isoindole

Fremstillet fra 2-[ (N-(2-(6,7-dimetoksy-isokinolyl-4)-etyl) -piperidyl-3) -metyl ] -5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[ (N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4 .

Utbytte: 64% av det teoretiske. Yield: 64% of the theoretical.

Smp.: 85-88°C. M.p.: 85-88°C.

Beregnet: C, 65,39; H, 7,19; N, 7,88 Calculated: C, 65.39; H, 7.19; N, 7.88

Funnet: C, 65,16; H, 7,27; N, 7,53 Found: C, 65.16; H, 7.27; N, 7.53

Eksempel 90 Example 90

2-[2- (N-(3-(pyridyl-4) -propyl) -piperidyl-2)-etyl]-5,6-dimetyl-1- okso- l. 3- dihydro- isoindol 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-5,6-dimethyl-1- oxo-l. 3- dihydro-isoindole

Fremstillet fra 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-5,6-dimetyl-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-5,6-dimethyl-phthalimide and zinc/glacial acetic acid, analogously to Example 4.

Utbytte: 73% av det teoretiske. Yield: 73% of the theoretical.

Smp.: 103-104°C. M.p.: 103-104°C.

Beregnet: C, 76,68; H, 8,49; N, 10,73 Calculated: C, 76.68; H, 8.49; N, 10.73

Funnet: C, 76,57; H, 8,54; N, 10,60 Found: C, 76.57; H, 8.54; N, 10.60

Eksempel 91 Example 91

2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-metyl]-5,6-dimetyl-1, 3- dihvdro- isoindol- trihvdroklorid- semihvdrat 2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-5,6-dimethyl-1, 3- dihydro-isoindole-trihydrochloride-semihydrate

Fremstillet fra 2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-metyl]-5,6-dimetyl-l-okso-l,3-dihydro-isoindol og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-5,6-dimethyl-1-oxo-1,3-dihydro-isoindole and lithium aluminum hydride in tetrahydrofuran/ ether, analogous to Example 3.

Utbytte: 68% av det teoretiske. Yield: 68% of the theoretical.

Smelteområde: 118-127°C (amorft) Melting range: 118-127°C (amorphous)

Beregnet: C, 59,03; H, 7,54; N, 8,98; Cl, 22,73 Calculated: C, 59.03; H, 7.54; N, 8.98; Cl, 22.73

Funnet: C, 58,93; H, 7,48; N, 8,84; Cl, 22,92 Found: C, 58.93; H, 7.48; N, 8.84; Cl, 22.92

Eksempel 92 Example 92

2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-5,6-dimetyl- 1. 3- dihydro- isoindol 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-5,6-dimethyl- 1.3- dihydro-isoindole

Fremstillet fra 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-5,6-dimetyl-l-okso-l,3-dihydro-isoindol og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-5,6-dimethyl-1-oxo-1,3-dihydro-isoindole and lithium aluminum hydride in tetrahydrofuran/ether, analogous to Example 3.

Utbytte: 70% av det teoretiske. Yield: 70% of the theoretical.

Smelteområde: 135-148°C (amorft) Melting range: 135-148°C (amorphous)

Beregnet: C, 54,59; H, 8,24; N, 7,63; Cl, 19,33 Calculated: C, 54.59; H, 8.24; N, 7.63; Cl, 19.33

Funnet: C, 54,48; H, 8,26; N, 7,51; Cl, 19,60 Found: C, 54.48; H, 8.26; N, 7.51; Cl, 19.60

Eksempel 93 Example 93

2-[(N-(1-(pyridyl-4)-metyl)-piperidyl-3)-metyl]-5,6-dimetoksy- 1. 3- dihydro- isoindol- trihydroklorid- trihvdrat 2-[(N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-5,6-dimethoxy- 1. 3- dihydro- isoindole- trihydrochloride- trihydrate

Fremstillet fra 2-[(N-(1-(pyridyl-4)-metyl)-piperidyl-3)-metyl]-5,6-dimetoksy-ftalimid og litiumaluminiumhydrid i eter, analogt med Eksempel 3. Prepared from 2-[(N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-5,6-dimethoxy-phthalimide and lithium aluminum hydride in ether, analogously to Example 3.

Utbytte: 68% av det teoretiske. Yield: 68% of the theoretical.

Smelteområde: 176-189°C (amorft) Melting range: 176-189°C (amorphous)

Beregnet: C, 49,76; H, 7,21; N, 7,91; Cl, 20,03 Calcd: C, 49.76; H, 7.21; N, 7.91; Cl, 20.03

Funnet: C, 49,93; H, 7,12; N, 8,00; Cl, 20,44 Found: C, 49.93; H, 7.12; N, 8.00; Cl, 20.44

Eksempel 94 2-[ (N-(2-(6,7-dimetoksy-isokinolyl-4)-etyl)-piperidyl-3)-metyl]-5,6-dimetyl-l,3-dihydro-isoindol-dihydroklorid-semihvdrat Example 94 2-[(N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-methyl]-5,6-dimethyl-1,3-dihydro-isoindole-dihydrochloride- semi-horizontal

Fremstillet fra 2-[(N-(2-(6,7-dimetoksy-isokinolyl-4)-etyl) -piperidyl-3) -metyl]-5,6-dimetyl-l-okso-l, 3-dihydro-isoindol og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-methyl]-5,6-dimethyl-1-oxo-1,3-dihydro- isoindole and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 22,7% av det teoretiske. Yield: 22.7% of the theoretical.

Smelteområde: 222-236°C (amorft) Melting range: 222-236°C (amorphous)

Beregnet: C, 62,22; H, 7,20; N, 7,50; Cl, 15,83 Calculated: C, 62.22; H, 7.20; N, 7.50; Cl, 15.83

Funnet: C, 62,01; H, 7,64; N, 7,08; Cl, 15,79 Found: C, 62.01; H, 7.64; N, 7.08; Cl, 15.79

Eksempel 95 Example 95

2- [ (N- (1- (pyridyl-4) -metyl) -piperidyl-3) -metyl]-5,6-metvlendioksy- 1, 3- dihydro- isoindol- trihydroklorid- semihydrat 2- [ (N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-5,6-methylenedioxy- 1, 3- dihydro- isoindole- trihydrochloride- hemihydrate

Fremstillet fra 2-[(N-(1-(pyridyl-4)-metyl)-piperidyl-3)-metyl]-5,6-metylendioksy-ftalimid og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-5,6-methylenedioxyphthalimide and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 55% av det teoretiske. Yield: 55% of the theoretical.

Smelteområde: 215-225°C (amorft) Melting range: 215-225°C (amorphous)

Beregnet: C, 53,68; H, 6,22; N, 8,94; Cl, 22,63 Calculated: C, 53.68; H, 6.22; N, 8.94; Cl, 22.63

Funnet: C, 53,60; H, 6,45; N, 8,65; Cl, 22,28 Found: C, 53.60; H, 6.45; N, 8.65; Cl, 22.28

Eksempel 96 Example 96

2 -[ (N-(3 -(pyridyl-4) -propyl)-pyrrolidyl-3) -metyl]-6,7-dimetyl-1,2,3,4-tetrahydro-isokinolin-trihydroklorid-monohydrat 2-[ (N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline-trihydrochloride monohydrate

Fremstillet fra 2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3) -metyl ] -6, 7-dimetyl-l-okso-l ,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 63% av det teoretiske. Yield: 63% of the theoretical.

Smp.: 254-256°C. M.p.: 254-256°C.

Beregnet: C, 58,71; H, 7,80; N, 8,56; Cl, 21,66 Calculated: C, 58.71; H, 7.80; N, 8.56; Cl, 21.66

Funnet: C, 58,53; H, 7,72; N, 8,25; Cl, 21,53 Found: C, 58.53; H, 7.72; N, 8.25; Cl, 21.53

Eksempel 97 Example 97

2 - [ (N-(1- (pyridyl-4) -metyl) -piperidyl-3) -metyl]-6,7-dimetoksy-1, 2, 3, 4- tetrahydro- isokinolin- trihydroklorid- dihydrat 2 - [ (N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1, 2, 3, 4- tetrahydro- isoquinoline- trihydrochloride- dihydrate

Fremstillet fra 2-[(N-(1-(pyridyl-4)-metyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 63% av det teoretiske. Yield: 63% of the theoretical.

Smelteområde: 158-169°C (amorft) Melting range: 158-169°C (amorphous)

Beregnet: C, 52,42; H, 7,27; N, 7,97; Cl, 20,18 Calculated: C, 52.42; H, 7.27; N, 7.97; Cl, 20,18

Funnet: C, 52,55; H, 7,49; N, 7,57; Cl, 20,25 Found: C, 52.55; H, 7.49; N, 7.57; Cl, 20.25

Eksempel 98 Example 98

2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-6,7-metylendioksy-1,2,3,4-tetrahydro-isokinolin-trihydroklorid-trihydrat 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-6,7-methylenedioxy-1,2,3,4-tetrahydro-isoquinoline-trihydrochloride-trihydrate

Fremstillet fra 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2) -etyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 90% av det teoretiske. Yield: 90% of the theoretical.

Smelteområde: 108-119°C (amorft) Melting range: 108-119°C (amorphous)

Beregnet: C, 52,58; H, 7,41; N, 7,36; Cl, 18,62 Calculated: C, 52.58; H, 7.41; N, 7.36; Cl, 18.62

Funnet: C, 52,56; H, 7,25; N, 7,38; Cl, 19,49 Found: C, 52.56; H, 7.25; N, 7.38; Cl, 19.49

Eksempel 99 Example 99

2-[(N-(3-(pyridyl-3)-propyl) -piperidyl-3)-metyl]-6,7-metylendioksy-1,2,3,4-tetrahydro-isokinolin-dihydroklorid-monohydrat 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride monohydrate

Fremstillet fra 2-[(N-(3-(pyridyl-3)-propyl)-piperidy1-3) -metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 72% av det teoretiske. Yield: 72% of the theoretical.

Smelteområde: 126-138°C (amorft) Melting range: 126-138°C (amorphous)

Beregnet: C, 59,50; H, 7,28; N, 8,67; Cl, 14,64 Calculated: C, 59.50; H, 7.28; N, 8.67; Cl, 14.64

Funnet: C, 59,57; H, 7,29; N, 8,49; Cl, 14,51 Found: C, 59.57; H, 7.29; N, 8.49; Cl, 14.51

Eksempel 100 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-1 . 2 . 3 . 4- tetrahydro- isokinolin- trihvdroklorid Example 100 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1. 2. 3. 4- tetrahydro- isoquinoline- trihydrochloride

Fremstillet fra 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 59% av det teoretiske. Yield: 59% of the theoretical.

Smelteområde: 138-154°C (amorft) Melting range: 138-154°C (amorphous)

Beregnet: C, 61,66; H, 7,86; N, 8,62; Cl, 21,84 Calculated: C, 61.66; H, 7.86; N, 8.62; Cl, 21.84

Funnet: C, 61,53; H, 8,00; N, 8,64; Cl, 21,35 Found: C, 61.53; H, 8.00; N, 8.64; Cl, 21.35

Eksempel 101 Example 101

2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetyl-l-okso-1,2,3,4-tetrahydro-isokinolin-dihydroklorid-monohvdrat 2-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride- monohvdrat

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormetyl-N-[3-(pyridyl-4)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(pyridyl-4)-propyl]-pyrrolidine, analogously to Example 2.

Utbytte: 39% av det teoretiske. Yield: 39% of the theoretical.

Smelteområde: 74-86°C (amorft) Melting range: 74-86°C (amorphous)

Beregnet: C, 61,53; H, 7,53; N, 8,97; Cl, 15,13 Calculated: C, 61.53; H, 7.53; N, 8.97; Cl, 15.13

Funnet: C, 61,42; H, 7,62; N, 8,83; Cl, 15,05 Found: C, 61.42; H, 7.62; N, 8.83; Cl, 15.05

Eksempel 102 Example 102

2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin-dihydroklorid-monohydrat 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride- monohydrate

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-benzensulfonsyre-N-[3-(pyridyl-3)-propyl)-piperidyl-3]-metylester i dimetylsulfoksyd med kalium-tert-butylat, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-benzenesulfonic acid-N-[3-(pyridyl-3-propyl)-piperidyl-3]-methyl ester in dimethylsulfoxide with potassium tert-butylate, analogously to Example 2.

Utbytte: 45% av det teoretiske. Yield: 45% of the theoretical.

Smelteområde: 140-148°C (amorft) Melting range: 140-148°C (amorphous)

Beregnet (x 2 HC1 x H20) : Calculated (x 2 HC1 x H20) :

C, 58,36; H, 7,25; N, 8,16; Cl, 13,78 C, 58.36; H, 7.25; N, 8.16; Cl, 13.78

Funnet: C, 58,35; H, 7,32; N, 8,04; Cl, 13,65 Found: C, 58.35; H, 7.32; N, 8.04; Cl, 13.65

Eksempel 103 Example 103

2-[(3-(N-(3-(pyridyl-4)-propyl)-piperidy1-3)-propyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin-dihydro- ' klorid- dihydrat 2-[(3-(N-(3-(pyridyl-4)-propyl)-piperidyl-3)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline -dihydro- ' chloride- dihydrate

Fremstillet fra 2-[3-(piperidyl-3)-propyl]-6,7-dimetoksy-l-okso-l, 2, 3, 4-tetrahydro-isokinolin og 4-(3-klorpropyl)pyridin, analogt med Eksempel 1. Prepared from 2-[3-(piperidyl-3)-propyl]-6,7-dimethoxy-1-oxo-1, 2, 3, 4-tetrahydro-isoquinoline and 4-(3-chloropropyl)pyridine, analogous to Example 1.

Utbytte: 48% av det teoretiske. Yield: 48% of the theoretical.

Smelteområde: 85-96°C (amorft) Melting range: 85-96°C (amorphous)

Beregnet: C, 57,84; H, 7,73; N, 7,49; Cl, 12,65 Calculated: C, 57.84; H, 7.73; N, 7.49; Cl, 12.65

Funnet: C, 57,71; H, 7,91; N, 7,35; Cl, 13,04 Found: C, 57.71; H, 7.91; N, 7.35; Cl, 13.04

Eksempel 104 Example 104

2-[3-(N-(2-(6,7-dimetoksy-isokinolyl-4)-etyl)-piperidyl-3)-propyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-dihydroklorid- monohydrat 2-[3-(N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-propyl]-6,7-dimethoxy-1-oxo-1,2,3, 4-tetrahydro-isoquinoline dihydrochloride monohydrate

Fremstillet fra 2-[3-(pyridyl-3)-propyl]-6,7-dimetoksy-l-okso-l, 2, 3, 4-tetrahydro-isokinolin og 4-(2-kloretyl)-6,7-dimetoksy-isokinolin, analogt med Eksempel 1. Prepared from 2-[3-(pyridyl-3)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 4-(2-chloroethyl)-6,7- dimethoxy-isoquinoline, analogous to Example 1.

Utbytte: 34% av det teoretiske. Yield: 34% of the theoretical.

Smelteområde: 162-171°C (amorft) Melting range: 162-171°C (amorphous)

Beregnet: C, 60,17; H, 7,10; N, 6,57; Cl, 11,10 Calculated: C, 60.17; H, 7.10; N, 6.57; Cl, 11.10

Funnet: C, 59,85; H, 7,00; N, 6,86; Cl, 11,04 Found: C, 59.85; H, 7.00; N, 6.86; Cl, 11.04

Eksempel 105 Example 105

2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-6,7-metylen-dioksv- l- okso- l. 2. 3, 4- tetrahydro- isokinolin- hydroklorid 2-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-6,7-methylene-dioxv- l- oxo- l. 2. 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormety1-N-[3-(pyridyl-3)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(pyridyl-3)-propyl]-piperidine, analogously to Example 2.

Utbytte: 60% av det teoretiske. Yield: 60% of the theoretical.

Smelteområde: 194-196°C (amorft) Melting range: 194-196°C (amorphous)

Beregnet: C, 64,92; H, 6,81; N, 9,46; Cl, 7,98 Calcd: C, 64.92; H, 6.81; N, 9.46; Cl, 7.98

Funnet: C, 64,91; H, 6,95; N, 9,67; Cl, 7,80 Found: C, 64.91; H, 6.95; N, 9.67; Cl, 7.80

Eksempel 106 Example 106

2-[(N-(1-(pyridyl-4)-metyl)-piperidyl-3) -metyl]-6,7-dimetoksy-1- okso- l. 2. 3, 4- tetrahvdro- isokinolin- dihvdroklorid- monohydrat 2-[(N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1- oxo- l. 2. 3, 4- tetrahydro- isoquinoline- dihydrochloride- monohydrate

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin i dimetylsulfoksyd méd kalium-tert-butylat og 3-klormetyl-N-[1-(pyridyl-4)-metyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline in dimethyl sulfoxide with potassium tert-butylate and 3-chloromethyl-N-[1-(pyridyl-4)-methyl]- piperidine, analogously to Example 2.

Utbytte: 41% av det teoretiske. Yield: 41% of the theoretical.

Smelteområde: 142-158°C (amorft) Melting range: 142-158°C (amorphous)

Beregnet: C, 56,78; H, 6,83; N, 8,63; Cl, 14,58 Calculated: C, 56.78; H, 6.83; N, 8.63; Cl, 14.58

Funnet: C, 56,45; H, 6,59; N, 8,66; Cl, 14,62 Found: C, 56.45; H, 6.59; N, 8.66; Cl, 14.62

Eksempel 107 Example 107

2- [(N-(2-(6,7-dimetoksy-isokinolyl-4)-etyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3;4-tetrahydro-isokinolin-dihvdroklorid 2- [(N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3;4- tetrahydroisoquinoline dihydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin i dimetylsulfoksyd med kalium-tert.butylat og 3-klormetyl-N-[2-(6,7-dimetoksy-isokinolyl-4)-etyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline in dimethylsulfoxide with potassium tert-butylate and 3-chloromethyl-N-[2-(6,7-dimethoxy-isoquinolyl- 4)-ethyl]-piperidine, analogously to Example 2.

Utbytte: 62% av det teoretiske. Yield: 62% of the theoretical.

Smelteområde: 148-162°C (amorft) Melting range: 148-162°C (amorphous)

Beregnet: C, 64,27; H, 7,01; N, 7,49; Cl, 12,65 Calculated: C, 64.27; H, 7.01; N, 7.49; Cl, 12.65

Funnet: C, 64,11; H, 7,20; N, 7,59; Cl, 12,89 Found: C, 64.11; H, 7.20; N, 7.59; Cl, 12.89

Eksempel 108 Example 108

2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin-dihvdroklorid- dihvdrat 2-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline- dihydrochloride- dihydrochloride

Fremstillet fra 6,7-metylehdioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 2-(2-kloretyl)-N-[3-(pyridyl-4)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-methylehdioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-chloroethyl)-N-[3-(pyridyl-4)-propyl]-piperidine, analogous to Example 2.

Smelteområde: 115-128°C (amorft) Melting range: 115-128°C (amorphous)

Beregnet: C, 56,59; H, 7,03; N, 7,92; Cl, 13,37 Calculated: C, 56.59; H, 7.03; N, 7.92; Cl, 13.37

Funnet: C, 56,61; H, 6,90; N, 7,84; Cl, 13,41 Found: C, 56.61; H, 6.90; N, 7.84; Cl, 13.41

Eksempel 109 Example 109

2- [ (N- (3 - (pyridyl-3) -propyl) -piperidyl-3) -metyl]-6,7-dimetyl-1- okso- l . 2. 3. 4- tetrahvdro- isokinolin- dihvdroklorid- dihvdrat 2-[ (N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1. 2. 3. 4- tetrahydro- isoquinoline- dihydrochloride- dihydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin i dimetylsulfoksyd med kalium-tert-butylat og 3-klormetyl-N-[3-(pyridyl-3)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline in dimethyl sulfoxide with potassium tert-butylate and 3-chloromethyl-N-[3-(pyridyl-3)-propyl]- piperidine, analogously to Example 2.

Utbytte: 62% av det teoretiske. Yield: 62% of the theoretical.

Smelteområde: 118-127°C (amorft) Melting range: 118-127°C (amorphous)

Beregnet: C, 60,00; H, 7,85; N, 8,39; Cl, 14,16 Calculated: C, 60.00; H, 7.85; N, 8.39; Cl, 14,16

Funnet: C, 60,24; H, 8,07; N, 8,36; Cl, 14,62 Found: C, 60.24; H, 8.07; N, 8.36; Cl, 14.62

Eksempel 110 Example 110

2- [ (N-(3- (pyridyl-3) -propyl) -pyrrolidyl-3) -metyl] -6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin-dihvdroklorid 2- [ (N-(3-(pyridyl-3)-propyl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline dihydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-kl orme ty 1-N- [3-(pyridyl-3) -propyl ]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-cl orme ty 1-N-[3-(pyridyl-3)-propyl]-pyrrolidine, analogously to Example 2.

Utbytte: 26% av det teoretiske. Yield: 26% of the theoretical.

Smelteområde: 102-113°C (amorft) Melting range: 102-113°C (amorphous)

Beregnet: C, 59,22; H, 6,27; N, 9,01; Cl, 15,20 Calculated: C, 59.22; H, 6.27; N, 9.01; Cl, 15,20

Funnet: C, 59,27; H, 6,49; N, 8,92; Cl, 14,48 Found: C, 59.27; H, 6.49; N, 8.92; Cl, 14.48

Eksempel 111 Example 111

2- [ (N- (3-(pyridyl-4) -propyl) -pyrrolidyl-3)-metyl]-7,8-metylen-dioksv- 2- okso- l. 3- dihydro- 2H- 3- benzazepin- dihvdroklorid 2- [ (N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylene-dioxv- 2- oxo- l. 3- dihydro- 2H- 3- benzazepine- dihydrochloride

Fremstillet fra 7,8-metylendioksy-2-okso-l,3-dihydro-2H-3- benzazepin og 3-klormety1-N-[3-(pyridyl-4)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[3-(pyridyl-4)-propyl]-pyrrolidine, analogous to Example 2.

Utbytte: 58% av det teoretiske. Yield: 58% of the theoretical.

Smelteområde: 132-141°C (amorft) Melting range: 132-141°C (amorphous)

Beregnet: C, 60,25; H, 6,11; N, 8,78; Cl, 14,82 Calculated: C, 60.25; H, 6.11; N, 8.78; Cl, 14.82

Funnet: C, 60,00; H, 6,40; N, 8,52; Cl, 14,56 Found: C, 60.00; H, 6.40; N, 8.52; Cl, 14.56

Eksempel 112 Example 112

2- [(N-(3-(pyridyl-3)-propyl)-piperid-3-yl)-metyl] -7,8-dimetoksy-2-okso-l, 3-dihydro-2H-3-benzazepin-dihydroklorid-dihvdrat 2-[(N-(3-(pyridyl-3)-propyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine- dihydrochloride-dihydrate

Fremstillet fra 7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin og 3-klormetyl-N-[3-(pyridyl-3)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[3-(pyridyl-3)-propyl]-piperidine, analogously to Example 2.

Utbytte: 67% av det teoretiske. Yield: 67% of the theoretical.

Smelteområde: 128-134°C (amorft) Melting range: 128-134°C (amorphous)

Beregnet: C, 57,34; H, 7,21; N, 7,71; Cl, 13,02 Calculated: C, 57.34; H, 7.21; N, 7.71; Cl, 13.02

Funnet: C, 57,80; H, 7,37; N, 7,92; Cl, 13,06 Found: C, 57.80; H, 7.37; N, 7.92; Cl, 13.06

Eksempel 113 Example 113

3- [ (N- (3- (pyridyl-3) -propyl) -piperidyl-3) -metyl] -7,8-dimetyl-2- okso- l. 3- dihvdro- 2H- 3- benzazepin- dihvdroklorid- dihydrat 3- [ (N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethyl-2- oxo- l. 3- dihydro- 2H- 3- benzazepine- dihydrochloride- dihydrate

Fremstillet fra 7,8-dimetyl-2-okso-l,3-dihydro-2H-3-benzazepin og 3-klormetyl-N-[3-(pyridyl-3)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[3-(pyridyl-3)-propyl]-piperidine, analogous to Example 2.

Utbytte: 94% av det teoretiske. Yield: 94% of the theoretical.

Smelteområde: 77-86°C (amorft) Melting range: 77-86°C (amorphous)

Beregnet: C, 60,92; H, 7,67; N, 8,19; Cl, 13,83 Calcd: C, 60.92; H, 7.67; N, 8.19; Cl, 13.83

Funnet: C, 60,75; H, 7,60; N, 8,37; Cl, 13,72 Found: C, 60.75; H, 7.60; N, 8.37; Cl, 13.72

Eksempel 114 Example 114

3- [2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-7,8-dimetyl- 2- okso- l. 3- dihvdro- 2H- 3- benzazepin- dihydroklorid 3- [2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-dimethyl- 2- oxo- l. 3- dihydro- 2H- 3- benzazepine- dihydrochloride

Fremstillet fra 7,8-dimetyl-2-okso-l,3-dihydro-2H-3-benzazepin og 2-(2-kloretyl)-N-[3-(pyridyl-4)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 2-(2-chloroethyl)-N-[3-(pyridyl-4)-propyl]-piperidine, analogous to Example 2.

Utbytte: 94% av det teoretiske. Yield: 94% of the theoretical.

Smelteområde: 118-130°C (amorft) Melting range: 118-130°C (amorphous)

Beregnet: C, 66,11; H, 7,60; N, 8,56; Cl, 14,45 Calculated: C, 66.11; H, 7.60; N, 8.56; Cl, 14.45

Funnet: C, 65,92; H, 7,86; N, 8,33; Cl, 14,09 Found: C, 65.92; H, 7.86; N, 8.33; Cl, 14.09

Eksempel 115 Example 115

3-[(N-(2-(6,7-dimetoksy-isokinolyl-4)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin-monohvdrat 3-[(N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H- 3-benzazepine monohydrate

Fremstillet fra 7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin og 3-klormetyl-N-[2-(6,7-dimetoksy-isokinolyl-4)-etyl]-piperidin, analogt med Eksempel 2. Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[2-(6,7-dimethoxy-isoquinolyl-4)-ethyl]-piperidine, analogous to Example 2.

Utbytte: 69% av det teoretiske. Yield: 69% of the theoretical.

Smelteområde: 85-96°C (amorft) Melting range: 85-96°C (amorphous)

Beregnet: C, 67,73; H, 7,15; N, 7,64 Calculated: C, 67.73; H, 7.15; N, 7.64

Funnet: C, 67,96; H, 7,19; N, 7,75 Found: C, 67.96; H, 7.19; N, 7.75

Eksempel 116 Example 116

3-[3-(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-propyl]-7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin-dihydroklorid-monohvdrat 3-[3-(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-propyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine- dihydrochloride monohydrate

Fremstillet fra 7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin og 3-(3-klorpropyl)-N-[3-(pyridyl-3)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-(3-chloropropyl)-N-[3-(pyridyl-3)-propyl]-piperidine, analogous to Example 2.

Utbytte: 72% av det teoretiske. Yield: 72% of the theoretical.

Smelteområde: 94-106°C (amorft) Melting range: 94-106°C (amorphous)

Beregnet: C, 60,64; H, 7,45; N, 7,57; Cl, 12,78 Calculated: C, 60.64; H, 7.45; N, 7.57; Cl, 12.78

Funnet: C, 60,80; H, 7,44; N, 7,46; Cl, 12,59 Found: C, 60.80; H, 7.44; N, 7.46; Cl, 12.59

Eksempel 117 Example 117

3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2) -etyl]-7,8-metylendioksy-2-okso-l,3-dihydro-2H-3-benzazepin-dihydroklorid- dihvdrat 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine- dihydrochloride-dihdrate

Fremstillet fra 7,8-metylendioksy-2-okso-l,3-dihydro-2H-3-benzazepin og 2-(2-kloretyl)-N-[3-(pyridyl-4)-propyl]-piperidin i dimetylsulfoksyd og kalium-tert-butylat, analogt med Eksempel 2. Prepared from 7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 2-(2-chloroethyl)-N-[3-(pyridyl-4)-propyl]-piperidine in dimethylsulfoxide and potassium tert-butylate, analogously to Example 2.

Utbytte: 67% av det teoretiske. Yield: 67% of the theoretical.

Smelteområde: 148-161°C (amorft) Melting range: 148-161°C (amorphous)

Beregnetr C, 57,56; H, 6,87; N, 7,74; Cl, 13,07 Calculated C, 57.56; H, 6.87; N, 7.74; Cl, 13.07

Funnet: C, 57,72; H, 7,03; N, 7,61; Cl, 13,62 Found: C, 57.72; H, 7.03; N, 7.61; Cl, 13.62

Eksempel 118 3-[(N-(l-(pyridyl-4)-metyl)-piperidyl-3)-metyl]-7,8-dimetyl-2- okso- l, 3- dihvdro- 2H- 3- benzazepin- dihvdroklorid- monohydrat Example 118 3-[(N-(1-(pyridyl-4)-methyl)-piperidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine- dihydrochloride monohydrate

Fremstillet fra 7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin og 3-klormetyl-N-[l-(pyridyl-4)-metyl]-piperidin i dimetylsulfoksyd og kalium-tert-butylat, analogt med Eksempel 2- Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[l-(pyridyl-4-methyl]-piperidine in dimethylsulfoxide and potassium tert- butylate, analogous to Example 2-

Utbytte: 75% av det teoretiske. Yield: 75% of the theoretical.

Smelteområde: 113-127°C (amorft) Melting range: 113-127°C (amorphous)

Beregnet: C, 61,79; H, 7,13; N, 9,01; Cl, 15,20 Calcd: C, 61.79; H, 7.13; N, 9.01; Cl, 15,20

Funnet: C, 61,55; H, 7,32; N, 9,04; Cl, 15,11 Found: C, 61.55; H, 7.32; N, 9.04; Cl, 15,11

Eksempel 119 Example 119

3- [ (N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-metyl]-7,8-metylendioksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihvdroklorid- monohydrat 3- [ (N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzazepine dihydrochloride monohydrate

Fremstillet fra 3-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-metyl]-7,8-metylendioksy-2-okso-l,3-dihydro-2H-3-benzazepin og 10% palladium/kull og et hydrogentrykk på 5 bar ved romtemperatur, analogt med Eksempel 5. Prepared from 3-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 10% palladium/coal and a hydrogen pressure of 5 bar at room temperature, analogous to Example 5.

Utbytte: 71% av det teoretiske. Yield: 71% of the theoretical.

Smelteområde: 95-106°C (amorft) Melting range: 95-106°C (amorphous)

Beregnet: C, 57,83; H, 6,67; N, 8,43; Cl, 14,22 Calculated: C, 57.83; H, 6.67; N, 8.43; Cl, 14.22

Funnet: C, 57,67; H, 6,82; N, 8,27; Cl, 14,05 Found: C, 57.67; H, 6.82; N, 8.27; Cl, 14.05

Eksempel 120 Example 120

3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-7,8-dimetyl-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid-semihvdrat 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine dihydrochloride semihydrate

Fremstillet fra 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-7,8-dimetyl-2-okso-l,3-dihydro-2H-3-benzazepin og 10% palladium/kull og et hydrogentrykk på 5 bar ved 80°C, analogt med Eksempel 5. Prepared from 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H-3- benzazepine and 10% palladium/charcoal and a hydrogen pressure of 5 bar at 80°C, analogous to Example 5.

Utbytte: 73% av det teoretiske. Yield: 73% of the theoretical.

Smp: 236-238°C M.p.: 236-238°C

Beregnet: C, 64,65; H, 8,04; N, 8,37; Cl, 14,14 Calculated: C, 64.65; H, 8.04; N, 8.37; Cl, 14,14

Funnet: C, 64,91; H, 8,02; N, 8,25; Cl, 13,92 Found: C, 64.91; H, 8.02; N, 8.25; Cl, 13.92

Eksempel 121 Example 121

3-[3-(N-(2-(2-metyl-pyridy1-6)-etyl)-piperidyl-3)-propyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid- monohvdrat 3-[3-(N-(2-(2-methyl-pyridyl-6-ethyl)-piperidyl-3)-propyl]-7,8-dimethoxy-2-oxo-1,3,4,5- tetrahydro-2H-3-benzazepine dihydrochloride monohydrate

Fremstillet fra 3-[3-(piperidyl-3)-propyl)-7,8-dimetoksy-2- okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-benzensulfonsyre-(6-metyl-pyridyl-2)-etylester i dimetylsulfoksyd med kalium-karbonat ved 120°C, analogt med Eksempel 1. Prepared from 3-[3-(piperidyl-3-propyl)-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-benzenesulfonic acid-(6-methyl -pyridyl-2)-ethyl ester in dimethylsulfoxide with potassium carbonate at 120°C, analogously to Example 1.

Utbytte: 29% av det teoretiske. Yield: 29% of the theoretical.

Smelteområde: 105-113°C (amorft) Melting range: 105-113°C (amorphous)

Beregnet: C, 60,42; H, 7,78; N, 7,55 Calculated: C, 60.42; H, 7.78; N, 7.55

Funnet: C, 60,68; H, 7,50; N, 7,42 Found: C, 60.68; H, 7.50; N, 7.42

Eksempel 122 Example 122

3- [(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihvdroklorid 3- [(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzazepine dihydrochloride

Fremstillet fra 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin ved hydrering ved 5 bar hydrogentrykk i etanol med 10% palladium/- kull ved 70°C, analogt med Eksempel 5. Prepared from 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine by hydration at 5 bar hydrogen pressure in ethanol with 10% palladium/charcoal at 70°C, analogously to Example 5.

Utbytte: 52% av det teoretiske. Yield: 52% of the theoretical.

Smelteområde: 113-122°C (amorft) Melting range: 113-122°C (amorphous)

Beregnet: C, 61,17; H, 7,30; N, 8,23 Calculated: C, 61.17; H, 7.30; N, 8.23

Funnet: C, 61,31; H, 7,50; N, 8,28 Found: C, 61.31; H, 7.50; N, 8.28

Eksempel 123 Example 123

3-[(N-(2-(6,7-dimetoksy-isokinolyl-4)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin x 1/ 2 H?03-[(N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5- tetrahydro-2H-3-benzazepine x 1/ 2 H?0

Fremstillet fra 3-[(N-(2-(6,7-dimetbksy-isokinolyl-4)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin ved hydrering under 5 bar hydrogentrykk med 10% palladium/kull i etanol ved 70°C, analogt med Eksempel 5. Prepared from 3-[(N-(2-(6,7-dimethoxy-isoquinolyl-4)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro- 2H-3-benzazepine by hydration under 5 bar hydrogen pressure with 10% palladium/charcoal in ethanol at 70°C, analogous to Example 5.

Utbytte: 50% av det teoretiske. Yield: 50% of the theoretical.

Smelteområde: 82-86°C (amorft) Melting range: 82-86°C (amorphous)

Beregnet: C, 66,40; H, 7,55; N, 7,48; Calculated: C, 66.40; H, 7.55; N, 7.48;

Funnet: C, 66,26; H, 7,50; N, 7,59; Found: C, 66.26; H, 7.50; N, 7.59;

Eksempel 124 Example 124

3-[3-(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-propyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid- dihydrat 3-[3-(N-(3-(pyridyl-3-propyl)-piperidyl-3)-propyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine dihydrochloride dihydrate

Fremstillet fra 3-[3-(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-propyl]-7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin ved hydrering under 5 bar hydrogentrykk med 10% palladium/kull i etanol ved 70°C, analogt med Eksempel 5. Prepared from 3-[3-(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-propyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3- benzazepine by hydration under 5 bar hydrogen pressure with 10% palladium/charcoal in ethanol at 70°C, analogously to Example 5.

Utbytte: 64% av det teoretiske. Yield: 64% of the theoretical.

Smelteområde: 106-115°C (amorft) Melting range: 106-115°C (amorphous)

Beregnet: C, 58,53; H, 7,89; N, 7,31; Cl, 12,34 Calculated: C, 58.53; H, 7.89; N, 7.31; Cl, 12.34

Funnet: C, 58,46; H, 7,61; N, 7,14; Cl, 12,57 Found: C, 58.46; H, 7.61; N, 7.14; Cl, 12.57

Eksempel 125 Example 125

3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-7,8-metylendioksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihvdroklorid- monohvdrat 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzazepine dihydrochloride monohydrate

Fremstillet fra 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-7,8-metylendioksy-2-okso-l,3-dihydro-2H-3-benzazepin Prepared from 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine

under 5 bar hydrogentrykk med 10% palladium/kull i etanol ved 80°C, analogt med Eksempel 5. under 5 bar hydrogen pressure with 10% palladium/coal in ethanol at 80°C, analogous to Example 5.

Utbytte: 81% av det teoretiske. Yield: 81% of the theoretical.

Smelteområde: 126-138°C (amorft) Melting range: 126-138°C (amorphous)

Beregnet: C, 58,58; H, 6,88; N, 8,19; Cl, 13,83 Calculated: C, 58.58; H, 6.88; N, 8.19; Cl, 13.83

Funnet: C, 58,43; H, 7,00; N, 7,85; Cl, 13,71 Found: C, 58.43; H, 7.00; N, 7.85; Cl, 13.71

Eksempel 126 3-[2-(N-(3-(pyridyl-4)-propyl) -piperidyl-2)-etyl]-7,8-metylendioksy-2-okso-l ,3,4,5-tetrahydro-2H-3-benzazepin-d ihvdrokiorid- monohvdrat Example 126 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine-dihydrochloride monohydrate

Fremstillet fra 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2) -etyl] -7,8-metylendioksy-2-okso-l, 3-dihydro-2H-3-benzazepin under 5 bar hydrogentrykk med 10% palladium/kull i etanol ved 80°C, analogt med Eksempel 5. Prepared from 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3- benzazepine under 5 bar hydrogen pressure with 10% palladium/charcoal in ethanol at 80°C, analogous to Example 5.

Utbytte: 74% av det teoretiske. Yield: 74% of the theoretical.

Smelteområde: 132-146°C (amorft) Melting range: 132-146°C (amorphous)

Beregnet: C, 59,31; H, 7,08; N, 7,98; Cl, 13,46 Calculated: C, 59.31; H, 7.08; N, 7.98; Cl, 13.46

Funnet: C, 59,18; H, 7,41; N, 7,80; Cl, 13,25 Found: C, 59.18; H, 7.41; N, 7.80; Cl, 13.25

Eksempel 127 Example 127

3 -[ (N- (3 - (pyridyl-3) -propyl) -piperidyl-3) -metyl] -7,8-dimetyl-2- okso- l . 3, 4, 5- tetrahydro- 2H- 3- benzazepin- dihvdroklorid 3-[ (N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethyl-2-oxo-1. 3, 4, 5- tetrahydro- 2H- 3- benzazepine dihydrochloride

Fremstillet fra 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3) -metyl]-7,8-dimetyl-2-okso-l,3-dihydro-2H-3-benzazepin og 5 bar hydrogentrykk med 10% palladium/kull i etanol ved 80°C, analogt med Eksempel 5. Prepared from 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 5 bar hydrogen pressure with 10% palladium/coal in ethanol at 80°C, analogous to Example 5.

Utbytte: 54% av det teoretiske. Yield: 54% of the theoretical.

Smelteområde: 92-105°C (amorft) Melting range: 92-105°C (amorphous)

Beregnet: C, 62,90; H, 7,92; N, 8,46; Cl, 14,28 Calculated: C, 62.90; H, 7.92; N, 8.46; Cl, 14.28

Funnet: C, 63,19; H, 7,90; N, 8,45; Cl, 14,30 Found: C, 63.19; H, 7.90; N, 8.45; Cl, 14.30

Eksempel 128 Example 128

3- [(N-(3-(pyridyl-4)-propyl) -pyrrolidyl-3)-metyl]-7,8-metylendioksy-l ,3,4,5-tetrahydro-2H-3-benzazepin-trihydro-klor id- monohvdrat 3- [(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydro- chlorine id monohydrate

Fremstillet fra 3-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3) -metyl ] -7,8-metylendioksy-2-okso-l ,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(pyridyl-4)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 73% av det teoretiske. Yield: 73% of the theoretical.

Smelteområde: 96-108°C (amorft) Melting range: 96-108°C (amorphous)

Beregnet: C, 55,33; H, 6,97; N, 8,06; Cl, 20,42 Calculated: C, 55.33; H, 6.97; N, 8.06; Cl, 20.42

Funnet: C, 55,06; H, 7,28; N, 7,77; Cl, 20,07 Found: C, 55.06; H, 7.28; N, 7.77; Cl, 20.07

Eksempel 129 Example 129

3-[ (N-(3-(pyridyl-3) -propyl) -piperidyl-3)-metyl]-7,8-dimetoksy- 1, 3, 4, 5- tetrahydro- 2H- 3- benzazepin- dihydroklorid 3-[ (N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethoxy- 1, 3, 4, 5- tetrahydro- 2H- 3- benzazepine- dihydrochloride

Fremstillet fra 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3) -metyl ] -7,8-dimetoksy-2-okso-l ,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 71% av det teoretiske. Yield: 71% of the theoretical.

Smp: 208-210°C M.p.: 208-210°C

Beregnet: C, 62,89; H, 7,91; N, 8,46; Cl, 14,28 Calcd: C, 62.89; H, 7.91; N, 8.46; Cl, 14.28

Funnet: C, 62,70; H, 7,53; N, 8,22; Cl, 14,50 Found: C, 62.70; H, 7.53; N, 8.22; Cl, 14.50

Eksempel 130 Example 130

3- [2- (N- (3- (pyridyl-4) -propyl) -piperidyl-2) -etyl] -7,8-metylendioksy-1,3,4,5-tetrahydro-2H-3-benzazepin-trihydroklorid 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine- trihydrochloride

Fremstillet fra 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2) -etyl ] -7,8-metylendioksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[2-(N-(3-(pyridyl-4-propyl)-piperidyl-2)-ethyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 63% av det teoretiske. Yield: 63% of the theoretical.

Smelteområde: 123-136°C (amorft) Melting range: 123-136°C (amorphous)

Beregnet: C, 58,81; H, 7,21; N, 7,91; Cl, 20,00 Calculated: C, 58.81; H, 7.21; N, 7.91; Cl, 20.00

Funnet: C, 58,51; H, 7,41; N, 7,92; Cl, 19,86 Found: C, 58.51; H, 7.41; N, 7.92; Cl, 19.86

Eksempel 131 Example 131

3 - [ (N- (3 - (pyridyl-3) -propyl) -piperidyl-3) -metyl] -7,8-metylendioksy-1,3,4,5-tetrahydro-2H-3-benzazepin-trihydroklorid- semihvdrat 3 - [ (N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydrochloride- semi-horizontal

Fremstillet fra 3-[ (N-(3-(pyridyl-3)-propyl)-piperidyl-3) -metyl ] -7 , 8-metylendioksy-2-okso-1,3,4, 5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[ (N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 75% av det teoretiske. Yield: 75% of the theoretical.

Smelteområde: 126-138°C (amorft) Melting range: 126-138°C (amorphous)

Beregnet: C, 57,09; H, 7,10; N, 7,99; Cl, 20,22 Calculated: C, 57.09; H, 7.10; N, 7.99; Cl, 20,22

Funnet: C, 57,05; H, 7,32; N, 8,05; Cl, 20,37 Found: C, 57.05; H, 7.32; N, 8.05; Cl, 20.37

Eksempel 132 Example 132

3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-etyl]-7,8-dimetvl- 1, 3. 4, 5- tetrahydro- 2H- 3- benzazepin- trihvdroklorid 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-dimethyl- 1, 3, 4, 5- tetrahydro- 2H- 3- benzazepine- trihydrochloride

Fremstillet fra 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2) -etyl]-7,8-dimetyl-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[2-(N-(3-(pyridyl-4)-propyl)-piperidyl-2)-ethyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 92% av det teoretiske. Yield: 92% of the theoretical.

Smp.: 180-182°C M.p.: 180-182°C

Beregnet: C, 62,96; H, 8,22; N, 8,16; Cl, 20,65 Calcd: C, 62.96; H, 8.22; N, 8.16; Cl, 20.65

Funnet: C, 63,00; H, 8,29; N, 8,16; Cl, 20,34 Found: C, 63.00; H, 8.29; N, 8.16; Cl, 20.34

Eksempel 133 Example 133

3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-metyl]-7,8-dimetyl-1. 3. 4. 5- tetrahydro- 2H- 3- benzazepin- trihydroklorid 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethyl-1. 3. 4. 5- tetrahydro- 2H- 3- benzazepine trihydrochloride

Fremstillet fra 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3) -metyl]-7,8-dimetyl-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(pyridyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 81% av det teoretiske. Yield: 81% of the theoretical.

Smelteområde: 184-196°C (amorft) Melting range: 184-196°C (amorphous)

Beregnet: C, 60,17; H, 8,16; N, 8,10; Cl, 20,49 Calculated: C, 60.17; H, 8.16; N, 8.10; Cl, 20.49

Funnet: C, 60,28; H, 8,25; N, 8,00; Cl, 20,39 Found: C, 60.28; H, 8.25; N, 8.00; Cl, 20.39

Eksempel 134 Example 134

3-[2-(N-(2-(6-metoksy-naftyl-2)-etyl)-piperidyl-2)-etyl]-7,8-dimetoksy- 2- okso- 1. 3, 4. 5- tetrahvdro- 2H- 3- benzazepin-hydroklorid 3-[2-(N-(2-(6-methoxy-naphthyl-2)-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy- 2- oxo- 1. 3, 4. 5- tetrahydro-2H-3-benzazepine hydrochloride

Fremstillet fra 3-[2-(piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-(6-metoksy-naf tyl-2 ) -etylbromid, analogt med Eksempel 1. Prepared from 3-[2-(piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(6-methoxy-naphth tyl-2)-ethyl bromide, analogously to Example 1.

Utbytte: 20% av det teoretiske. Yield: 20% of the theoretical.

Smp.: 158-160°C Melting point: 158-160°C

Beregnet: C, 69,48; H, 7,47; N, 5,06; Cl, 6,41 Calcd: C, 69.48; H, 7.47; N, 5.06; Cl, 6.41

Funnet: C, 69,40; H, 7,56; N, 5,17; Cl, 6,62 Found: C, 69.40; H, 7.56; N, 5.17; Cl, 6.62

Eksempel 135 3-[2-(N-(2-(5-metyl-6-metoksy-naftyl-2)-etyl)-piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin- hydroklorid Example 135 3-[2-(N-(2-(5-methyl-6-methoxy-naphthyl-2)-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1, 3,4,5-tetrahydro-2H-3-benzazepine hydrochloride

Fremstillet fra 3-[2-(piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(5-metyl-6-metoksy-naftyl-2)-etylbromid, analogt med Eksempel 1. Utbytte: 28% av det teoretiske. Prepared from 3-[2-(piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(5-methyl-6 -methoxy-naphthyl-2)-ethyl bromide, analogous to Example 1. Yield: 28% of the theoretical.

Smp.: 140-143°C M.p.: 140-143°C

Beregnet: C, 69,88; H, 7,64; N, 4,94; Cl, 6,25 Calcd: C, 69.88; H, 7.64; N, 4.94; Cl, 6.25

Funnet: C, 69,06; H, 7,57; N, 4,84; Cl, 6,44Found: C, 69.06; H, 7.57; N, 4.84; Cl, 6.44

Eksempel 136 Example 136

3-[2-(N-(2-naftyl-l-oksy)-etyl)-piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid 3-[2-(N-(2-naphthyl-1-oxy)-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H -3-benzazepine hydrochloride

Fremstillet fra 3-[2-(piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(naftyl-l-oksy)-etylbromid, analogt med Eksempel 1. Prepared from 3-[2-(piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-1-oxy )-ethyl bromide, analogous to Example 1.

Utbytte: 27% av det teoretiske. Yield: 27% of the theoretical.

Smp.: 146-148°C M.p.: 146-148°C

Beregnet: C, 69,06; H, 7,29; N, 5,20; Cl, 6,58 Calculated: C, 69.06; H, 7.29; N, 5.20; Cl, 6.58

Funnet: C, 69,00; H, 7,07; N, 5,31; Cl, 6,68 Found: C, 69.00; H, 7.07; N, 5.31; Cl, 6.68

Eksempel 137 Example 137

3-[2-(N-(2-(naftyl-1)-etyl)-piperidyl-2)-etyl]-7,8-dimetoksy-2- okso- l, 3, 4, 5- tetrahydro- 2H- 3- benzazepin- hydroklorid 3-[2-(N-(2-(naphthyl-1)-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1, 3, 4, 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[2-(piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(naftyl-1)-etylbromid, analogt med Eksempel 1. Prepared from 3-[2-(piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-1)- ethyl bromide, analogous to Example 1.

Utbytte: 24% av det teoretiske: Yield: 24% of the theoretical:

Smp.: 148-150°C Melting point: 148-150°C

Beregnet: C, 71,18; H, 7,51; N, 5,36; Cl, 6,78 Calculated: C, 71.18; H, 7.51; N, 5.36; Cl, 6.78

Funnet: C, 70,92; H, 7,44; N, 5,57; Cl, 7,06 Found: C, 70.92; H, 7.44; N, 5.57; Cl, 7.06

Eksempel 138 Example 138

3-[2-(N-(4-(naftyl-2-oksy)-butyl)-piperidyl-2)-etyl]-7,8-dimetoksy- 2- okso- 1, 3, 4, 5- tetrahvdro- 2H- benzazepin- hvdroklorid 3-[2-(N-(4-(naphthyl-2-oxy)-butyl)-piperidyl-2)-ethyl]-7,8-dimethoxy- 2- oxo- 1, 3, 4, 5- tetrahydro- 2H-benzazepine hydrochloride

Fremstillet fra 3-[2-(piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l/3,4,5-tetrahydro-2H-3-benzazepin og 4-(naftyl-2-oksy)-butylbromid, analogt med Eksempel 1. Prepared from 3-[2-(piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1/3,4,5-tetrahydro-2H-3-benzazepine and 4-(naphthyl-2-oxy )-butyl bromide, analogous to Example 1.

Utbytte: 39% av det teoretiske. Yield: 39% of the theoretical.

Smp.: 112-114°C M.p.: 112-114°C

Beregnet: C, 69,88; H, 7,64; N, 4,64; Cl, 6,25 Calcd: C, 69.88; H, 7.64; N, 4.64; Cl, 6.25

Funnet: C, 69,69; H, 7,58; N, 4,82; Cl, 6,52 Found: C, 69.69; H, 7.58; N, 4.82; Cl, 6.52

Eksempel 139 Example 139

3-[2-(N-(2-(naftyl-2)-etyl)-piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hvdroklorid 3-[2-(N-(2-(naphthyl-2-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine hydrochloride

Fremstillet fra 3-[2-(piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(naftyl-2)-etylbromid, analogt med Eksempel 1. Prepared from 3-[2-(piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-2)- ethyl bromide, analogous to Example 1.

Utbytte: 41% av det teoretiske. Yield: 41% of the theoretical.

Smp.: 120-122°C M.p.: 120-122°C

Beregnet: C, 71,18; H, 7,51; N, 5,36; Cl, 6,78 Calculated: C, 71.18; H, 7.51; N, 5.36; Cl, 6.78

Funnet: C, 71,10; H, 7,31; N, 5,40; Cl, 7,05 Found: C, 71.10; H, 7.31; N, 5.40; Cl, 7.05

Eksempel 140 Example 140

3-[2-(N-((2-metyl-naftyl-l)-metyl)-piperidyl-2)-etyl]-7,8-dimetoksv- 2- okso- l. 3, 4, 5- tetrahydro- 2H- 3- benzazepin-hydroklorid 3-[2-(N-((2-methyl-naphthyl-1)-methyl)-piperidyl-2)-ethyl]-7,8-dimethoxy- 2- oxo- l. 3, 4, 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[2-(piperidyl-2)-etyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og l-klormetyl-2-metyl-naftalen, analogt med Eksempel 1. Prepared from 3-[2-(piperidyl-2)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and l-chloromethyl-2-methyl- naphthalene, analogous to Example 1.

Utbytte: 24% av det teoretiske. Yield: 24% of the theoretical.

Smp.: 144-146°C M.p.: 144-146°C

Beregnet: C, 71,18; H, 7,51; N, 5,36; Cl, 6,78 Calculated: C, 71.18; H, 7.51; N, 5.36; Cl, 6.78

Funnet: C, 70,93; H, 7,38; N, 5,48; Cl, 6,89 Found: C, 70.93; H, 7.38; N, 5.48; Cl, 6.89

Eksempel 141 3-[(N-(2-(naftyl-2)-etyl)-heksahydroazepin-3-yl)-metyl]-7,8-dimetoksy- 2- okso- 1. 3. 4. 5- tetrahvdro- 2H- 3- benzazepin-hvdroklorid Example 141 3-[(N-(2-(naphthyl-2)-ethyl)-hexahydroazepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1.3.4.5-tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(heksahydro-azepin-3-yl)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(naftyl-2)-etylbromid, analogt med Eksempel 1. Prepared from 3-[(hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-2 )-ethyl bromide, analogous to Example 1.

Utbytte: 58% av det teoretiske. Yield: 58% of the theoretical.

Smp.: 204-205°C M.p.: 204-205°C

Beregnet: C, 71,18; H, 7,52; N, 5,36; Cl, 6,78 Calculated: C, 71.18; H, 7.52; N, 5.36; Cl, 6.78

Funnet: C, 71,41; H, 7,51; N, 5,35; Cl, 6,50 Found: C, 71.41; H, 7.51; N, 5.35; Cl, 6.50

Eksempel 142 Example 142

3-[(N-(2-(naftyl-2)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2- okso- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepin- hydroklorid 3-[(N-(2-(naphthyl-2)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2- oxo- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(naftyl-2)-etylbromid, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-2)-ethyl bromide, analogous to Example 1.

Utbytte: 35% av det teoretiske. Yield: 35% of the theoretical.

Smp.: 239-240°C M.p.: 239-240°C

Beregnet: C, 70,78; H, 7,33; N, 5,50; Cl, 6,96 Calculated: C, 70.78; H, 7.33; N, 5.50; Cl, 6.96

Funnet: C, 70,70; H, 7,10; N, 5,46; Cl, 7,16 Found: C, 70.70; H, 7.10; N, 5.46; Cl, 7.16

Eksempel 143 Example 143

3- [(N-((naftyl-2)-metyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2- okso- l. 3. 4. 5- tetrahvdro- 2H- 3- benzazepin 3- [(N-((naphthyl-2)-methyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-l. 3. 4. 5- tetrahydro- 2H- 3- benzazepine

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-brommetyl-naftalen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-bromomethyl-naphthalene, analogously to Example 1 .

Utbytte: 27% av det teoretiske. Yield: 27% of the theoretical.

Smp.: 176-177°C. M.p.: 176-177°C.

Beregnet: C, 75,95; H, 7,47; N, 6,11 Calculated: C, 75.95; H, 7.47; N, 6.11

Funnet: C, 76,11; H, 7,28; N, 6,10 Found: C, 76.11; H, 7.28; N, 6.10

Eksempel 144 Example 144

3-[ (N-(4-(naftyl-2-oksy)-butyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-hvdroklorid 3-[ (N-(4-(naphthyl-2-oxy)-butyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 4-(naftyl-2-oksy)-butylbromid, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 4-(naphthyl-2-oxy)- butyl bromide, analogous to Example 1.

Utbytte: 24% av det teoretiske. Yield: 24% of the theoretical.

Smp.: 196-197°C M.p.: 196-197°C

Beregnet: C, 69,48; H, 7,47; N, 5,06; Cl, 6,41 Calcd: C, 69.48; H, 7.47; N, 5.06; Cl, 6.41

Funnet: C, 69,30; H, 7,36; N, 4,99; Cl, 6,56 Found: C, 69.30; H, 7.36; N, 4.99; Cl, 6.56

Eksempel 145 Example 145

3-[(N-(4-(naftyl-1)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2- okso- l. 3. 4. 5- tetrahvdro- 2H- 3- benzazepin- hvdroklorid 3-[(N-(4-(naphthyl-1)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2- oxo- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(naftyl-l)-etylbromid, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-1)-ethyl bromide, analogous to Example 1.

Utbytte: 18% av det teoretiske. Yield: 18% of the theoretical.

Smp.: 230-231°C. M.p.: 230-231°C.

Beregnet: C, 70,78; H, 7,33; N, 5,50; Cl, 6,96 Calculated: C, 70.78; H, 7.33; N, 5.50; Cl, 6.96

Funnet: C, 70,71; H, 7,07; N, 5,67; Cl, 6,99 Found: C, 70.71; H, 7.07; N, 5.67; Cl, 6.99

Eksempel 146 Example 146

3- [(N-(2-(naftyl-l-oksy)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-hvdroklorid 3- [(N-(2-(naphthyl-1-oxy)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-(naftyl-l-oksy)-etylbromid, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-1-oxy)- ethyl bromide, analogous to Example 1.

Utbytte: 40% av det teoretiske. Yield: 40% of the theoretical.

Smp.: 214-215°C. M.p.: 214-215°C.

Beregnet: C, 68,62; H, 7,10; N, 5,34; Cl, 6,75 Calculated: C, 68.62; H, 7.10; N, 5.34; Cl, 6.75

Funnet: C, 68,40; H, 7,10; N, 5,21; Cl, 6,77 Found: C, 68.40; H, 7.10; N, 5.21; Cl, 6.77

Eksempel 147 Example 147

3-[ (N-((2-metyl-naftyl-l)-metyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid 3-[ (N-((2-methyl-naphthyl-1)-methyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og l-klormetyl-2-metyl-naftalen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 1-chloromethyl-2-methyl-naphthalene, analogous to Example 1.

Utbytte: 67% av det teoretiske. Yield: 67% of the theoretical.

Smp.: 242-243°C. M.p.: 242-243°C.

Beregnet: C, 70,78; H, 7,33; N, 5,50; Cl, 6,96 Calculated: C, 70.78; H, 7.33; N, 5.50; Cl, 6.96

Funnet: C, 70,50; H, 7,22; N, 5,34; Cl, 6,89 Found: C, 70.50; H, 7.22; N, 5.34; Cl, 6.89

Eksempel 148 Example 148

3-[(N-(2-(6-metoksy-naftyl-2)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy- 2- okso- l, 3. 4. 5- tetrahydro- 2H- 3- benzazepin-hydroklorid 3-[(N-(2-(6-methoxy-naphthyl-2)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy- 2-oxo-l, 3. 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-(6-metoksy-naf tyl-2) -etylbromid, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(6-methoxy-naphthyl- 2) -ethyl bromide, analogously to Example 1.

Utbytte: 50% av det teoretiske. Yield: 50% of the theoretical.

Smp.: 156-157°C M.p.: 156-157°C

Beregnet: C, 74,07; H, 7,62; N, 5,57 Calculated: C, 74.07; H, 7.62; N, 5.57

Funnet: C, 73,90; H, 7,55; N, 5,64 Found: C, 73.90; H, 7.55; N, 5.64

Eksempel 149 Example 149

3-[(N-(2-(5-metyl-6-metoksy-naft-2-yl)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid 3-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3, 4,5-tetrahydro-2H-3-benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(5-metyl-6-metoksy-naft-2-yl)-etylbromid, analogt med Eksempel 1. Utbytte: 53% av det teoretiske. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(5-methyl-6-methoxy -naphth-2-yl)-ethyl bromide, analogously to Example 1. Yield: 53% of the theoretical.

Smp.: 240-241°C M.p.: 240-241°C

Beregnet: C, 69,48; H, 7,47; N, 5,06; Cl, 6,41 Calcd: C, 69.48; H, 7.47; N, 5.06; Cl, 6.41

Funnet: C, 69,58; H, 7,48; N, 5,00; Cl, 6,54 Found: C, 69.58; H, 7.48; N, 5.00; Cl, 6.54

Eksempel 150 2-[(N-(2-(3,4-dimetoksy-f enyl) -etyl) -piperidyl-3) -metyl] -5,6-dimetoksy- l- okso- 1, 3- dihydro- isoindol- hvdroklorid Example 150 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole - Hydrochloride

Fremstillet fra 2-[ (piperidyl-3)-metyl]-5,6-dimetoksy-1,3-dihydro-isoindol og 2-(3,4-dimetoksy-f enyl) -etylbromid, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole and 2-(3,4-dimethoxy-phenyl)-ethyl bromide, analogously to Example 1.

Utbytte: 68% av det teoretiske. Yield: 68% of the theoretical.

Smp.: 225-226°C M.p.: 225-226°C

Beregnet: C, 63,60; H, 7,18; N, 5,20; Cl, 7,22 Calculated: C, 63.60; H, 7.18; N, 5.20; Cl, 7.22

Funnet: C, 63,61; H, 7,30; N, 5,70; Cl, 7,44 Found: C, 63.61; H, 7.30; N, 5.70; Cl, 7.44

Eksempel 151 Example 151

2- [ (N- (2- (6-metoksy-naf tyl-2) -etyl) -piperidyl-3) -metyl ] - 5, 6- dimetoksv- l- okso- l. 3- dihydro- isoindol- hydroklorid 2- [ (N-(2-(6-Methoxy-naphthyl-2)-ethyl)-piperidyl-3)-methyl] - 5, 6- dimethoxy- l - oxo- l. 3- dihydro- isoindole- hydrochloride

Fremstillet fra 2- [ (piperidyl-3) -metyl] -5,6-dimetoksy-l-okso-l ,3-dihydro-isoindol og 2-(6-metoksy-naftyl-2)-etylbromid, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole and 2-(6-methoxy-naphthyl-2)-ethyl bromide, analogously to Example 1 .

Utbytte: 75% av det teoretiske. Yield: 75% of the theoretical.

Smp. : 234-236°C Temp. : 234-236°C

Beregnet: C, 68,16; H, 6,90; N, 5,48; Cl, 6,94 Calculated: C, 68.16; H, 6.90; N, 5.48; Cl, 6.94

Funnet: C, 68,10; H, 7,10; N, 5,39; Cl, 7,10 Found: C, 68.10; H, 7.10; N, 5.39; Cl, 7.10

Eksempel 152 Example 152

2-[(N-(2-(naftyl-l-oksy)-etyl)-piperidyl-3)-metyl]-5,6-dimetoksy- l- okso- 1. 3- dihydro- isoindol- hydroklorid 2-[(N-(2-(naphthyl-1-oxy)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy- l - oxo- 1.3- dihydro- isoindole- hydrochloride

Fremstillet fra 2-[ (piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-l, 3-dihydro-isoindol og 2-(naftyl-l-oksy)-etylbromid, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole and 2-(naphthyl-1-oxy)-ethyl bromide, analogously to Example 1.

Utbytte: 60% av det teoretiske. Yield: 60% of the theoretical.

Smp.: 150-152°C M.p.: 150-152°C

Beregnet: C, 67,66; H, 6,69; N, 5,63; Cl, 7,13 Calculated: C, 67.66; H, 6.69; N, 5.63; Cl, 7.13

Funnet: C, 67,50; H, 6,76; N, 5,74; Cl, 7,54 Found: C, 67.50; H, 6.76; N, 5.74; Cl, 7.54

Eksempel 153 2-[(N-(2-(4-metylfenyl)-etyl)-piperidyl-3)-metyl]-5,6-dimetoksv- l- okso- 1, 3- dihydro- isoindol Example 153 2-[(N-(2-(4-methylphenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole

Fremstillet fra 2-[(piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-isoindol og 2-(4-metylfenyl)-etylbromid, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-isoindole and 2-(4-methylphenyl)-ethyl bromide, analogously to Example 1.

Utbytte: 57% av det teoretiske. Yield: 57% of the theoretical.

Smp.: 134-136°C M.p.: 134-136°C

Beregnet: C, 73,50; H, 7,90; N, 6,86 Calculated: C, 73.50; H, 7.90; N, 6.86

Funnet: C, 73,40; H, 8,04; N, 7,06 Found: C, 73.40; H, 8.04; N, 7.06

Eksempel 154 Example 154

2-[(N-(2-(3-metoksyfenyl)-etyl)-piperidyl-3)-metyl]-5,6-dimetoksv- l- okso- 1. 3- dihydro- isoindol- hydroklorid 2-[(N-(2-(3-methoxyphenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy- l - oxo- 1.3- dihydro- isoindole- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-isoindol og 2-(3-metoksyfenyl)-etylbromid, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-isoindole and 2-(3-methoxyphenyl)-ethyl bromide, analogously to Example 1.

Utbytte: 54% av det teoretiske. Yield: 54% of the theoretical.

Smp.: 226-228°C. M.p.: 226-228°C.

Beregnet: C, 65,28; H, 7,01; N, 6,09; Cl, 7,71 Calculated: C, 65.28; H, 7.01; N, 6.09; Cl, 7.71

Funnet: C, 65,30; H, 7,37; N, 5,91; Cl, 7,61 Found: C, 65.30; H, 7.37; N, 5.91; Cl, 7.61

Eksempel 155 Example 155

2-[(N-(2-(5-metyl-6-metoksy-naftyl-2)-etyl)-piperidyl-3)-metvl1- 5, 6- dimetoksv- l- okso- l. 3- dihydro- isoindol- hydroklorid 2-[(N-(2-(5-methyl-6-methoxy-naphthyl-2)-ethyl)-piperidyl-3)-methyl- 5, 6- dimethoxy- l- oxo- l. 3- dihydro-isoindole - hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-l, 3-dihydro-isoindol og 2-(5-metyl-6-metoksy-naftyl-2)-etylbromid, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole and 2-(5-methyl-6-methoxy-naphthyl-2)-ethyl bromide, analogous to Example 1.

Utbytte: 38% av det teoretiske. Yield: 38% of the theoretical.

Smp.: 214-216°C. M.p.: 214-216°C.

Beregnet: C, 68,62; H, 7,10; N, 5,33; Cl, 6,75 Calculated: C, 68.62; H, 7.10; N, 5.33; Cl, 6.75

Funnet: C, 68,94; H, 7,23; N, 4,98; Cl, 6,61 Found: C, 68.94; H, 7.23; N, 4.98; Cl, 6.61

Eksempel 156 Example 156

2- [(N-(2-(4-nitrofenyl)-etyl)-piperidyl-3)-metyl]-5,6-dimetoksy- l- okso- l, 3- dihydro- isoindol- hvdroklorid 2- [(N-(2-(4-nitrophenyl)-ethyl)-piperidyl-3)-methyl]-5,6-dimethoxy- l - oxo- l, 3- dihydro- isoindole- hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-l, 3-dihydro-isoindol og 2-(4-nitrofenyl)-etylbromid, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1, 3-dihydro-isoindole and 2-(4-nitrophenyl)-ethyl bromide, analogously to Example 1.

Utbytte: 79% av det teoretiske. Yield: 79% of the theoretical.

Smp.: 215-218°C. M.p.: 215-218°C.

Beregnet: C, 60,56; H, 6,35; N, 8,83; Cl, 7,45 Calculated: C, 60.56; H, 6.35; N, 8.83; Cl, 7.45

Funnet: C, 60,41; H, 6,26; N, 8,84; Cl, 7,62 Found: C, 60.41; H, 6.26; N, 8.84; Cl, 7.62

Eksempel 157 Example 157

3- [ (N- (2- (tienyl-2) -etyl) -piperidyl-3) -metyl] -7, 8-dimetoksy-2- okso- l, 3, 4, 5- tetrahydro- 2H- 3- benzazepin- hydroklorid 3- [ (N-(2-(thienyl-2)-ethyl)-piperidyl-3)-methyl]-7, 8-dimethoxy-2-oxo-l, 3, 4, 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-(2-brometyl)-tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(2-bromomethyl)-thiophene, analogous to Example 1.

Utbytte: 43% av det teoretiske. Yield: 43% of the theoretical.

Smp. : 232-236°C Temp. : 232-236°C

Beregnet: C, 61,99; H, 7,15; N, 6,02; Cl, 7,62; S, 6,89 Funnet: C, 61,90; H, 7,06; N, 5,78; Cl, 7,96; S, 6,84 Calculated: C, 61.99; H, 7.15; N, 6.02; Cl, 7.62; S, 6.89 Found: C, 61.90; H, 7.06; N, 5.78; Cl, 7.96; S, 6.84

Eksempel 158 Example 158

3- [ (N- (2- (tienyl-3) -etyl) -piperidyl-3) -metyl] -7,8-dimetoksy-2- okso- 1. 3. 4. 5- tetrahvdro- 2H- 3- benzazepin- hydroklorid 3- [ (N-(2-(thienyl-3)-ethyl)-piperidyl-3)-methyl] -7,8-dimethoxy-2- oxo- 1. 3. 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 3-(2-brometyl)-tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(2-bromomethyl)-thiophene, analogous to Example 1.

Utbytte: 36% av det teoretiske. Yield: 36% of the theoretical.

Smp.: sintrer ved 75-80°, smelter ved 225-23 0°C Melting point: sinters at 75-80°, melts at 225-23 0°C

Beregnet: C, 61,99; H, 7,15; N, 6,02; Cl, 7,62; S, 6,89 Funnet: C, 62,00; H, 7,08; N, 5,98; Cl, 8,43; S, 6,62 Calculated: C, 61.99; H, 7.15; N, 6.02; Cl, 7.62; S, 6.89 Found: C, 62.00; H, 7.08; N, 5.98; Cl, 8.43; S, 6.62

Eksempel 159 Example 159

3- [ (N- (4- (tienyl-2) -butyl) -piperidyl-3) -metyl] -7,8-dimetoksy-2- okso- l, 3, 4. 5- tetrahvdro- 2H- 3- benza2epin- hvdroklorid 3- [ (N-(4-(thienyl-2)-butyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benza2epine hydrochloride

Fremstillet fra 3-[ (piperidyl-3) -metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-(4-brombutyl)-tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(4-bromobutyl)-thiophene, analogous to Example 1.

Utbytte: 68% av det teoretiske. Yield: 68% of the theoretical.

Smelteområde: 190-196°C. Melting range: 190-196°C.

Beregnet: C, 63,33; H, 7,56; N, 5,68; Cl, 7,19; S, 6,50 Funnet: C, 63,18; H, 7,72; N, 5,72; Cl, 7,29; S, 6,59 Calculated: C, 63.33; H, 7.56; N, 5.68; Cl, 7.19; S, 6.50 Found: C, 63.18; H, 7.72; N, 5.72; Cl, 7.29; S, 6.59

Eksempel 160 Example 160

3- [ (N-(2-(benzo[b] furyl-2) -etyl) -piperidyl-3) -metyl]-7,8-dimetoksy- 2- okso- l. 3, 4, 5- tetrahydro- 2H- 3- benzazepin-hydroklorid 3- [ (N-(2-(benzo[b]furyl-2)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy- 2- oxo- l. 3, 4, 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3- [ (piperidyl-3) -metyl] -7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-(2-brometyl)-benzo[b]furan, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(2-bromomethyl)-benzo[ b]furan, analogous to Example 1.

Utbytte: 22% av det teoretiske. Yield: 22% of the theoretical.

Smp.: høyere enn 216°C (dekomp.). M.p.: higher than 216°C (decomp.).

Beregnet: C, 67,39; H, 7,07; N, 5,61 Calculated: C, 67.39; H, 7.07; N, 5.61

Funnet: C, 67,14; H, 7,36; N, 5,53 Found: C, 67.14; H, 7.36; N, 5.53

Eksempel 161 Example 161

3- [ (N- (2- (benzo[b] tienyl-3) -etyl) -piperidyl-3) -metyl] -7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hvdroklorid 3- [ (N-(2-(benzo[b]thienyl-3)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 3-(2-brometyl)-benzo[b]tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(2-bromomethyl)-benzo[ b]thiophene, analogously to Example 1.

Utbytte: 73% av det teoretiske. Yield: 73% of the theoretical.

Smelteområde: 70-75°C (dekomp.). Melting range: 70-75°C (decomp.).

Beregnet: C, 65,29; H, 6,85; N, 5,44 Calculated: C, 65.29; H, 6.85; N, 5.44

Funnet: C, 65,10; H, 6,87; N, 5,73 Found: C, 65.10; H, 6.87; N, 5.73

Eksempel 162 3-[(N-(2-(4-metoksy-benzo[b]tienyl-3)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid Example 162 3-[(N-(2-(4-methoxy-benzo[b]thienyl-3)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3, 4,5-tetrahydro-2H-3-benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 3-(2-kloretyl)-4-metoksy-benzo[b]tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(2-chloroethyl)-4- methoxy-benzo[b]thiophene, analogous to Example 1.

Utbytte: 25% av det teoretiske. Yield: 25% of the theoretical.

Smelteområde: 85-105°C (dekomp.). Melting range: 85-105°C (decomp.).

Beregnet: C, 63,96; H, 6,84; N, 5,14; Cl, 6,50; S, 5,88 Funnet: C, 63,95; H, 6,85; N, 4,99; Cl, 6,53; S, 5,75 Calcd: C, 63.96; H, 6.84; N, 5.14; Cl, 6.50; S, 5.88 Found: C, 63.95; H, 6.85; N, 4.99; Cl, 6.53; S, 5.75

Eksempel 163 Example 163

3-[(N-(2-(6-metylsulfony1oksy-benzo[b]tieny1-3)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid 3-[(N-(2-(6-methylsulfonyloxy-benzo[b]thienyl-3)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4, 5-tetrahydro-2H-3-benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 3-[2-(metylsulfonyloksy)-etyl]-6-metylsulfony1oksy-benzo[b]tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-[2-(methylsulfonyloxy)-ethyl ]-6-methylsulphonyloxy-benzo[b]thiophene, analogously to Example 1.

Utbytte: 55% av det teoretiske. Yield: 55% of the theoretical.

Smp.: 90°C (dekomp.). Melting point: 90°C (decomp.).

Beregnet: C, 57,18; H, 6,12; N, 4,60; Cl, 5,82; S, 10,53 Funnet: C, 57,25; H, 6,14; N, 4,50; Cl, 5,97; S, 10,36 Calculated: C, 57.18; H, 6.12; N, 4.60; Cl, 5.82; S, 10.53 Found: C, 57.25; H, 6.14; N, 4.50; Cl, 5.97; S, 10.36

Eksempel 164 Example 164

3-[(N-(5-(tienyl-2)-pentyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2- okso- l. 3. 4. 5- tetrahvdro- 2H- 3- benzazepin- hydroklorid 3-[(N-(5-(thienyl-2)-pentyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2- oxo- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 2-(5-metylsulfonyl-oksy-pentyl)-tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(5-methylsulfonyl-oxy-pentyl )-thiophene, analogous to Example 1.

Utbytte: 39% av det teoretiske. Yield: 39% of the theoretical.

Smp.: 177°C M.p.: 177°C

Beregnet: C, 63,95; H, 7,75; N, 5,52; Cl, 6,99; S, 6,32 Funnet: C, 63,70; H, 7,92; N, 5,40; Cl, 7,24; S, 6,62 Calculated: C, 63.95; H, 7.75; N, 5.52; Cl, 6.99; S, 6.32 Found: C, 63.70; H, 7.92; N, 5.40; Cl, 7.24; S, 6.62

Eksempel 165 Example 165

3- [ (N- (2- (furyl-2) -etyl) -piperidyl-3) -metyl] -7,8-dimetoksy-2- okso- 1. 3. 4, 5- tetrahydro- 2H- 3- ben2azepin- hydroklorid 3- [ (N-(2-(furyl-2)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2- oxo- 1. 3. 4, 5- tetrahydro- 2H- 3- ben2azepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-behzazepin og 2-(2-metylsulfonyl-oksy-etyl)-furan, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-behzazepine and 2-(2-methylsulfonyl-oxy-ethyl )-furan, analogous to Example 1.

Utbytte: 44% av det teoretiske. Yield: 44% of the theoretical.

Smelteområde: 205-215°C. Melting range: 205-215°C.

Beregnet: C, 64,20; H, 7,41; N, 6,24; Cl, 7,90 Calculated: C, 64.20; H, 7.41; N, 6.24; Cl, 7.90

Funnet: C, 64,00; H, 7,45; N, 6,00; Cl, 7,80 Found: C, 64.00; H, 7.45; N, 6.00; Cl, 7.80

Eksempel 166 Example 166

3- [ (N-(3-(furyl-2) -propyl) -piperidyl-3) -metyl]-7,8-dimetoksy-2- okso- 1, 3, 4. 5- tetrahvdro- 2H- 3- benzazepin- hydroklorid 3- [ (N-(3-(furyl-2)-propyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2- oxo- 1, 3, 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 3-(furyl-2)-propionaldehyd, analogt med Eksempel 9. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(furyl-2)-propionaldehyde, analogous to Example 9.

Utbytte: 11% av det teoretiske. Yield: 11% of the theoretical.

Smp.: 201-206°C. M.p.: 201-206°C.

Beregnet: C, 64,85; H, 7,62; N, 6,05; Cl, 7,66 Calcd: C, 64.85; H, 7.62; N, 6.05; Cl, 7.66

Funnet: C, 64,88; H, 7,76; N, 5,93; Cl, 7,55 Found: C, 64.88; H, 7.76; N, 5.93; Cl, 7.55

Eksempel 167 Example 167

3- [ (N- (6- (tienyl-2) -heksyl) -piperidyl-3) -metyl] -7,8-dimetoksy-2- okso- 1, 3, 4, 5- tetrahydro- 2H- 3- benzazepin- hydroklorid 3- [ (N-(6-(thienyl-2)-hexyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2- oxo- 1, 3, 4, 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 2-(6-metylsulfonyl-oksy-heksyl)-tiofen, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(6-methylsulfonyl-oxy-hexyl )-thiophene, analogous to Example 1.

Utbytte: 27% av det teoretiske. Yield: 27% of the theoretical.

Smp.: 160°C. Melting point: 160°C.

Beregnet: C, 64,39; H, 8,10; N, 5,40; Cl, 6,79 Calculated: C, 64.39; H, 8.10; N, 5.40; Cl, 6.79

Funnet: C, 64,55; H, 7,90; N, 5,23; Cl, 7,00 Found: C, 64.55; H, 7.90; N, 5.23; Cl, 7.00

Eksempel 168 Example 168

3-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid 3-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 3-(3-metylsulfony1-oksy-propyl)-indol, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(3-methylsulfonyl-1-oxy-propyl )-indole, analogous to Example 1.

Utbytte: 19% av det teoretiske. Yield: 19% of the theoretical.

Smp.: > 80°C (dekomp.). Melting point: > 80°C (decomp.).

Beregnet: C, 60,42; H, 6,30; N, 6,45 Calculated: C, 60.42; H, 6.30; N, 6.45

Funnet: C, 60,32; H, 6,57; N, 6,67 Found: C, 60.32; H, 6.57; N, 6.67

Eksempel 169 Example 169

3- [ (N- (2- (indolyl-3) -etyl) -piperidyl-3) -metyl] -7,8-dimetoksy-2- okso- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepin- hvdroklorid 3- [ (N-(2-(indolyl-3)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2- oxo- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og 3-(2-metylsulfony 1-oksy-etyl)-indol, analogt med Eksempel 1. Prepared from 3-[(piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(2-methylsulfony 1-oxy- ethyl)-indole, analogous to Example 1.

Utbytte: 23% av det teoretiske. Yield: 23% of the theoretical.

Smp.: > 80°C (dekomp.). Melting point: > 80°C (decomp.).

Beregnet: C, 65,53; H, 6,42; N, 7,69 Calculated: C, 65.53; H, 6.42; N, 7.69

Funnet: C, 65,33; H, 6,55; N, 7,80 Found: C, 65.33; H, 6.55; N, 7.80

Eksempel 170 Example 170

2-[(N-(3-(naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl ] -6,7-metylendioksy-l-okso-l ,2,3,4-tetrahydro-isokinolin 2-[(N-(3-(naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormetyl-[N-(3-naftyl-2-oksy)-propyl]-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-[N-(3-naphthyl-2-oxy)-propyl]-hexahydro-azepine, analogous to Example 2.

Utbytte: 21% av det teoretiske. Yield: 21% of the theoretical.

Smp.: 74-7 6°C. M.p.: 74-76°C.

Beregnet (x 2 H20): C, 64,45; H, 7,02; N, 5,01; Cl, 6,34 Funnet: C, 64,32; H, 7,20; N, 5,28; Cl, 6,44 Calcd (x 2 H 2 O): C, 64.45; H, 7.02; N, 5.01; Cl, 6.34 Found: C, 64.32; H, 7.20; N, 5.28; Cl, 6.44

Eksempel 171 Example 171

2-[(N-(3-(naftyl-2)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetyl-1- okso- l. 2. 3, 4- tetrahydro- isokiholin 2-[(N-(3-(naphthyl-2)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1- oxo-l. 2. 3, 4- tetrahydro- isoquicholine

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(p-toluensulfonyloksymetyl)-N-[3-(naftyl-2)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulfonyloxymethyl)-N-[3-(naphthyl-2)-propyl]-pyrrolidine, analogous to Example 2.

Utbytte: 20% av det teoretiske. Yield: 20% of the theoretical.

Smp. : 72-76°C Temp. : 72-76°C

Beregnet (x H20) : C, 72,41; H, 7,75; N, 5,82; Cl, 7,36 Funnet: C, 72,27; H, 7,85; N, 5,70; Cl, 7,96 Calcd (x H 2 O) : C, 72.41; H, 7.75; N, 5.82; Cl, 7.36 Found: C, 72.27; H, 7.85; N, 5.70; Cl, 7.96

Eksempel 172 Example 172

2- [(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,3,4,5-tetrahydro-isokinolin og 3-(p-toluensulfonyloksymetyl)-N-[3-(5,6-dimetoksy-naftyl-2-oksy)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,3,4,5-tetrahydro-isoquinoline and 3-(p-toluenesulfonyloxymethyl)-N-[3-(5,6-dimethoxy-naphthyl-2-oxy) -propyl]-pyrrolidine, analogously to Example 2.

Utbytte: 9,5% av det teoretiske. Yield: 9.5% of the theoretical.

Smp.: 60-63°C M.p.: 60-63°C

Beregnet (x H20): C, 63,20; H, 7,01; N, 4,75; Cl, 6,02 Funnet: C, 63,40; H, 7,04; N, 4,49; Cl, 6,38 Calcd (x H 2 O): C, 63.20; H, 7.01; N, 4.75; Cl, 6.02 Found: C, 63.40; H, 7.04; N, 4.49; Cl, 6.38

Eksempel 173 Example 173

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin- hvdroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2, 3,4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(p-toluensulfonyloksymetyl)-N-[3-(5,6-dimetoksy-naftyl-2-oksy)-propyl]-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulfonyloxymethyl)-N-[3-(5,6-dimethoxy-naphthyl-2-oxy) -propyl]-hexahydro-azepine, analogous to Example 2.

Utbytte: 63,2% av det teoretiske. Yield: 63.2% of the theoretical.

Smp.: 199-201°C M.p.: 199-201°C

Beregnete C, 66,15; H, 7,23; N, 4,67; Cl, 5,92 Calculated C, 66.15; H, 7.23; N, 4.67; Cl, 5.92

Funnet: C, 65,99; H, 7,00; N, 4,44; Cl, 6,02 Found: C, 65.99; H, 7.00; N, 4.44; Cl, 6.02

Eksempel 174 Example 174

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-6,7-dimetoksy-l,2,3,4-tetrahydro-isokinolin-dihydroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-6,7-dimethoxy-1,2,3,4- tetrahydroisoquinoline dihydrochloride

Fremstillet fra 2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1, 2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 86,3% av det teoretiske. Yield: 86.3% of the theoretical.

Smp.: 114-116°C M.p.: 114-116°C

Beregnet: C, 61,97; H, 7,56; N, 4,38; Cl, 11,08 Calculated: C, 61.97; H, 7.56; N, 4.38; Cl, 11.08

Funnet: C, 62,05; H, 7,65; N, 4,06; Cl, 10,84 Found: C, 62.05; H, 7.65; N, 4.06; Cl, 10.84

Eksempel 175 Example 175

2-[(N-(2-(4-metoksyfenyl)-etyl)-pyrrolidy1-3)-metyl]-6,7-metylendioksy- 1. 2. 3. 4- tetrahvdro- isokinolin- dihydroklorid 2-[(N-(2-(4-methoxyphenyl)-ethyl)-pyrrolidy1-3)-methyl]-6,7-methylenedioxy- 1. 2. 3. 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(2-(4-metoksyfenyl)-etyl)-pyrrolidyl-3-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og Prepared from 2-[(N-(2-(4-methoxyphenyl)-ethyl)-pyrrolidyl-3-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and

litiumaluminiumhydrid/tetrahydrofuran, analogt med Eksempel 3. Utbytte: 86,7% av det teoretiske. lithium aluminum hydride/tetrahydrofuran, analogous to Example 3. Yield: 86.7% of the theoretical.

Smp.: 213-215°C M.p.: 213-215°C

Beregnet: C, 60,49; H, 6,98; N, 5,87; Cl, 14,88 Calcd: C, 60.49; H, 6.98; N, 5.87; Cl, 14.88

Funnet: C, 60,59; H, 6,96; N, 5,84; Cl, 14,98 Found: C, 60.59; H, 6.96; N, 5.84; Cl, 14.98

Eksempel 176 Example 176

2-[(N-(3-(3,4-dimetoksy-fenoksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(3,4-dimethoxy-phenoxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra l-okso-1,2,3,4-tetrahydro-6,7-metylendioksy-isokinolin og N-[3-(3,4-dimetoksy-fenoksy)-propyl]-3-benzosulfonyloksymetyl-pyrrolidin, analogt med Eksempel -2. Prepared from 1-oxo-1,2,3,4-tetrahydro-6,7-methylenedioxy-isoquinoline and N-[3-(3,4-dimethoxy-phenoxy)-propyl]-3-benzosulfonyloxymethyl-pyrrolidine, analogous to Example -2.

Utbytte: 57,4% av det teoretiske. Yield: 57.4% of the theoretical.

Smp.: 108-110°C. M.p.: 108-110°C.

Beregnet: C, 59,76; H, 6,74; N, 5,35; Cl, 7,02 Calcd: C, 59.76; H, 6.74; N, 5.35; Cl, 7.02

Funnet: C, 60,07; H, 6,87; N, 5,23; Cl, 7,61 Found: C, 60.07; H, 6.87; N, 5.23; Cl, 7.61

Eksempel 177 Example 177

2- [(N-(2-(4-metoksyfenyl)-etyl)-pyrrolidy1-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(2-(4-methoxyphenyl)-ethyl)-pyrrolidy1-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 1-okso-l,2,3,4-tetrahydro-6,7-metylendioksy-isokinolin og N-[2-(4-metoksyfenyl)-etyl]-3-benzensulfonyloksymetyl-pyrrolidin, analogt med Eksempel 2. Utbytte: 54,7% av det teoretiske. Prepared from 1-oxo-1,2,3,4-tetrahydro-6,7-methylenedioxy-isoquinoline and N-[2-(4-methoxyphenyl)-ethyl]-3-benzenesulfonyloxymethyl-pyrrolidine, analogously to Example 2. Yield : 54.7% of the theoretical.

Smp.: 105-108°C M.p.: 105-108°C

Beregnet: C, 62,26; H, 6,74; N, 6,05; Cl, 7,97 Calculated: C, 62.26; H, 6.74; N, 6.05; Cl, 7.97

Funnet: C, 62,34; H, 6,74; N, 5,88; Cl, 8,05 Found: C, 62.34; H, 6.74; N, 5.88; Cl, 8.05

Eksempel 178 Example 178

3- [(N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl]-7,8-dimetvl- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepin x 2. 5 HCl x H?Q 3- [(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepine x 2.5 HCl x H?Q

Fremstillet fra 3-[(N-(2-(6-metyl-pyridyl-2)-etyl) - pyrrolidyl-3)-metyl]-7,8-dimetyl-2-okso-l ,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Prepared from 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5- tetrahydro-2H-3-benzazepine and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3.

Utbytte: 50% av det teoretiske. Yield: 50% of the theoretical.

Smp: 80-91°C amorft Mp: 80-91°C amorphous

Beregnet: C, 61,68; H, 8,18; N, 8,63; Cl, 18,21 Calculated: C, 61.68; H, 8.18; N, 8.63; Cl, 18,21

Funnet: C, 61,55; H, 8,36; N, 8,44; Cl, 18,10 Found: C, 61.55; H, 8.36; N, 8.44; Cl, 18.10

Eksempel 179 Example 179

3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl]-7,8-dimetyl-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid- semih<y>drat 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine dihydrochloride semihydrate

Fremstillet fra 3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl]-7,8-dimetyl-2-okso-1,3-dihydro-2H-3-benzazepin med 10% palladium/kull ved 5 bar hydrogen og ved 80°C i etanol, analogt med Eksempel 5. Prepared from 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H- 3-benzazepine with 10% palladium/charcoal at 5 bar hydrogen and at 80°C in ethanol, analogous to Example 5.

Utbytte: 92% av det teoretiske. Yield: 92% of the theoretical.

Smp.: 86-94°C amorft M.p.: 86-94°C amorphous

Beregnet: C, 63,41; H, 7,66; N, 8,87; Cl, 14,97 Calculated: C, 63.41; H, 7.66; N, 8.87; Cl, 14.97

Funnet: C, 63,52; H, 7,14; N, 8,81; Cl, 14,94 Found: C, 63.52; H, 7.14; N, 8.81; Cl, 14.94

Eksempel 180 Example 180

2-[(N-(3-(6-metoksy-nafty1-2-oksy)-propyl)-pyrrolidyl-3) - metvl1- 6. 7- dimetyl- l- okso- l. 2. 3, 4- tetrahydro- isokinolin 2-[(N-(3-(6-Methoxy-naphthy1-2-oxy)-propyl)-pyrrolidyl-3)-methyl-1-6.7-dimethyl-1-oxo-1.2.3.4-tetrahydro - isoquinoline

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(p-toluensulfonyloksymetyl)-N-[3-(6-metoksy-naf tyl -2 -oksy) -propyl] -pyrrolidin, analogt med Eksempel 2. Utbytte: 44,7% av det teoretiske. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulfonyloxymethyl)-N-[3-(6-methoxy-naphthyl-2-oxy)- propyl]-pyrrolidine, analogously to Example 2. Yield: 44.7% of the theoretical.

Smp.: 102-104°C. M.p.: 102-104°C.

Beregnet: C, 76,24; H, 7,68; N, 5,93 Calculated: C, 76.24; H, 7.68; N, 5.93

Funnet: C, 75,90; H, 7,62; N, 5,94 Found: C, 75.90; H, 7.62; N, 5.94

Eksempel 181 Example 181

2- [(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-pyrrolidyl-3)-metvl1- 6. 7- dimetoksv- l, 2, 3, 4- tetrahvdro- isokinolin 2- [(N-(3-(6-Methoxy-naphthyl-2-oxy)-propyl)-pyrrolidyl-3)-methyl- 6.7-dimethoxy-1,2,3,4-tetrahydro- isoquinoline

Fremstillet fra 2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran og eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3, 4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran and ether, analogously to Example 3.

Utbytte: 68% av det teoretiske. Yield: 68% of the theoretical.

Smp.: 106-108°C. M.p.: 106-108°C.

Beregnet: C, 73,44; H, 7,82; N, 5,71 Calculated: C, 73.44; H, 7.82; N, 5.71

Funnet: C, 73,26; H, 7,72; N, 5,81 Found: C, 73.26; H, 7.72; N, 5.81

Eksempel 182 Example 182

3- [(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-metylen-dioksv- 2- okso- 1. 3, 4, 5- tetrahvdro- 2H- 3- benzazepin- monohvdrat 3- [(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylene-dioxv- 2- oxo- 1. 3, 4, 5- tetrahydro- 2H- 3- benzazepine monohydrate

Fremstillet fra 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-metylendioksy-2-okso-l,3-dihydro-2H-3-benzazepin med 20% palladium/kull ved 5 bar hydrogen i etanol ved 80°C, analogt med Eksempel 5. Prepared from 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine with 20% palladium/coal at 5 bar hydrogen in ethanol at 80°C, analogous to Example 5.

Utbytte: 40% av det teoretiske. Yield: 40% of the theoretical.

Smelteområde: 67-74°C Melting range: 67-74°C

Beregnet: C, 69,95; H, 7,17; N, 9,06 Calculated: C, 69.95; H, 7.17; N, 9.06

Funnet: C, 70,00; H, 7,03; N, 8,97 Found: C, 70.00; H, 7.03; N, 8.97

Eksempel 183 Example 183

3-[(N- (2-(6-metyl-pyridyl-2)-etyl)-pyrrolid-3-yl)-metyl]-7,8-dimetyl-2-okso-l, 3-dihydro-2H-3-benzazepin-dihydroklorid-semihvdrat 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H- 3-benzazepine dihydrochloride semihydrate

Fremstillet fra 7,8-dimetyl-2-okso-l, 3-dihydro-2H-3-benzazepin og 3-klormetyl-N-[2-(6-metyl-pyridyl-2)-etyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[2-(6-methyl-pyridyl-2)-ethyl]-pyrrolidine, analogous to Example 2.

Utbytte: 81% av det teoretiske. Yield: 81% of the theoretical.

Smp.: 86-98°C amorft M.p.: 86-98°C amorphous

Beregnet: C, 63,68; H, 7,27; N, 8,91; Cl, 15,04 Calculated: C, 63.68; H, 7.27; N, 8.91; Cl, 15.04

Funnet: C, 63,39; H, 7,43; N, 8,87; Cl, 14,93 Found: C, 63.39; H, 7.43; N, 8.87; Cl, 14.93

Eksempel 184 Example 184

2-[(N-(3-(3-metylfenoksy)-propyl)-piperidy1-3)-metyl]-6,7-dimetoksv- l- okso- 1. 2. 3, 4- tetrahvdro- isokinolin- hydroklorid 2-[(N-(3-(3-methylphenoxy)-propyl)-piperidy1-3)-methyl]-6,7-dimethoxy- l - oxo- 1. 2. 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(3-metylfenoksy)-propyl]-3-benzensulfonyl-oksymetyl -piperidin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3-methylphenoxy)-propyl]-3-benzenesulfonyl-oxymethyl-piperidine, analogously to Example 2 .

Utbytte: 75,6% av det teoretiske. Yield: 75.6% of the theoretical.

Smp.: 106-109°C amorft M.p.: 106-109°C amorphous

Beregnet: C, 63,95; H, 7,75; N, 5,52; Cl, 7,25 Calculated: C, 63.95; H, 7.75; N, 5.52; Cl, 7.25

Funnet: C, 64,66; H, 7,91; N, 5,48; Cl, 7,28 Found: C, 64.66; H, 7.91; N, 5.48; Cl, 7.28

Eksempel 185 Example 185

2-[ (N-(2-(5-metyl-6-metoksy-naft-2-yl)-pyrrolidyl-3)-metyl]-6,7-metylendioksy-l-okso-l ,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[ (N-(2-(5-methyl-6-methoxy-naphth-2-yl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4 -tetrahydro-isoquinoline hydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(p-toluensulfonyloksymetyl)-N-[2-(5-metyl-6-metoksy-naft-2-yl)-etyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulfonyloxymethyl)-N-[2-(5-methyl-6-methoxy-naphth-2- yl)-ethyl]-pyrrolidine, analogously to Example 2.

Utbytte: 27,1% av det teoretiske. Yield: 27.1% of the theoretical.

Smp. : 249-251°C Temp. : 249-251°C

Beregnet: C, 68,43; H, 6,53; N, 5,50; Cl, 6,96 Calcd: C, 68.43; H, 6.53; N, 5.50; Cl, 6.96

Funnet: C, 68,47; H, 6,66; N, 5,30; Cl, 7,16 Found: C, 68.47; H, 6.66; N, 5.30; Cl, 7.16

Eksempel 186 Example 186

2-[(N-(3-(naftyl-2)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-isokinolin-hydroklorid 2-[(N-(3-(naphthyl-2)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-isoquinoline hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(p-toluensulfonyloksymetyl)-N-[3-(naftyl-2)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulfonyloxymethyl)-N-[3-(naphthyl-2)-propyl]-pyrrolidine, analogous to Example 2.

Utbytte: 20,2% av det teoretiske. Yield: 20.2% of the theoretical.

Smp.: 84-86°C M.p.: 84-86°C

Beregnet: C, 67,88; H, 7,26; N, 5,46; Cl, 6,91 Calcd: C, 67.88; H, 7.26; N, 5.46; Cl, 6.91

Funnet: C, 67,86; H, 7,40; N, 5,40; Cl, 7,17 Found: C, 67.86; H, 7.40; N, 5.40; Cl, 7.17

Eksempel 187 Example 187

2-[(N-(3-(3,4-dimetoksyfenoksy)-propyl)-pyrrolidyl-3)-metyl]-6. 7- dimetoksv- l. 2. 3, 4- tetrahydro- isokinolin- dihydroklorid 2-[(N-(3-(3,4-dimethoxyphenoxy)-propyl)-pyrrolidyl-3)-methyl]-6. 7- dimethoxy- l. 2. 3, 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-[3-(3,4-dimetoksyfenoksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-[3-(3,4-dimethoxyphenoxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3.

Utbytte: 92,3% av det teoretiske. Yield: 92.3% of the theoretical.

Smp. : 220-221°C Temp. : 220-221°C

Beregnet: C, 59,20; H, 6,88; N, 5,31; Cl, 13,44 Calculated: C, 59.20; H, 6.88; N, 5.31; Cl, 13.44

Funnet: C, 59,28; H, 6,97; N, 5,20; Cl, 13,44 Found: C, 59.28; H, 6.97; N, 5.20; Cl, 13.44

Eksempel 188 Example 188

2-[ (N-(2-(3,4-dimetoksyfenyl)-etyl)-pyrrolidyl-3)-metyl]-6,7-dimetvl- l- okso- 1. 2, 3, 4- tetrahydro- isokinolin 2-[ (N-(2-(3,4-dimethoxyphenyl)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1, 2, 3, 4- tetrahydro- isoquinoline

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[2-(3,4-dimetoksyfenyl)-etyl]-3-benzensulfonyloksymetyl-pyrrolidin, analogt med Eksempel 2. Utbytte: 70% av det teoretiske. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(3,4-dimethoxyphenyl)-ethyl]-3-benzenesulfonyloxymethyl-pyrrolidine, analogously to Example 2 .Yield: 70% of the theoretical.

Smp.: 168-170°C M.p.: 168-170°C

Beregnet: C, 73,90; H, 8,11; N, 6,63 Calculated: C, 73.90; H, 8.11; N, 6.63

Funnet: C, 73,96; H, 8,11; N, 6,55 Found: C, 73.96; H, 8.11; N, 6.55

Eksempel 189 Example 189

2-[(N-(3-(4-metoksyfenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksv- l- okso- 1. 2, 3, 4- tetrahydro- isokinoliri- hvdroklorid 2-[(N-(3-(4-methoxyphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy- l - oxo- 1. 2, 3, 4- tetrahydro- isoquinoliri- hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(4-metoksyfenoksy)-propyl]-3-benzensulfonyloksymetyl-piperidin, analogt med Eksempel 2. Utbytte: 78,7% av det teoretiske. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxyphenoxy)-propyl]-3-benzenesulfonyloxymethyl-piperidine, analogous to Example 2. Yield : 78.7% of the theoretical.

Smp.: 98-102°C M.p.: 98-102°C

Beregnet: C, 63,08; H, 7,51; N, 5,35; Cl, 7,02 Calculated: C, 63.08; H, 7.51; N, 5.35; Cl, 7.02

Funnet: C, 62,87; H, 7,69; N, 5,16; Cl, 7,28 Found: C, 62.87; H, 7.69; N, 5.16; Cl, 7.28

Eksempel 19 0 Example 19 0

2-[(N-(3-(3-metoksyfenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksy- l- okso- 1. 2, 3, 4- tetrahvdro- isokinolin- hydroklorid 2-[(N-(3-(3-methoxyphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy- l - oxo- 1. 2, 3, 4- tetrahydro- isoquinoline- hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(3-metoksyfenoksy)-propyl]-3-benzensulfonyloksymetyl-piperidin, analogt med Eksempel 2. Utbytte: 87% av det teoretiske. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3-methoxyphenoxy)-propyl]-3-benzenesulfonyloxymethyl-piperidine, analogous to Example 2. Yield : 87% of the theoretical.

Smp.: 103-105°C M.p.: 103-105°C

Beregnet: C, 64,21; H, 7,38; N, 5,55; Cl, 7,02 Calculated: C, 64.21; H, 7.38; N, 5.55; Cl, 7.02

Funnet: C, 64,00; H, 7,55; N, 5,37; Cl, 7,12 Found: C, 64.00; H, 7.55; N, 5.37; Cl, 7.12

Eksempel 191 Example 191

2 -[ (N-(3-(3-metoksyfenoksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksy- 1, 2, 3. 4- tetrahvdro- isokinolin- dihydroklorid 2 -[ (N-(3-(3-Methoxyphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy- 1, 2, 3. 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(3-(3-metoksyfenoksy)-propyl)-piperidyl-3) -metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(3-methoxyphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3.

Utbytte: 95,4% av det teoretiske. Yield: 95.4% of the theoretical.

Smp.: 170-173°C M.p.: 170-173°C

Beregnet: C, 60,43; H, 7,70; N, 5,22; Cl, 13,21 Calculated: C, 60.43; H, 7.70; N, 5.22; Cl, 13.21

Funnet: C, 60,50; H, 7,71; N, 4,91; Cl, 12,97 Found: C, 60.50; H, 7.71; N, 4.91; Cl, 12.97

Eksempel 192 Example 192

2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-pyrrolidyl-3)-metyl]-6,7-dimetyl- l, 2, 3. 4- tetrahvdro- isokinolin- dihvdroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl- 1, 2, 3. 4- tetrahydro- isoquinoline- dihydrochloride

Fremstillet fra 2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-pyrrolidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- isoquinoline and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3.

Utbytte: 94,1% av det teoretiske. Yield: 94.1% of the theoretical.

Smp.: 260-262°C M.p.: 260-262°C

Beregnet: C, 64,85; H, 7,96; N, 5,82; Cl, 14,73 Calcd: C, 64.85; H, 7.96; N, 5.82; Cl, 14.73

Funnet: C, 64,60; H, 8,11; N, 5,91; Cl, 14,67 Found: C, 64.60; H, 8.11; N, 5.91; Cl, 14.67

Eksempel 193 Example 193

2- [(N-(3-(6-metoksy-nafty1-2-oksy)-propyl)-azacyklookty1-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2- [(N-(3-(6-methoxy-naphthy1-2-oxy)-propyl)-azacyclooctyl-3-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4- tetrahydroisoquinoline hydrochloride

Fremstillet fra 2-[(azacyklooktyl-3)-metyl]-6,7-dimetoksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(3-klorpropoksy)-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 24,4% av det teoretiske. Prepared from 2-[(azacyclooctyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-6-methoxy-naphthalene, analogous to Example 1. Yield: 24.4% of the theoretical.

Smp.: 176-178°C M.p.: 176-178°C

Beregnet: C, 67,96; H, 7,43; N, 4,80; Cl, 6,08 Calcd: C, 67.96; H, 7.43; N, 4.80; Cl, 6.08

Funnet: C, 67,74; H, 7,29; N, 4,71; Cl, 6,23 Found: C, 67.74; H, 7.29; N, 4.71; Cl, 6.23

Eksempel 194 Example 194

3- [(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetyl-2- okso- l. 3. 4. 5- tetrahvdro- 2H- 3- benzazepin- hydroklorid 3- [(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-2- oxo- l. 3. 4. 5- tetrahydro- 2H- 3- benzazepine hydrochloride

Fremstillet fra 3-[(pyrrolidyl-3)-metyl]-7,8-dimetyl-2-okso-l,2,3,4-tetrahydro-2H-3-benzazepin og 3-(3-benzensulfonyloksy-propyl)-indol, analogt med Eksempel 1. Utbytte: 62% av det teoretiske. Prepared from 3-[(pyrrolidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,2,3,4-tetrahydro-2H-3-benzazepine and 3-(3-benzenesulfonyloxy-propyl)- indole, analogous to Example 1. Yield: 62% of the theoretical.

Smp.: 106-108°C M.p.: 106-108°C

Beregnet: C, 69,47; H, 7,91; N, 8,68; Cl, 7,32 Calcd: C, 69.47; H, 7.91; N, 8.68; Cl, 7.32

Funnet: C, 69,57; H, 7,80; N, 8,67; Cl, 8,51 Found: C, 69.57; H, 7.80; N, 8.67; Cl, 8.51

Eksempel 195 Example 195

3-[ (N- (3 - (6-metoksy-naftyl-2-oksy) -propyl) -heksahydro-azepinyl- 3) - metvl 1 - 7, 8- dimetoksy- l , 2. 3, 4- tetrahvdro- 2H- 3- benzazepin 3-[ (N-(3 - (6-Methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl- 3)- methyl 1 - 7, 8- dimethoxy- l, 2, 3, 4- tetrahydro- 2H- 3- benzazepine

Fremstillet fra 3-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl) -heksahydro-azepinyl-3) -metyl] -7,8-dimetoksy-l,2,3,4-tetrahydro-2-okso-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-1,2,3,4- tetrahydro-2-oxo-2H-3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 26,8% av det teoretiske. Yield: 26.8% of the theoretical.

Smp.: 98-100°C Melting point: 98-100°C

Beregnet (x H20): C, 71,97; H, 8,42; N, 5,09 Calcd (x H 2 O): C, 71.97; H, 8.42; N, 5.09

Funnet: C, 72,07; H, 8,23; N, 5,10 Found: C, 72.07; H, 8.23; N, 5,10

Eksempel 196 Example 196

3-[ (N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 ) -metyl]-1,2,3,4-tetrahydro-2-okso-2H-3-benzazepin 3-[ (N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-1,2,3,4-tetrahydro-2-oxo-2H- 3-benzazepine

Fremstillet fra 3-[(heksahydro-azepinyl-3)-metyl]-l,2,3,4-tetrahydro-2-okso-2H-3-benzazepin og 2-(3-klorpropoksy)-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 45% av det teoretiske. Prepared from 3-[(hexahydro-azepinyl-3)-methyl]-1,2,3,4-tetrahydro-2-oxo-2H-3-benzazepine and 2-(3-chloropropoxy)-6-methoxy-naphthalene, analogous to Example 1. Yield: 45% of the theoretical.

Smp.: 109-111°C M.p.: 109-111°C

Beregnet: C, 72,50; H, 7,74; N, 5,12 Calculated: C, 72.50; H, 7.74; N, 5.12

Funnet: C, 72,35; H, 7,68; N, 4,93 Found: C, 72.35; H, 7.68; N, 4.93

Eksempel 197 Example 197

2- [ (N- (3- (6-metoksy-naftyl-2-oksy) -propyl) -heksahydro-azepinyl-3 )-metyl]-1,3-dihydro-5,6-dimetoksy-isoindol 2-[ (N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-1,3-dihydro-5,6-dimethoxy-isoindole

Fremstillet fra 2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl) -heksahydro-azepinyl-3) -metyl ] -5,6-dimetoksy-ftalimid og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and lithium aluminum hydride in tetrahydrofuran/ether, analogous to Example 3.

Utbytte: 49,2% av det teoretiske. Yield: 49.2% of the theoretical.

Smp.: 104-146°C M.p.: 104-146°C

Beregnet: C, 73,78; H, 7,99; N, 5,55 Calculated: C, 73.78; H, 7.99; N, 5.55

Funnet: C, 73,63; H, 7,99; N, 5,39 Found: C, 73.63; H, 7.99; N, 5.39

Eksempel 198 Example 198

3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetyl-1, 3, 4, 5- tetrahvdro- 2H- 3- benzazepin- dihydroklorid- moriohydrat 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-1, 3, 4, 5- tetrahydro- 2H- 3- benzazepine- dihydrochloride- moriohydrate

Fremstillet fra 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetyl-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 65% av det teoretiske. Yield: 65% of the theoretical.

Smp. : 168-170°C Temp. : 168-170°C

Beregnet: C, 66,39; H, 8,16; N, 8,29; Cl, 13,99 Calculated: C, 66.39; H, 8.16; N, 8.29; Cl, 13.99

Funnet: C, 66,29; H, 8,44; N, 8,08; Cl, 14,08 Found: C, 66.29; H, 8.44; N, 8.08; Cl, 14.08

Eksempel 199 Example 199

3-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-1,3,4,5-tetrahydro-7,8-metylendioksy-2H-3-benzazepin 3-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-1,3,4,5-tetrahydro-7,8-methylenedioxy- 2H-3-benzazepine

Fremstillet fra 3-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-1,3,4,5-tetrahydro-7,8-metylendioksy-2-okso-2H-3-benzazepin og Prepared from 3-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-1,3,4,5-tetrahydro-7,8- methylenedioxy-2-oxo-2H-3-benzazepine and

litiumaluminiumhydrid/tetrahydrofuran/eter, analogt med Eksempel 3. lithium aluminum hydride/tetrahydrofuran/ether, analogous to Example 3.

Utbytte: 25% av det teoretiske. Yield: 25% of the theoretical.

Smp.: 109-111°C M.p.: 109-111°C

Beregnet: C, 74,39; H, 7,80; N, 5,42 Calculated: C, 74.39; H, 7.80; N, 5.42

Funnet: C, 74,27; H, 7,94; N, 5,43 Found: C, 74.27; H, 7.94; N, 5.43

Eksempel 2 00 Example 2 00

3-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-1,3,4,5-tetrahydro-7,8-metylendioksy-2-okso-2H-3- 3-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-1,3,4,5-tetrahydro-7,8-methylenedioxy- 2-oxo-2H-3-

benz a z ep in- hydrokiorid benz a z ep in- hydrochioride

Fremstillet fra 3-[(heksahydro-azepinyl-3)-metyl]-1,3,4,5-tetrahydro-7,8-metylendioksy-2-okso-2H-3-benzazepin og 2-(3-klorpropoksy)-6-metoksy-naftalen, analogt med Eksempel 1. Prepared from 3-[(hexahydro-azepinyl-3)-methyl]-1,3,4,5-tetrahydro-7,8-methylenedioxy-2-oxo-2H-3-benzazepine and 2-(3-chloropropoxy)- 6-methoxy-naphthalene, analogous to Example 1.

Utbytte: 68,1% av det teoretiske. Yield: 68.1% of the theoretical.

Smelteområde: 104-108°C Melting range: 104-108°C

Beregnet (x 2 H20): C, 65,46; H, 7,38; N, 4,79; Cl, 6,06 Funnet: C, 65,60; H, 7,25; N, 5,01; Cl, 6,43 Calcd (x 2 H 2 O): C, 65.46; H, 7.38; N, 4.79; Cl, 6.06 Found: C, 65.60; H, 7.25; N, 5.01; Cl, 6.43

Eksempel 201 Example 201

2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-6,7-methylenedioxy-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(3-klorpropoksy)-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 18,2% av det teoretiske. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-6-methoxy- naphthalene, analogous to Example 1. Yield: 18.2% of the theoretical.

Smp.: 65-67°C M.p.: 65-67°C

Beregnet: C, 65,19; H, 6,88; N, 4,90; Cl, 6,20 Calculated: C, 65.19; H, 6.88; N, 4.90; Cl, 6.20

Funnet: C, 65,20; H, 6,75; N, 4,82; Cl, 6,54 Found: C, 65.20; H, 6.75; N, 4.82; Cl, 6.54

Eksempel 202 Example 202

2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4- tetrahydroisoquinoline

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(benzensulfonyloksymetyl)-N-[3-(6-metoksy-naftyl-2-oksy)-propyl]-piperidin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(benzenesulfonyloxymethyl)-N-[3-(6-methoxy-naphthyl-2-oxy)-propyl]- piperidine, analogously to Example 2.

Utbytte: 5,3% av det teoretiske. Yield: 5.3% of the theoretical.

Smp.: 144-146°C M.p.: 144-146°C

Beregnet: C, 71,69; H, 6,82; N, 5,57 Calcd: C, 71.69; H, 6.82; N, 5.57

Funnet: C, 71,52; H, 6,62; N, 5,46 Found: C, 71.52; H, 6.62; N, 5.46

Eksempel 203 Example 203

2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-5,6-dimetyl-l,3-dihydro-l-okso-isoindol 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-5,6-dimethyl-1,3-dihydro-1-oxo- isoindole

Fremstillet fra 2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-5,6-dimetyl-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethyl-phthalimide and zinc/glacial acetic acid, analogous to Example 4.

Utbytte: 18,2% av det teoretiske. Yield: 18.2% of the theoretical.

Smp.: 232-234°C M.p.: 232-234°C

Beregnet (x aceton): C, 74,97; H, 8,14; N, 5,14 Funnet: C, 74,96; H, 7,90; N, 5,30 Calculated (x acetone): C, 74.97; H, 8.14; N, 5.14 Found: C, 74.96; H, 7.90; N, 5.30

Eksempel 204 Example 204

2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-6,7-dimethyl-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og 2-(3-klor-propoksy)-6-metoksy-naftalen, analogt med Eksempel 1. Utbytte: 17,3% av det teoretiske. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloro-propoxy)-6- methoxy-naphthalene, analogous to Example 1. Yield: 17.3% of the theoretical.

Smelteområde: 68-73°C. Melting range: 68-73°C.

Beregnet (x 2 H20): C, 67,06; H, 7,93; N, 4,46; Cl, 6,66 Funnet: C, 67,05; H, 7,73; N, 4,88; Cl, 6,18 Calcd (x 2 H 2 O): C, 67.06; H, 7.93; N, 4.46; Cl, 6.66 Found: C, 67.05; H, 7.73; N, 4.88; Cl, 6.18

Eksempel 205 Example 205

2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4- tetrahydroisoquinoline

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-(benzensylfonyloksymetyl)-N-[3-(6-metoksy-naftyl-2-oksy)-propyl]-piperidin, analogt med Eksempel 2. Utbytte: 12,9% av det teoretiske. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(benzenesulfonyloxymethyl)-N-[3-(6-methoxy-naphthyl-2-oxy)-propyl]- piperidine, analogous to Example 2. Yield: 12.9% of the theoretical.

Smp.: 124-126°C M.p.: 124-126°C

Beregnet: C, 71,79; H, 7,38; N, 5,40 Calculated: C, 71.79; H, 7.38; N, 5.40

Funnet: C, 71,83; H, 7,33; N, 5,21 Found: C, 71.83; H, 7.33; N, 5.21

Eksempel 206 Example 206

3-[ (N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-1,3,4,5-tetrahydro-7,8-dimetoksy-2H-3-benzazepin 3-[ (N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-1,3,4,5-tetrahydro-7,8- dimethoxy-2H-3-benzazepine

Fremstillet fra 3-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-1,3,4,5-tetrahydro-7,8-dimetoksy-2-okso-2H-3-benzazepin og Prepared from 3-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-1,3,4,5-tetrahydro-7, 8-dimethoxy-2-oxo-2H-3-benzazepine and

1itiumaluminiumhydrid/tetrahydrofuran/eter, analogt med Eksempel 3. 1lithium aluminum hydride/tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 29,1% av det teoretiske. Yield: 29.1% of the theoretical.

Smp.: 94-96°C M.p.: 94-96°C

Beregnet: C, 72,57; H, 8,24; N, 4,98 Calculated: C, 72.57; H, 8.24; N, 4.98

Funnet: C, 72,56; H, 8,35; N, 4,94 Found: C, 72.56; H, 8.35; N, 4.94

Eksempel 207 Example 207

2- [(N-(3-(6-metoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3) -metyl]-1,3-dihydro-5,6-dimetoksy-l-okso-isoindol 2- [(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-1,3-dihydro-5,6-dimethoxy-1-oxo- isoindole

Fremstillet fra 2-[(N-(3-(6-metoksy-naftyl-2-oksy)-propyl) -heksahydro-azepinyl-3) -metyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogous to Example 4.

Utbytte: 20,5% av det teoretiske. Yield: 20.5% of the theoretical.

Smp.: 265-267°C M.p.: 265-267°C

Beregnet (x 2 H20): C, 67,13; H, 7,63; N, 5,05 Calcd (x 2 H 2 O): C, 67.13; H, 7.63; N, 5.05

Funnet: C, 67,11; H, 7,64; N, 5,07 Found: C, 67.11; H, 7.64; N, 5.07

Eksempel 208 Example 208

3- [(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl) -heksahydro-azepinyl-3 )-metyl]-1,3,4,5-tetrahydro-7,8-dimetoksy-2-okso-2H-3- benzazepin 3- [(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-1,3,4,5-tetrahydro-7,8- dimethoxy-2-oxo-2H-3-benzazepine

Fremstillet fra 3-[(heksahydro-azepinyl-3)-metyl]-l,3,4,5-tetrahydro-7,8-dimetoksy-2-okso-2H-3-benzazepin og 2-(3-klorpropoksy)-5,6-dimetoksy-naftalen, analogt med Eksempel 1. Prepared from 3-[(hexahydro-azepinyl-3)-methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2-oxo-2H-3-benzazepine and 2-(3-chloropropoxy)- 5,6-dimethoxy-naphthalene, analogous to Example 1.

Utbytte: 52,4% av det teoretiske. Yield: 52.4% of the theoretical.

Smp.: 129-131°C. M.p.: 129-131°C.

Beregnet: C, 70,81; H, 7,69; N, 4,86 Calculated: C, 70.81; H, 7.69; N, 4.86

Funnet: C, 70,66; H, 7,84; N, 4,63 Found: C, 70.66; H, 7.84; N, 4.63

Eksempel 209 Example 209

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-5,6-dimetoksy-l,3-dihydro-isoindol-dih<y>droklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole- dihydrochloride

Fremstillet fra 2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-5,6-dimetoksy-ftalimid og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and lithium aluminum hydride in tetrahydrofuran/ ether, analogous to Example 3.

Utbytte: 48,2% av det teoretiske. Yield: 48.2% of the theoretical.

Smelteområde: 172-177°C Melting range: 172-177°C

Beregnet (x H20): C, 61,43; H, 7,41; N, 4,47; Cl, 11,33 Funnet: C, 61,50; H, 7,71; N, 4,59; Cl, 11,45 Calcd (x H 2 O): C, 61.43; H, 7.41; N, 4.47; Cl, 11.33 Found: C, 61.50; H, 7.71; N, 4.59; Cl, 11.45

Eksempel 210 Example 210

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3) -metyl]-5,6-dimetoksy-l,3-dihydro-l-okso-isoindol-hvdroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-1,3-dihydro-1- oxo-isoindole hydrochloride

Fremstillet fra 2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogous to Example 4.

Utbytte: 36,4% av det teoretiske. Yield: 36.4% of the theoretical.

Smelteområde.: 215-223°C Melting range: 215-223°C

Beregnet (x H20): C, 61,87; H, 7,30; N, 4,50; Cl, 5,70 Funnet: C, 62,08; H, 7,15; N, 4,55; Cl, 5,80 Calcd (x H 2 O): C, 61.87; H, 7.30; N, 4.50; Cl, 5.70 Found: C, 62.08; H, 7.15; N, 4.55; Cl, 5.80

Eksempel 211 Example 211

2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-5,6-dimetoksy-1,3-dihydro-isoindol-dihydroklorid-monohydrat 2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole dihydrochloride monohydrate

Fremstillet fra 2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-5,6-dimetoksy-ftalimid og litiumaluminiumhydrid i tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-5,6-dimethoxy-phthalimide and lithium aluminum hydride in tetrahydrofuran, analogously to Example 3.

Utbytte: 87% av det teoretiske. Yield: 87% of the theoretical.

Smp.: 262-264°C M.p.: 262-264°C

Beregnet: C, 61,17; H, 7,30; N, 8,23; Cl, 13,89 Calculated: C, 61.17; H, 7.30; N, 8.23; Cl, 13.89

Funnet: C, 61,34; H, 7,26; N, 7,92; Cl, 13,90 Found: C, 61.34; H, 7.26; N, 7.92; Cl, 13.90

Eksempel 212 Example 212

3-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-1,3,4,5-tetrahydro-7,8-dimetyl-2H-3-benzazepin- dihvdroklorid 3-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-1,3,4,5-tetrahydro-7,8- dimethyl-2H-3-benzazepine dihydrochloride

Fremstillet fra 3-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3)-metyl]-1,3,4,5-tetrahydro-7,8-dimetyl-2-okso-2H-3-benzazepin og litiumaluminiumhydrid/tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-1,3,4,5-tetrahydro-7, 8-dimethyl-2-oxo-2H-3-benzazepine and lithium aluminum hydride/tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 76,9% av det teoretiske. Yield: 76.9% of the theoretical.

Smelteområde: 138-144°C Melting range: 138-144°C

Beregnet: C, 67,64; H, 8,01; N, 4,64; Cl, 11,74 Calculated: C, 67.64; H, 8.01; N, 4.64; Cl, 11.74

Funnet: C, 67,73; H, 8,26; N, 4,47; Cl, 11,50 Found: C, 67.73; H, 8.26; N, 4.47; Cl, 11.50

Eksempel 213 Example 213

3-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-1,3,4,5-tetrahydro-7,8-dimetyl-2-okso-2H-3-benzazepin- hvdroklorid 3-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-1,3,4,5-tetrahydro-7,8- dimethyl-2-oxo-2H-3-benzazepine hydrochloride

Fremstillet fra 3-[(heksahydro-azepinyl-3)-metyl]-1,3,4,5-tetrahydro-7,8-dimetyl-2-okso-2H-3-benzazepin og 2-(3-klorpropoksy)-5,6-dimetoksy-naftalen, analogt med Eksempel 1. Utbytte: 47,5% av det teoretiske. Prepared from 3-[(hexahydro-azepinyl-3)-methyl]-1,3,4,5-tetrahydro-7,8-dimethyl-2-oxo-2H-3-benzazepine and 2-(3-chloropropoxy)- 5,6-dimethoxy-naphthalene, analogous to Example 1. Yield: 47.5% of the theoretical.

Smelteområde: 90-96°C Melting range: 90-96°C

Beregnet: C, 68,15; H, 7,90; N, 4,67; Cl, 5,91 Calculated: C, 68.15; H, 7.90; N, 4.67; Cl, 5.91

Funnet: C, 67,93; H, 7,94; N, 5,05; Cl, 6,09 Found: C, 67.93; H, 7.94; N, 5.05; Cl, 6.09

Eksempel 214 Example 214

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(3-klorpropoksy)-5,6-dimetoksy-naftalen, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-5,6-dimethoxy- naphthalene, analogous to Example 1.

Utbytte: 22,5% av det teoretiske. Yield: 22.5% of the theoretical.

Smelteområde: 93-98°C. Melting range: 93-98°C.

Beregnet (x H20): C, 63,42; H, 6,69; N, 4,77; Cl, 6,03 Funnet: C, 63,59; H, 6,80; N, 4,70; Cl, 6,28 Calcd (x H 2 O): C, 63.42; H, 6.69; N, 4.77; Cl, 6.03 Found: C, 63.59; H, 6.80; N, 4.70; Cl, 6.28

Eksempel 215 Example 215

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-pyrrolidyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(pyrrolidyl-3)-metyl]-6,7-metylendioksy-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(3-klorpropoksy)-5,6-dimetoksy-naftalen, analogt med Eksempel 1. Utbytte: 22,5% av det teoretiske. Prepared from 2-[(pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-5,6-dimethoxy- naphthalene, analogous to Example 1. Yield: 22.5% of the theoretical.

Smp. : 87-90°C. Temp. : 87-90°C.

Beregnet (x H20) : C, 62,87; H, 6,50; N, 4,88; Cl, 6,18 Funnet: C, 62,72; H, 6,38; N, 4,93; Cl, 6,30 Calcd (x H 2 O) : C, 62.87; H, 6.50; N, 4.88; Cl, 6.18 Found: C, 62.72; H, 6.38; N, 4.93; Cl, 6.30

Eksempel 216 Example 216

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3, 4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l, 2,3,4-tetrahydro-isokinolin og 2-(3-klorpropoksy)-5,6-dimetoksy-naftalen, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1, 2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-5,6-dimethoxy- naphthalene, analogous to Example 1.

Utbytte: 21,3% av det teoretiske. Yield: 21.3% of the theoretical.

Smp.: 72-78°C. M.p.: 72-78°C.

Beregnet (x H20): C, 67,30; H, 7,59; N, 4,90; Cl, 6,21 Funnet: C, 67,44; H, 7,74; N, 5,06; Cl, 6,53 Calcd (x H 2 O): C, 67.30; H, 7.59; N, 4.90; Cl, 6.21 Found: C, 67.44; H, 7.74; N, 5.06; Cl, 6.53

Eksempel 217 Example 217

2-[(N-(3-(5,6-dimetoksy-naftyl-2-oksy)-propyl)-heksahydro-azepinyl-3) -metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin- hvdroklorid 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2, 3,4-tetrahydro-isoquinoline hydrochloride

Fremstillet fra 2-[(heksahydro-azepinyl-3)-metyl]-6,7-dimetyl-l-okso-1,2,3,4-tetrahydro-isokinolin og 2-(3-klor-propoksy) -5 , 6-dimetoksy-naf talen, analogt med Eksempel 1. Utbytte: 12% av det teoretiske. Prepared from 2-[(hexahydro-azepinyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloro-propoxy)-5, 6-dimethoxy-naphthalene, analogous to Example 1. Yield: 12% of the theoretical.

Smelteområde: 84-90°C Melting range: 84-90°C

Beregnet (x H20): C, 67,73; H, 7,73; N, 4,78; Cl, 6,06 Funnet: C, 67,64; H, 7,81; N, 4,94; Cl, 6,20 Calcd (x H 2 O): C, 67.73; H, 7.73; N, 4.78; Cl, 6.06 Found: C, 67.64; H, 7.81; N, 4.94; Cl, 6.20

Eksempel 218 Example 218

2-[(N-(2-(4-metoksyfeny1)-etyl)-heksahydro-az epinyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(2-(4-methoxyphenyl)-ethyl)-hexahydro-az epinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline -hydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[2-(4-metoksyfenyl)-etyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(4-methoxyphenyl)-ethyl]-3-chloromethyl-hexahydro-azepine, analogously to Example 2 .

Utbytte: 46,7% av det teoretiske. Yield: 46.7% of the theoretical.

Smp.: 101-105°C M.p.: 101-105°C

Beregnet: C, 62,44; H, 7,26; N, 5,60; Cl, 7,50 Calculated: C, 62.44; H, 7.26; N, 5.60; Cl, 7.50

Funnet: C, 62,62; H, 7,27; N, 5,48; Cl, 7,66 Found: C, 62.62; H, 7.27; N, 5.48; Cl, 7.66

Eksempel 219 Example 219

2-[(N-(3-(4-metoksy-fenoksy)-propyl)-heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(4-metoksy-fenoksy)propyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxy-phenoxy)propyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2.

Utbytte: 43,8% av det teoretiske. Yield: 43.8% of the theoretical.

Smp.: 123-126°C. M.p.: 123-126°C.

Beregnet: C, 62,23; H, 7,16; N, 5,37; Cl, 7,05 Calculated: C, 62.23; H, 7.16; N, 5.37; Cl, 7.05

Funnet: C, 62,42; H, 7,34; N, 5,30; Cl, 6,94 Found: C, 62.42; H, 7.34; N, 5.30; Cl, 6.94

Eksempel 220 Example 220

2-[(N-(3-(4-metoksy-fenoksy)-propyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(4-metoksy-fenoksy)-propyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2.

Utbytte: 42% av det teoretiske. Yield: 42% of the theoretical.

Smp.: 172-173°C M.p.: 172-173°C

Beregnet: C, 69,04; H, 8,07; N, 5,75; Cl, 7,28 Calculated: C, 69.04; H, 8.07; N, 5.75; Cl, 7.28

Funnet: C, 69,06; H, 8,25; N, 5,57; Cl, 7,39 Found: C, 69.06; H, 8.25; N, 5.57; Cl, 7.39

Eksempel 221 Example 221

2-[(N-(3-(4-metoksy-fenoksy)-propyl)-heksahydro-azepinyl-3) - metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[ 3-(4-metoksy-f enoksy)-propyl]-3-klorme tyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2.

Utbytte: 63,3% av det teoretiske. Yield: 63.3% of the theoretical.

Smelteområde: 115-120°C. Melting range: 115-120°C.

Beregnet: C, 62,58; H, 7,67; N, 5,21; Cl, 6,83 Calculated: C, 62.58; H, 7.67; N, 5.21; Cl, 6.83

Funnet: C, 62,44; H, 7,68; N, 4,91; Cl, 6,81 Found: C, 62.44; H, 7.68; N, 4.91; Cl, 6.81

Eksempel 222 Example 222

2-[ (N- (2 -(4-metoksyfenyl) -etyl) -heksahydro-azepinyl-3) -metyl]-6,7-dimetoksy-l-okso-l ,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[ (N-(2-(4-methoxyphenyl)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline- hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[2-(4-metoksyfenyl)-etyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(4-methoxyphenyl)-ethyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2 .

Utbytte: 51,6% av det teoretiske. Yield: 51.6% of the theoretical.

Smp.: 110-113°C. M.p.: 110-113°C.

Beregnet: C, 61,75; H, 7,87; N, 5,28; Cl, 7,25 Calcd: C, 61.75; H, 7.87; N, 5.28; Cl, 7.25

Funnet: C, 61,84; H, 8,02; N, 5,16; Cl, 7,22 Found: C, 61.84; H, 8.02; N, 5.16; Cl, 7.22

Eksempel 223 Example 223

2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[2-(3,4-dimetoksyfenyl)-etyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(3,4-dimethoxyphenyl)-ethyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2.

Utbytte: 45,5% av det teoretiske. Yield: 45.5% of the theoretical.

Smp.: 107-111°C. M.p.: 107-111°C.

Beregnet: C, 62,61; H, 7,69; N, 5,21; Cl, 6,60 Calculated: C, 62.61; H, 7.69; N, 5.21; Cl, 6.60

Funnet: C, 62,78; H, 8,00; N, 5,00; Cl, 6,43 Found: C, 62.78; H, 8.00; N, 5.00; Cl, 6.43

Eksempel 224 Example 224

2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[2-(3,4-dimetoksyfenyl)-etyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(3,4-dimethoxyphenyl)-ethyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2.

Utbytte: 44,8% av det teoretiske. Yield: 44.8% of the theoretical.

Smp.: 162-163°C M.p.: 162-163°C

Beregnet: C, 66,57; H, 8,18; N, 5,54; Cl, 7,02 Calculated: C, 66.57; H, 8.18; N, 5.54; Cl, 7.02

Funnet: C, 66,67; H, 8,47; N, 5,35; Cl, 7,11 Found: C, 66.67; H, 8.47; N, 5.35; Cl, 7.11

Eksempel 225 Example 225

2-[(N-(3-(3-metyl-fenoksy)-propyl)-heksahydro-azepinyl-3)-metyl]-6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(3-methyl-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(3-metyl-fenoksy)-propyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3-methyl-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2.

Utbytte: 46,8% av det teoretiske. Yield: 46.8% of the theoretical.

Smp.: 159-161°C. M.p.: 159-161°C.

Beregnet: C, 65,37; H, 7,31; N, 5,64; Cl, 7,28 Calculated: C, 65.37; H, 7.31; N, 5.64; Cl, 7.28

Funnet: C, 65,44; H, 7,40; N, 5,39; Cl, 7,23 Found: C, 65.44; H, 7.40; N, 5.39; Cl, 7.23

Eksempel 22 6 Example 22 6

2-[(N-(3-(3-metyl-fenoksy)-propyl)-heksahydro-azepinyl-3)-metyl]-6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hydroklorid 2-[(N-(3-(3-methyl-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- isoquinoline hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(3-metoksy-fenoksy)-propyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3-methoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2.

Utbytte: 55,2% av det teoretiske. Yield: 55.2% of the theoretical.

Smp.: 107-111°C. M.p.: 107-111°C.

Beregnet: C, 65,67; H, 7,87; N, 5,47; Cl, 7,05 Calculated: C, 65.67; H, 7.87; N, 5.47; Cl, 7.05

Funnet: C, 65,47; H, 8,00; N, 5,50; Cl, 6,97 Found: C, 65.47; H, 8.00; N, 5.50; Cl, 6.97

Eksempel 227 Example 227

2-[(N-(3-(3,4-metylendioksy-fenoksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin- hvdroklorid 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-6,7-dimethyl-1-oxo-1,2,3,4- tetrahydroisoquinoline hydrochloride

Fremstillet fra 6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(3,4-metylendioksy-fenoksy)-propyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Utbytte: 40,6% av det teoretiske. Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3,4-methylenedioxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2. Yield: 40.6% of the theoretical.

Smp.: 123-126°C. M.p.: 123-126°C.

Beregnet: C, 64,78; H, 7,57; N, 5,39; Cl, 6,83 Calcd: C, 64.78; H, 7.57; N, 5.39; Cl, 6.83

Funnet: C, 64,88; H, 7,59; N, 5,29; Cl, 7,18 Found: C, 64.88; H, 7.59; N, 5.29; Cl, 7.18

Eksempel 228 Example 228

2- [ (N- (3- (3,4-dimetoksy-f enoksy) -propyl) -heksahydro-azepinyl-3) -metyl] -6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin-hvdroklorid 2-[ (N-(3-(3,4-dimethoxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4 -tetrahydro-isoquinoline hydrochloride

Fremstillet fra 6,7-dimetoksy-l-okso-l,2,3,4-tetrahydro-isokinolin og N-[3-(3,4-dimetoksy-fenoksy)-propyl]-3-klormetyl-heksahydro-azepin, analogt med Eksempel 2. Utbytte: 30,6% av det teoretiske. Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3,4-dimethoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine, analogous to Example 2. Yield: 30.6% of the theoretical.

Smp.: 101-105°C. M.p.: 101-105°C.

Beregnet: C, 62,61; H, 7,59; N, 5,01; Cl, 6,46 Calculated: C, 62.61; H, 7.59; N, 5.01; Cl, 6.46

Funnet: C, 62,56; H, 7,76; N, 4,94; Cl, 6,39 Found: C, 62.56; H, 7.76; N, 4.94; Cl, 6.39

Eksempel 229 Example 229

2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-heksahydro-azepinyl-3)-metvl]- 5, 6- dimetoksy- l- okso- l, 3- dihydro- isoindol- hvdroklorid 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-hexahydro-azepinyl-3)-methyl]- 5, 6- dimethoxy- l- oxo- ol, 3- dihydro- isoindole- hydrochloride

Fremstillet fra 2-[(N-(2-(3,4-dimetoksyfenyl)-etyl)-heksahydro-azepinyl-3)-metyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4.

Utbytte: 41,8% av det teoretiske. Yield: 41.8% of the theoretical.

Smp.: 150-151°C. M.p.: 150-151°C.

Beregnet: C, 61,99; H, 7,57; N, 5,35; Cl, 6,57 Calculated: C, 61.99; H, 7.57; N, 5.35; Cl, 6.57

Funnet: C, 61,89; H, 7,48; N, 5,17; Cl, 6,52 Found: C, 61.89; H, 7.48; N, 5.17; Cl, 6.52

Eksempel 230 Example 230

2-[ (N- (3 - (3 -metyl - f enoksy) -propyl) -heksahydro-azepinyl-3) - metvl1- 5. 6- dimetoksy- l- okso- l. 3- dihvdro- isoindol- hvdroklorid 2-[ (N- (3 - (3-methyl-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl- 5. 6- dimethoxy- l- oxo- l. 3- dihydro-isoindole- hydrochloride

Fremstillet fra 2-[(N-(3-(3-metyl-fenoksy)-propyl)-heksahydro-azepinyl-3)-metyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-(3-methyl-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4.

Utbytte: 88,9% av det teoretiske. Yield: 88.9% of the theoretical.

Smp.: 95-100°C. Melting point: 95-100°C.

Beregnet: C, 63,95; H, 7,75; N, 5,52; Cl, 7,25 Calculated: C, 63.95; H, 7.75; N, 5.52; Cl, 7.25

Funnet: C, 64,09; H, 7,64; N, 5,35; Cl, 7,37 Found: C, 64.09; H, 7.64; N, 5.35; Cl, 7.37

Eksempel 231 Example 231

2-[ (N- (3 -(4-metoksy-fenoksy) -propyl) -heksahydro-azepinyl-3)-metvl 1 - 5. 6- dimetoksv- l- okso- l. 3- dihydro- isoindol- hvdroklorid 2-[ (N-(3-(4-Methoxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl-1-5.6-dimethoxy-1-oxo-1.3-dihydro-isoindole-hydrochloride

Fremstillet fra 2-[(N-(3-(4-metoksy-fenoksy)-propyl) - heksahydro-azepinyl-3)-metyl]-5> 6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5>6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4.

Utbytte: 87,1% av det teoretiske. Yield: 87.1% of the theoretical.

Smp.: 107-112°C M.p.: 107-112°C

Beregnet: C, 61,99; H, 7,51; N, 5,35; Cl, 7,02 Calculated: C, 61.99; H, 7.51; N, 5.35; Cl, 7.02

Funnet: C, 62,07; H, 7,37; N, 5,28; Cl, 7,31 Found: C, 62.07; H, 7.37; N, 5.28; Cl, 7.31

Eksempel 232 Example 232

2-[(N-(3-(3,4-metylendioksy-fenoksy)-propyl)-heksahydro-azepinyl-3 ) -metyl] -5,6-dimetoksy-l-okso-l, 3-dihydro-isoindol-hvdroklorid 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole- hydrochloride

Fremstillet fra 2-[(N-(3-(3,4-metylendioksy-fenoksy)-propyl)-heksahydro-azepinyl-3)-metyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4 .

Utbytte: 59% av det teoretiske. Yield: 59% of the theoretical.

Smp.: 104-107°C M.p.: 104-107°C

Beregnet: C, 60,38; H, 6,94; N, 5,20; Cl, 7,31 Calculated: C, 60.38; H, 6.94; N, 5.20; Cl, 7.31

Funnet: C, 60,40; H, 7,15; N, 4,95; Cl, 7,25 Found: C, 60.40; H, 7.15; N, 4.95; Cl, 7.25

Eksempel 233 Example 233

2- [(N-(3-(3,4-metylendioksy-fenoksy)-propyl)-heksahydro-azepinyl-3 )-metyl]-5,6-dimetoksy-l-okso-l,3-dihydro-isoindol-hvdroklorid 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepinyl-3 )-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole- hydrochloride

Fremstillet fra 2-[(N-(3-(3,4-metylendioksy-fenoksy)-propyl)-heksahydro-azepinyl-3) -metyl]-5,6-dimetoksy-ftalimid og sink/iseddik, analogt med Eksempel 4. Prepared from 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepinyl-3)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid, analogously to Example 4 .

Utbytte: 79,4% av det teoretiske. Yield: 79.4% of the theoretical.

Smp.: 112-116°C M.p.: 112-116°C

Beregnet: C, 62,23; H, 7,15; N, 5,37; Cl, 7,05 Calculated: C, 62.23; H, 7.15; N, 5.37; Cl, 7.05

Funnet: C, 62,16; H, 7,25; N, 4,96; Cl, 7,03 Found: C, 62.16; H, 7.25; N, 4.96; Cl, 7.03

Eksempel 234 Example 234

3- [(N-(3-(pyridyl-3)-propyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin-d ihydrokiorid- 3- [(N-(3-(pyridyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine- dihydrochloride

dihvdrat dihvrated

Fremstillet fra 7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin og N-[3-(pyridyl-3)-propyl]-3-klormetyl-heksahydro-azepin i dimetylsulfoksyd med kalium-tert-butylat, analogt med Eksempel 2. Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and N-[3-(pyridyl-3)-propyl]-3-chloromethyl-hexahydro-azepine in dimethylsulfoxide with potassium- tert-butylate, analogous to Example 2.

Utbytte: 86% av det teoretiske. Yield: 86% of the theoretical.

Smp.: 106-108°C M.p.: 106-108°C

Beregnet: C, 58,05; H, 7,40; N, 7,52; Cl, 12,69 Calculated: C, 58.05; H, 7.40; N, 7.52; Cl, 12.69

Funnet: C, 57,94; H, 7,55; N, 7,75; Cl, 12,42 Found: C, 57.94; H, 7.55; N, 7.75; Cl, 12.42

Eksempel 235 Example 235

3-[(N-(3-(pyridyl-3)-propyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid-dihydrat 3-[(N-(3-(pyridyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine dihydrochloride dihydrate

Fremstillet fra 3-[(N-(3-(pyridyl-3)-propyl)-heksahydro-azepinyl-3 )-metyl]-7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin og 5 bar hydrogen i nærvær av 10% palladium på kull i dimetylformamid ved 80°C, analogt med Eksempel 5. Prepared from 3-[(N-(3-(pyridyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3- benzazepine and 5 bar hydrogen in the presence of 10% palladium on charcoal in dimethylformamide at 80°C, analogously to Example 5.

Utbytte: 43% av det teoretiske. Yield: 43% of the theoretical.

Smp.: 119-121°C M.p.: 119-121°C

Beregnet: C, 57,85; H, 7,73; N, 7,49; Cl, 12,65 Calculated: C, 57.85; H, 7.73; N, 7.49; Cl, 12.65

Funnet: C, 57,74; H, 7,79; N, 7,23; Cl, 12,50 Found: C, 57.74; H, 7.79; N, 7.23; Cl, 12.50

Eksempel 236 Example 236

3-[ (N- (3- (pyridyl-3) -propyl) -heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-l ,3,4,5-tetrahydro-2H-3-benzazepin-trihydroklorid-monohydrat 3-[(N-(3-(pyridyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine- trihydrochloride monohydrate

Fremstillet fra 3-[ (N-(3-(pyridyl-3)-propyl)-heksahydro-azepinyl-3 ) -metyl ] -7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran og dietyleter, analogt med Eksempel 3. Prepared from 3-[ (N-(3-(pyridyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine and lithium aluminum hydride in tetrahydrofuran and diethyl ether, analogously to Example 3.

Utbytte: 82% av det teoretiske. Yield: 82% of the theoretical.

Smp.: 139-141°C. M.p.: 139-141°C.

Beregnet: C, 57,39; H, 7,85; N, 7,43; Cl, 18,82 Calculated: C, 57.39; H, 7.85; N, 7.43; Cl, 18.82

Funnet: C, 57,42; H, 8,15; N, 7,56; Cl, 19,04 Found: C, 57.42; H, 8.15; N, 7.56; Cl, 19.04

Eksempel 237 Example 237

2- [ (N- (1- (pyridyl-3) -metyl) -pyrrolidyl-3) -metyl ] -6,7-metylendioksy-l-okso-l ,2,3,4-tetrahydro-isokinolin-dihydroklorid-dih<y>drat 2- [ (N-(1-(pyridyl-3)-methyl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride- di<y>drat

Fremstillet fra 6,7-metylendioksy-l-okso-l,2,3,4-tetrahydro-isokinolin og 3-klormetyl-N-[(pyridyl-3)-metyl]-pyrrolidin i dimetylsulfoksyd med kalium-tert-butylat, analogt med Eksempel 2. Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[(pyridyl-3-methyl]-pyrrolidine in dimethylsulfoxide with potassium tert-butylate, analogous to Example 2.

Utbytte: 46% av det teoretiske. Yield: 46% of the theoretical.

Smp.: 91-93°C. M.p.: 91-93°C.

Beregnet: C, 53,17; H, 6,16; N, 8,85; Cl, 14,95 Calculated: C, 53.17; H, 6.16; N, 8.85; Cl, 14.95

Funnet: C, 53,31; H, 5,93; N, 8,71; Cl, 15,01 Found: C, 53.31; H, 5.93; N, 8.71; Cl, 15.01

Eksempel 238 Example 238

2- [ (N- (1- (pyridyl-3) -metyl) -pyrrolidyl-3) -metyl ]-6,7-metylendioksy-l ,2,3,4-tetrahydro-isokinolin-trihydro- 2- [ (N-(1-(pyridyl-3)-methyl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1,2,3,4-tetrahydro-isoquinoline-trihydro-

klorid - 1, 5 x hydrat chloride - 1.5 x hydrate

Fremstillet fra 2-[(N-(l-(pyridyl-3)-metyl)-pyrrolidyl-3) -metyl ] -6,7-metylendioksy-l-okso-l ,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i tetrahydrofuran og dietyleter, analogt med Eksempel 3. Prepared from 2-[(N-(1-(pyridyl-3)-methyl)-pyrrolidyl-3)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in tetrahydrofuran and diethyl ether, analogously to Example 3.

Utbytte: 67% av det teoretiske. Yield: 67% of the theoretical.

Smp.: 178-181°C. M.p.: 178-181°C.

Beregnet: C, 51,70; H, 6,41; N, 8,61; Cl, 21,80 Calculated: C, 51.70; H, 6.41; N, 8.61; Cl, 21.80

Funnet: C, 51,63; H, 6,62; N, 8,45; Cl, 21,07 Found: C, 51.63; H, 6.62; N, 8.45; Cl, 21.07

Eksempel 239 Example 239

3- [ (N-(2-(6-metyl-pyridyl-2)-etyl)-heksahydro-azepinyl-3)-metyl] -7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin-dihydroklorid- dihvdrat 3- [ (N-(2-(6-methyl-pyridyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl] -7,8-dimethoxy-2-oxo-1,3-dihydro-2H- 3-benzazepine dihydrochloride dihydrogen

Fremstillet fra 7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin og N-[2-(6-metyl-pyridy1-2)-etyl]-3-klormetyl-heksahydro-azepin i dimetylsulfoksyd med kalium-tert-butylat, analogt med Eksempel 2. Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and N-[2-(6-methyl-pyridy1-2)-ethyl]-3-chloromethyl-hexahydro-azepine in dimethylsulfoxide with potassium tert-butylate, analogously to Example 2.

Utbytte: 63% av det teoretiske. Yield: 63% of the theoretical.

Smp.: 134-136°C M.p.: 134-136°C

Beregnet: C, 58,05; H, 7,40; N, 7,52; Cl, 12,69 Calculated: C, 58.05; H, 7.40; N, 7.52; Cl, 12.69

Funnet: C, 58,15; H, 7,60; N, 7,45; Cl, 12,45 Found: C, 58.15; H, 7.60; N, 7.45; Cl, 12.45

Eksempel 240 Example 240

3-[ (N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin-dihydroklorid x 1, 5 hydrat 3-[ (N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3- benzazepine dihydrochloride x 1.5 hydrate

Fremstillet fra 7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin og 3-klormetyl-N-[2-(6-metyl-pyridyl-2)-etyl]-pyrrolidin i dimetylsulfoksyd med kalium-tert-butylat, analogt med Eksempel 2. Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[2-(6-methyl-pyridyl-2)-ethyl]-pyrrolidine in dimethylsulfoxide with potassium tert-butylate, analogously to Example 2.

Utbytte: 61% av det teoretiske. Yield: 61% of the theoretical.

Smp.: 78-80°C. Melting point: 78-80°C.

Beregnet: C, 57,58; H, 6,96; N, 8,06; Cl, 13,60 Calculated: C, 57.58; H, 6.96; N, 8.06; Cl, 13.60

Funnet: C, 57,40; H, 7,18; N, 8,24; Cl, 13,39 Found: C, 57.40; H, 7.18; N, 8.24; Cl, 13.39

Eksempel 241 Example 241

3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin- dihvdroklorid x 2, 5 hydrat 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5- tetrahydro-2H-3-benzazepine dihydrochloride x 2.5 hydrate

Fremstillet fra 3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3-dihydro-2H-3-benzazepin og 5 bar hydrogen i nærvær av palladium/kull og dimetylformamid, analogt med Eksempel 5. Utbytte: 34% av det teoretiske. Prepared from 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro- 2H-3-benzazepine and 5 bar hydrogen in the presence of palladium/charcoal and dimethylformamide, analogously to Example 5. Yield: 34% of the theoretical.

Smp.: 112-114°C. M.p.: 112-114°C.

Beregnet: C, 56,93; H, 7,78; N, 7,38; Cl, 12,45 Calculated: C, 56.93; H, 7.78; N, 7.38; Cl, 12.45

Funnet: C, 56,83; H, 8,04; N, -7,43; Cl, 12,26 Found: C, 56.83; H, 8.04; N, -7.43; Cl, 12.26

Eksempel 242 Example 242

3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-l,3,4,5-tetrahydro-2H-3-benzazepin-trihvdroklorid- dihydrat 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H- 3-benzazepine trihydrochloride dihydrate

Fremstillet fra 3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuranog dietyleter, analogt med Eksempel 3. Utbytte: 74% av det teoretiske. Prepared from 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4, 5-tetrahydro-2H-3-benzazepine and lithium aluminum hydride in tetrahydrofuran and diethyl ether, analogously to Example 3. Yield: 74% of the theoretical.

Smp.: 148-150°C. Melting point: 148-150°C.

Beregnet: C, 55,61; H, 7,95; N, 7,20; Cl, 18,24 Calculated: C, 55.61; H, 7.95; N, 7.20; Cl, 18,24

Funnet: C, 55,72; H, 8,10; N, 7,03; Cl, 18,00 Found: C, 55.72; H, 8.10; N, 7.03; Cl, 18.00

Eksempel 243 Example 243

3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid- dihydrat 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine dihydrochloride dihydrate

Fremstillet fra 3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin og palladium/kull i dimetylformamid ved 50°C og 6 bar hydrogen, analogt med Eksempel 5. Prepared from 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H- 3-benzazepine and palladium/charcoal in dimethylformamide at 50°C and 6 bar hydrogen, analogously to Example 5.

Utbytte: 28% av det teoretiske. Yield: 28% of the theoretical.

Smp.: 87-90°C. M.p.: 87-90°C.

Beregnet: C, 56,38; H, 7,38; N, 7,89; Cl, 13,31 Calculated: C, 56.38; H, 7.38; N, 7.89; Cl, 13.31

Funnet: C, 56,33; H, 7,53; N, 8,09; Cl, 13,43 Found: C, 56.33; H, 7.53; N, 8.09; Cl, 13.43

Eksempel 244 Example 244

3-[(N-(2-(6-metyl-pyridyl-2)-etyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-l,3,4,5-tetrahydro-2H-3-benzazepin-trihydroklorid-dihydrat 3-[(N-(2-(6-methyl-pyridyl-2)-ethyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3- benzazepine trihydrochloride dihydrate

Fremstillet fra 7,8-dimetoksy-l,3,4,5-tetrahydro-2H-3-benzazepin og N-[(2-(6-metyl-pyridyl-2)-etylj-S-Cbenzensulf onyloksymetyl) -pyrrolidin i dimetylformamid og trietylamin, analogt med Eksempel 2. Prepared from 7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine and N-[(2-(6-methyl-pyridyl-2)-ethylj-S-Cbenzenesulfonyloxymethyl)-pyrrolidine in dimethylformamide and triethylamine, analogously to Example 2.

Utbytte: 42% av det teoretiske. Yield: 42% of the theoretical.

Smp.: 225-227°C M.p.: 225-227°C

Beregnet: C, 54,10; H, 7,62; N, 7,57; Cl, 19,16 Calculated: C, 54.10; H, 7.62; N, 7.57; Cl, 19,16

Funnet: C, 54,18; H, 7,55; N, 7,51; Cl, 19,30 Found: C, 54.18; H, 7.55; N, 7.51; Cl, 19.30

Eksempel 245 Example 245

2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-1,3-dihydro-isoindol x 1,5 benzensulfonat-trihydrat 2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole x 1.5 benzenesulfonate trihydrate

Fremstillet fra 2-[(piperidyl-3)-metyl]-5,6-dimetoksy-l-okso-l, 3-dihydro-isoindol og 3-(3-benzensulfonyloksy-propyl)-indol i dimetylformamid og trietylamin, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole and 3-(3-benzenesulfonyloxy-propyl)-indole in dimethylformamide and triethylamine, analogously to Example 1.

Utbytte: 45% av det teoretiske. Yield: 45% of the theoretical.

Smp.: 87-89°C. M.p.: 87-89°C.

Beregnet: C, 58,51; H, 6,54; N, 5,68 Calculated: C, 58.51; H, 6.54; N, 5.68

Funnet: C, 58,66; H, 6,43; N, 5,34 Found: C, 58.66; H, 6.43; N, 5.34

Eksempel 246 Example 246

2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l ,2,3,4-tetrahydro-isokinolin-benzensulfonat-dihydrat 2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline-benzenesulfonate- dihydrate

Fremstillet fra 2-[(piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l, 2 , 3 , 4-tetrahydro-isokinolin og 3-(3-benzensulfonyloksy-propyl)-indol i dimetylformamid og trietylamin, analogt med Eksempel 1. Prepared from 2-[(piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(3-benzenesulfonyloxy-propyl)-indole in dimethylformamide and triethylamine, analogously to Example 1.

Utbytte: 94% av det teoretiske. Yield: 94% of the theoretical.

Smp.: 117-119°C. M.p.: 117-119°C.

Beregnet: C, 65,46; H, 7,27; N, 6,73 Calculated: C, 65.46; H, 7.27; N, 6.73

Funnet: C, 65,51; H, 6,91; N, 6,72 Found: C, 65.51; H, 6.91; N, 6.72

Eksempel 247 Example 247

3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-hydroklorid-monohydrat 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3- benzazepine hydrochloride monohydrate

Fremstillet fra 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3) -metyl]-7,8-dimetoksy-2-okso-1,3-dihydro-2H-3-benzazepin og 5 bar hydrogen i nærvær av palladium/kull i dimetylformamid ved 80°C, analogt med Eksempel 5. Prepared from 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 5 bar hydrogen in the presence of palladium/charcoal in dimethylformamide at 80°C, analogously to Example 5.

Utbytte: 58% av det teoretiske. Yield: 58% of the theoretical.

Smp.: 128-130°C. Melting point: 128-130°C.

Beregnet: C, 65,16; H, 7,42; N, 8,14; Cl, 6,87 Calculated: C, 65.16; H, 7.42; N, 8.14; Cl, 6.87

Funnet: C, 65,12; H, 7,55; N, 8,11; Cl, 7,06 Found: C, 65.12; H, 7.55; N, 8.11; Cl, 7.06

Eksempel 248 Example 248

3-[(N-(3-(indolyl-3)-propyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin-monohydrat 3-[(N-(3-(indolyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine monohydrate

Fremstillet fra 3-[(heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 3-(3-benzensulfonyloksy-propyl)-indol i dimetylformamid og trietylamin, analogt med Eksempel 1. Prepared from 3-[(hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(3-benzenesulfonyloxy-propyl )-indole in dimethylformamide and triethylamine, analogously to Example 1.

Utbytte: 49% av det teoretiske. Yield: 49% of the theoretical.

Smp. : 56-58°C. Temp. : 56-58°C.

Beregnet: C, 70,98; H, 8,14; N, 8,27 Calcd: C, 70.98; H, 8.14; N, 8.27

Funnet: C, 71,08; H, 8,10; N, 8,16 Found: C, 71.08; H, 8.10; N, 8.16

Eksempel 249 Example 249

3-[(N-(3-(indolyl-3)-propyl)-heksahydro-azepinyl-3)-metyl]-7,8-metylendioksy-l,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid-monohydrat 3-[(N-(3-(indolyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine- dihydrochloride monohydrate

Fremstillet fra 3-[(N-(3-(indolyl-3)-propyl)-heksahydro-azepinyl-3 )-metyl]-7,8-metylendioksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Utbytte: 56% av det teoretiske. Prepared from 3-[(N-(3-(indolyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3. Yield: 56% of the theoretical.

Smp.: 155-158°C M.p.: 155-158°C

Beregnet: C, 62,26; H, 7,50; N, 7,63; Cl, 12,88 Funnet: C, 62,31; H, 7,82; N, 7,40; Cl, 12,89 Calculated: C, 62.26; H, 7.50; N, 7.63; Cl, 12.88 Found: C, 62.31; H, 7.82; N, 7.40; Cl, 12.89

Eksempel 250 Example 250

3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-1,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid-monohydrat 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine dihydrochloride- monohydrate

Fremstillet fra 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Prepared from 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3.

Utbytte: 60% av det teoretiske. Yield: 60% of the theoretical.

Smp.: 125-128°C M.p.: 125-128°C

Beregnet: C, 62,44; H, 7,67; N, 7,80; Cl, 13,16 Calculated: C, 62.44; H, 7.67; N, 7.80; Cl, 13,16

Funnet: C, 62,35; H, 7,87; N, 7,59; Cl, 13,67 Found: C, 62.35; H, 7.87; N, 7.59; Cl, 13.67

Eksempel 251 Example 251

2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-1. 2. 3, 4- tetrahvdro- isokinolin- dihydroklorid- monohydrat 2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1. 2. 3, 4- tetrahydro- isoquinoline- dihydrochloride- monohydrate

Fremstillet fra 2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i dietyleter og tetrahydrofuran, analogt med Eksempel 3. Prepared from 2-[(N-(3-(indolyl-3)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in diethyl ether and tetrahydrofuran, analogously to Example 3.

Utbytte: 90% av det teoretiske. Yield: 90% of the theoretical.

Smp. : 198-201°C Temp. : 198-201°C

Beregnet: C, 66,38; H, 8,16; N, 8,29; Cl, 14,00 Calculated: C, 66.38; H, 8.16; N, 8.29; Cl, 14.00

Funnet: C, 66,29; H, 8,21; N, 8,46; Cl, 13,82 Found: C, 66.29; H, 8.21; N, 8.46; Cl, 13.82

Eksempel 252 Example 252

3-[(N-(3-(indolyl-3)-propyl)-heksahydro-azepinyl-3)-metyl]-7,8-metylendioksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin-monohydrat 3-[(N-(3-(indolyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine monohydrate

Fremstillet fra 3-[(heksahydro-azepinyl-3)-metyl]-7,8-metylendioksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og 3-(3-benzensulfonyloksy-propyl)-indol, analogt med Eksempel 1. Utbytte: 61,5% av det teoretiske. Prepared from 3-[(hexahydro-azepinyl-3)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(3-benzenesulfonyloxy-propyl )-indole, analogous to Example 1. Yield: 61.5% of the theoretical.

Smp.: 62-64°C M.p.: 62-64°C

Beregnet: C, 70,84; H, 7,59; N, 8,55 Calcd: C, 70.84; H, 7.59; N, 8.55

Funnet: C, 70,73; H, 7,59; N, 8,42 Found: C, 70.73; H, 7.59; N, 8.42

Eksempel 253 Example 253

2-[ (N-(3-(indolyl-3) -propyl) -pyrrolidyl-3) -metyl]-6,7-dimetyl-1, 2. 3, 4- tetrahvdro- isokinolin- dihvdroklorid- semihydrat 2-[ (N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1, 2, 3, 4- tetrahydro- isoquinoline- dihydrochloride- hemihydrate

Fremstillet fra 2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3) -metyl]-6,7-dimetyl-l-okso-l,2,3,4-tetrahydro-isokinolin og litiumaluminiumhydrid i eter, analogt med Eksempel 3. Prepared from 2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminum hydride in ether, analogous to Example 3.

Utbytte: 86% av det teoretiske. Yield: 86% of the theoretical.

Smp.: 143-145°C. M.p.: 143-145°C.

Beregnet: C, 67,06; H, 7,92; N, 8,69; Cl, 14,66 Calculated: C, 67.06; H, 7.92; N, 8.69; Cl, 14.66

Funnet: C, 66,92; H, 8,07; N, 8,48; Cl, 14,87 Found: C, 66.92; H, 8.07; N, 8.48; Cl, 14.87

Eksempel 254 Example 254

2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-6,7-dimetyl-l- okso- 1, 2. 3, 4- tetrahydro- isokinolin- hvdroklorid x 1, 5 hydrat 2-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-6,7-dimethyl-1- oxo- 1, 2, 3, 4- tetrahydro- isoquinoline- hydrochloride x 1.5 hydrate

Fremstillet fra 2-[(pyrrolidyl-3)-metyl]-6,7-dimetyl-l-okso-l, 2,3,4-tetrahydro-isokinolin og 3-(3-benzensulfonyloksy-propyl) -indol, analogt med Eksempel 1. Prepared from 2-[(pyrrolidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(3-benzenesulfonyloxy-propyl)-indole, analogous to Example 1.

Utbytte: 67% av det teoretiske. Yield: 67% of the theoretical.

Smp.: 117-120°C. M.p.: 117-120°C.

Beregnet: C, 67,69; H, 7,78; N, 8,77; Cl, 7,40 Calculated: C, 67.69; H, 7.78; N, 8.77; Cl, 7.40

Funnet: C, 67,62; H, 7,80; N, 8,72; Cl, 7,93 Found: C, 67.62; H, 7.80; N, 8.72; Cl, 7.93

Eksempel 255 Example 255

3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-metylendioksy-1,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid x 1,5 hydrat 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine dihydrochloride x 1.5 hydrate

Fremstillet fra 7,8-metylendioksy-l,3,4,5-tetrahydro-2H-3-benzazepin og 3-(benzensulfonyloksy-metyl)-N-[3-(indolyl-3)-propyl]-pyrrolidin, analogt med Eksempel 2. Prepared from 7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(benzenesulfonyloxy-methyl)-N-[3-(indolyl-3)-propyl]-pyrrolidine, analogous to Example 2.

Utbytte: 75% av det teoretiske. Yield: 75% of the theoretical.

Smp.: 191-193°C M.p.: 191-193°C

Beregnet: C, 61,01; H, 7,21; N, 7,90; Cl, 13,34 Calculated: C, 61.01; H, 7.21; N, 7.90; Cl, 13.34

Funnet: C, 60,90; H, 7,27; N, 7,85; Cl, 13,70 Found: C, 60.90; H, 7.27; N, 7.85; Cl, 13.70

Eksempel 256 Example 256

3-[(N-(3-(indolyl-3)-propyl)-heksahydro-azepinyl-3)-metyl]-7,8-dimetoksy-l,3,4,5-tetrahydro-2H-3-benzazepin-dihydroklorid- 3-[(N-(3-(indolyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine- dihydrochloride

monohydrat monohydrate

Fremstillet fra 3-[(N-(3-(indolyl-3)-propyl)-heksahydro-azepinyl-3 )-metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran og dietyleter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(indolyl-3)-propyl)-hexahydro-azepinyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- 2H-3-benzazepine and lithium aluminum hydride in tetrahydrofuran and diethyl ether, analogously to Example 3.

Utbytte: 53% av det teoretiske. Yield: 53% of the theoretical.

Smp.: 158-160°C. Melting point: 158-160°C.

Beregnet: C, 63,58; H, 8,00; N, 7,41; Cl, 12,51 Calculated: C, 63.58; H, 8.00; N, 7.41; Cl, 12.51

Funnet: C, 63,41; H, 8,18; N, 7,36; Cl, 12,23 Found: C, 63.41; H, 8.18; N, 7.36; Cl, 12.23

Eksempel 257 Example 257

3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetyl-1. 3. 4. 5- tetrahvdro- 2H- 3- benzazepin- dihydroklorid- monohydrat 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-1. 3. 4. 5- tetrahydro- 2H- 3- benzazepine- dihydrochloride- monohydrate

Fremstillet fra 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-metyl]-7,8-dimetyl-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin og litiumaluminiumhydrid i tetrahydrofuran/eter, analogt med Eksempel 3. Prepared from 3-[(N-(3-(indolyl-3)-propyl)-pyrrolidyl-3)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H- 3-benzazepine and lithium aluminum hydride in tetrahydrofuran/ether, analogously to Example 3.

Utbytte: 65% av det teoretiske. Yield: 65% of the theoretical.

Smp.: 168-170°C M.p.: 168-170°C

Beregnet: C, 66,39; H, 8,16; N, 8,29; Cl, 13,99 Calculated: C, 66.39; H, 8.16; N, 8.29; Cl, 13.99

Funnet: C, 66,29; H, 8,44; N, 8,08; Cl, 14,08 Found: C, 66.29; H, 8.44; N, 8.08; Cl, 14.08

Claims (5)

1. Analogifremgangsmåte for fremstilling av terapeutisk aktive cykliske aminderivater med den generelle formel hvor A betyr en -CH2-, -CH2-CH2- eller -CH=CH-gruppe, B er en -CH2-, -CH2-CH2-, -CO- eller -CH2CO-gruppe, X hvor karbonatomet merket med X, er knyttet til fenylkjemen, E er en rettkjedet alkylengruppe med 1-3 karbonatomer som eventuelt er substituert med en alkylgruppe med 1-3 karbonatomer, G er en rettkjedet alkylengruppe med 1-6 karbonatomer, hvor den metylengruppe som er forbundet med en aromatisk eller heteroaromatisk rest R, kan være erstattet med et oksygenatom, Rj og R2 betyr hver en (C1-C3)alkyl- eller (C1~C3)alkoksy-gruppe, eller Rx og R2 sammen utgjør en alkylendioksygruppe med 1 eller 2 karbonatomer, m betyr tallet 1, 2, 3, 4, 5 eller 6, og n betyr tallet 0, 1, 2 eller 3, hvor imidlertid n + m må utgjøre tallet 3, 4, 5 eller 6, og R betyr en eventuelt metylsubstituert furyl-, tienyl-, pyridyl-, benzo[b]furyl- eller benzo[b]tienylgruppe, en benzo[b]tienylgruppe som er substituert med et halogenatom, en metoksy- eller metansulfonyloksygruppe, en naftylgruppe som eventuelt er mono- eller disubstituert med metyl- eller metoksygrupper, hvor substituentene kan være like eller forskjellige, eller når B utgjør en -CH2- eller C0-gruppe, en fenylgruppe som eventuelt er substituert med en metylendioksygruppe, en fenylgruppe som er mono- eller disubstituert med metyl- eller metoksygrupper, hvor substituentene kan være like eller forskjellige, deres N-oksyder og deres farmasøytisk akseptable syreaddisjonssalter, karakterisert ved at a) en forbindelse med den generelle formel hvor Ri, R2, A, B, E, m og n er som ovenfor definert, omsettes med en forbindelse med den generelle formel Zl - G - R , (III) hvor R og G er som ovenfor definert, og Zx er en nukleofil utgående gruppe, en hydroksygruppe, eller hvor Zi sammen med hydrogenatomet i den nabostilte metylengruppe utgjør et oksygenatom, eller b) en forbindelse med den generelle formel hvor Rj., R2, A og B er som ovenfor definert, omsettes med en forbindelse med den generelle formel hvor R, E, G, m og n er som ovenfor definert og Z2 utgjør en nukleofil utgående gruppe, eller c) for fremstilling av forbindelser med den generelle formel I, hvor B utgjør en -CH2- eller -CH2CH2-gruppe, en forbindelse med den generelle formel hvor R, Rlf R2, E, G, m og n er som ovenfor definert, Ax utgjør en -CH2-, -CH2-CH2-, -CH=CH- eller -CO-gruppe, og Bx utgjør en -CO- eller -CH2CO-gruppe, X hvor det karbonatom som er merket med X er tilknyttet f enyl-kjernen, reduseres, eller d) for fremstilling av forbindelser med den generelle formel I, hvor A utgjør en -CH2-gruppe og B en -CO- eller -CH2CO-gruppe, en forbindelse med den generelle formel hvor R, Rlr R2, E, G, m og n er som ovenfor definert og B2 utgjør en -CO- eller -CH2CO-gruppe, X hvor karbonatomet som er merket med X er tilknyttet fenylkjernen, reduseres med nascerende hydrogen, eller . e) for fremstilling av forbindelser med den generelle formel I, hvor G, med unntak av rester som inneholder et svovelatom, en sulfinyl-eller sulfonylgruppe, har de for G ovenfor angitte betydninger, og A utgjør -CH2-CH2-gruppen og B -CH2-, -C0-eller -CH2CO-gruppen, en forbindelse med den generelle formel hvor R, Rlr R2, B, E, m og n er som ovenfor definert, Gj, med unntak av rester som inneholder et svovelatom, en sulfinyl-eller sulfonylgruppe, har de for G ovenfor angitte betydninger, og B3 utgjør en -CH2-, -C0-eller -CH2CO-gruppe, hydreres, og om nødvendig en beskyttelsesrest anvendt under omsetningene a) til e) benyttet til beskyttelse av reaktive grupper, som hydroksy-, amino-, alkylamino- eller iminogrupper deretter avspaltes, og/eller en således oppnådd forbindelse med den generelle formel I, hvor R inneholder en nitrogruppe, eventuelt overføres ved reduksjon i en tilsvarende aminoforbindelse med den generelle formel I, og/eller en således oppnådd forbindelse med den generelle formel I, hvor R inneholder en aminogruppe, eventuelt overføres ved acylering i en tilsvarende alkanoylaminoforbindelse med den generelle formel I, og/eller en således oppnådd forbindelse med den generelle formel I, overføres i sine fysiologisk akseptable syreaddisjonssalter med uorganiske eller organiske syrer.1. Analogous method for the preparation of therapeutically active cyclic amine derivatives of the general formula where A means a -CH2-, -CH2-CH2- or -CH=CH group, B is a -CH2-, -CH2-CH2-, -CO- or -CH2CO group, X where the carbon atom marked with X is linked to the phenyl atom, E is a straight-chain alkylene group with 1-3 carbon atoms which is optionally substituted with an alkyl group with 1-3 carbon atoms, G is a straight-chain alkylene group with 1-6 carbon atoms, where the methylene group connected to an aromatic or heteroaromatic residue R can be replaced by an oxygen atom, Rj and R2 each mean a (C1-C3)alkyl or (C1-C3)alkyl group, or Rx and R2 together form an alkylenedioxy group with 1 or 2 carbon atoms, m means the number 1, 2, 3, 4, 5 or 6, and n means the number 0, 1, 2 or 3, where however n + m must be the number 3, 4, 5 or 6, and R means an optionally methyl-substituted furyl, thienyl, pyridyl, benzo[b]furyl or benzo[b]thienyl group, a benzo[b]thienyl group which is substituted by a halogen atom, a methoxy or methanesulfonyloxy group, a naphthyl group which optionally is mono- or disubstituted with methyl or methoxy groups, where the substituents may be the same or different, or when B constitutes a -CH2- or C0 group, a phenyl group which is optionally substituted with a methylenedioxy group, a phenyl group which is mono- or disubstituted with methyl or methoxy groups, where the substituents may be the same or different, their N-oxides and their pharmaceutically acceptable acid addition salts, characterized in that a) a compound of the general formula where Ri, R2, A, B, E, m and n are as defined above, reacted with a compound of the general formula Zl-G-R, (III) where R and G are defined as above, and Zx is a nucleophilic leaving group, a hydroxy group, or where Zi together with the hydrogen atom in the adjacent methylene group forms an oxygen atom, or b) a compound with the general formula where Rj., R2, A and B are as defined above, reacted with a compound of the general formula where R, E, G, m and n are as above defined and Z2 constitutes a nucleophilic leaving group, or c) for the preparation of compounds of the general formula I, where B constitutes a -CH2- or -CH2CH2 group, a compound with the general formula where R, Rlf R2, E, G, m and n are as defined above, Ax constitutes a -CH2-, -CH2-CH2-, -CH=CH- or -CO group, and Bx constitutes a -CO- or -CH2CO group, X where the carbon atom marked with X is attached to the phenyl nucleus, is reduced, or d) for the preparation of compounds of the general formula I, where A constitutes a -CH2 group and B a -CO- or -CH2CO group, a compound with the general formula where R, Rlr R2, E, G, m and n are as defined above and B2 constitutes a -CO- or -CH2CO group, X where the carbon atom marked with X is attached to the phenyl nucleus, is reduced by nascent hydrogen, or . e) for the preparation of compounds of the general formula I, where G, with the exception of residues containing a sulfur atom, a sulfinyl or sulfonyl group, have the meanings given for G above, and A constitutes the -CH2-CH2 group and B - The CH2, -C0 or -CH2CO group, a compound of the general formula where R, Rlr R2, B, E, m and n are as defined above, Gj, with the exception of residues containing a sulfur atom, a sulfinyl or sulfonyl group, have the meanings given for G above, and B3 forms a -CH2-, -C0- or -CH2CO group, is hydrogenated, and if necessary, a protective residue used during the reactions a) to e) used to protect reactive groups, such as hydroxy, amino, alkylamino or imino groups are then cleaved off, and/or a thus obtained compound of the general formula I, where R contains a nitro group, optionally transferred by reduction into a corresponding amino compound of the general formula I, and/or a thus obtained compound of the general formula I, where R contains an amino group, optionally transferred by acylation into a corresponding alkanoylamino compound of the general formula I, and/or a thus obtained compound of the general formula I is transferred in its physiologically acceptable acid addition salts with inorganic or organic acids. 2. Fremgangsmåte ifølge krav 1, for fremstilling av 3-[(N-(2-(naftyl-2)-etyl)-piperidyl-3)-metyl]-7,8-dimetoksy-2-okso-1,3,4,5-tetrahydro-2H-3-benzazepin, og dens farmasøytisk akseptable syreaddisjonssalter, karakterisert ved anvendelse av tilsvarende utgangsforbindelser.2. Process according to claim 1, for the production of 3-[(N-(2-(naphthyl-2)-ethyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3, 4,5-tetrahydro-2H-3-benzazepine, and its pharmaceutically acceptable acid addition salts, characterized by the use of corresponding output connections. 3. Fremgangsmåte ifølge krav 1, for fremstilling av 3 - [ 2 - (N- (2 - (6-metoksy-naf tyl-2) -etyl) -piperidyl-2) -etyl ]-7,8-dimetoksy-2-okso-l, 3 , 4,5-tetrahydro-2H-3-benzazepin, karakterisert ved anvendelse av tilsvarende utgangsforbindelser.3. Method according to claim 1, for the production of 3-[2-(N-(2-(6-methoxy-naphthyl-2)-ethyl)-piperidyl-2)-ethyl]-7,8-dimethoxy-2 -oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, characterized by using corresponding starting compounds. 4. Fremgangsmåte ifølge krav 1, for fremstilling av 2- [ (N- (3 - (4-metoksyf enoksy) -propyl) -piperidyl-3) -metyl] -6,7-dimetyl-l-okso-1,2,3,4-tetrahydro-isokinolin, karakterisert ved anvendelse av tilsvarende utgangsforbindelser.4. Process according to claim 1, for the preparation of 2-[(N-(3-(4-methoxyphenoxy)-propyl)-piperidyl-3)-methyl]-6,7-dimethyl-1-oxo-1,2 ,3,4-tetrahydro-isoquinoline, characterized by the use of corresponding starting compounds. 5. Fremgangsmåte ifølge krav 1, for fremstilling av 3 -[ (N-(4-(tienyl-2) -butyl) -piperidyl-3) -metyl]-7,8-dimetoksy-2-okso-l,3,4,5-tetrahydro-2H-3-benzazepin, karakterisert ved anvendelse av tilsvarende utgangsforbindelser.5. Process according to claim 1, for the preparation of 3-[ (N-(4-(thienyl-2)-butyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3, 4,5-tetrahydro-2H-3-benzazepine, characterized using corresponding starting compounds.
NO882258A 1987-05-25 1988-05-24 ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE CYCLIC AMINE DERIVATIVES NO171017C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873717561 DE3717561A1 (en) 1987-05-25 1987-05-25 INDOL, ISOCHINOLINE AND BENZAZEPINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Publications (4)

Publication Number Publication Date
NO882258D0 NO882258D0 (en) 1988-05-24
NO882258L NO882258L (en) 1988-11-28
NO171017B true NO171017B (en) 1992-10-05
NO171017C NO171017C (en) 1993-01-13

Family

ID=6328351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882258A NO171017C (en) 1987-05-25 1988-05-24 ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE CYCLIC AMINE DERIVATIVES

Country Status (21)

Country Link
EP (1) EP0292840B1 (en)
JP (1) JP2634190B2 (en)
KR (1) KR960009432B1 (en)
AT (1) ATE126225T1 (en)
AU (1) AU607765B2 (en)
CA (2) CA1330993C (en)
DD (1) DD284678A5 (en)
DE (2) DE3717561A1 (en)
DK (1) DK282188A (en)
ES (1) ES2076147T3 (en)
FI (1) FI94343C (en)
GR (1) GR3017550T3 (en)
HU (1) HU198201B (en)
IE (1) IE68842B1 (en)
IL (1) IL86477A (en)
IN (1) IN169514B (en)
NO (1) NO171017C (en)
NZ (1) NZ224756A (en)
PT (1) PT87567B (en)
SU (1) SU1561823A3 (en)
ZA (1) ZA883680B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3640641A1 (en) * 1986-11-28 1988-07-14 Thomae Gmbh Dr K NEW HETEROAROMATIC AMINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3835291A1 (en) * 1988-04-19 1989-11-02 Bayer Ag 1,3-DISUBSTITUTED PYRROLIDINES
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
EP0351283A1 (en) * 1988-07-12 1990-01-17 Synthelabo 2-[(4-Piperidinyl)methyl]-2,3-dihydro-1H-isoindole and 2,3,4,5-tetrahydro-1H-benzazepine derivatives, their preparation and therapeutical use
US4952692A (en) * 1989-04-04 1990-08-28 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
NZ235841A (en) * 1989-10-27 1993-03-26 Du Pont (n-phthalimidoalkyl) piperidine derivatives and pharmaceutical compositions
EP0497843A4 (en) * 1989-10-27 1992-09-23 The Du Pont Merck Pharmaceutical Company (n-phthalimidoalkyl) piperidines
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
ATE441417T1 (en) 2002-12-20 2009-09-15 Glaxo Group Ltd BENZOADUAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
FR2868776B1 (en) * 2004-04-13 2008-04-18 Servier Lab NOVEL PROCESS FOR THE SYNTHESIS OF 1,3-DIHYDRO-2H-3-BENZAZEPIN-2-ONE DERIVATIVES AND THE APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS SALTS OF ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID
WO2007021308A1 (en) * 2005-08-12 2007-02-22 Astrazeneca Ab Metabotropic glutamate-receptor-potentiating isoindolones
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
MY152078A (en) 2007-09-14 2014-08-15 Ortho Mcneil Janssen Pharm 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
RU2512283C2 (en) 2008-11-28 2014-04-10 Янссен Фармасьютикалз, Инк. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EA020671B1 (en) 2009-05-12 2014-12-30 Янссен Фармасьютикалз, Инк. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS
PT2430022E (en) 2009-05-12 2013-12-26 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
RU2014109079A (en) 2011-08-12 2015-09-20 Бёрингер Ингельхайм Ветмедика Гмбх PHARMACEUTICAL COMPOSITION WITH MASKED TASTE
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
ME03518B (en) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
WO2015110435A1 (en) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JP6931456B2 (en) * 2017-04-03 2021-09-08 川崎化成工業株式会社 Photopolymerization sensitizer containing 2-haloalkoxy-6-substituted oxynaphthalene compound and 2-haloalkoxy-6-substituted oxynaphthalene compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639718A1 (en) * 1976-09-03 1978-03-16 Thomae Gmbh Dr K NEW PHENYLAETHYLAMINE
DE3119874A1 (en) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "BENZAZEPINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS"
DE3418270A1 (en) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach NEW AMINOTETRAL DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3418271A1 (en) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach NEW BENZAZEPINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3541811A1 (en) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K NEW CYCLIC AMINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
EP0306375A1 (en) * 1987-08-07 1989-03-08 Synthelabo 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their use in therapy
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
FR2686339B1 (en) * 1992-01-22 1994-03-11 Adir Cie NOVEL NAPHTHALENIC AMIDES AND SULFONAMIDES, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
EP0292840A2 (en) 1988-11-30
HUT46906A (en) 1988-12-28
NO171017C (en) 1993-01-13
NO882258D0 (en) 1988-05-24
HU198201B (en) 1989-08-28
IL86477A (en) 1992-07-15
DD284678A5 (en) 1990-11-21
DE3717561A1 (en) 1988-12-08
IL86477A0 (en) 1988-11-15
KR880013924A (en) 1988-12-22
JP2634190B2 (en) 1997-07-23
AU1656288A (en) 1988-12-01
CA1330993C (en) 1994-07-26
EP0292840A3 (en) 1990-04-11
EP0292840B1 (en) 1995-08-09
PT87567B (en) 1992-09-30
FI94343B (en) 1995-05-15
IE68842B1 (en) 1996-07-10
IE881559L (en) 1988-11-25
AU607765B2 (en) 1991-03-14
FI882418A0 (en) 1988-05-23
DK282188D0 (en) 1988-05-24
FI882418A (en) 1988-11-26
SU1561823A3 (en) 1990-04-30
KR960009432B1 (en) 1996-07-19
GR3017550T3 (en) 1995-12-31
DE3854280D1 (en) 1995-09-14
ZA883680B (en) 1990-01-31
PT87567A (en) 1989-05-31
NZ224756A (en) 1991-02-26
IN169514B (en) 1991-11-02
DK282188A (en) 1988-11-26
ATE126225T1 (en) 1995-08-15
CA1287226C (en) 1991-08-06
JPS6445381A (en) 1989-02-17
NO882258L (en) 1988-11-28
ES2076147T3 (en) 1995-11-01
FI94343C (en) 1995-08-25

Similar Documents

Publication Publication Date Title
NO171017B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE CYCLIC AMINE DERIVATIVES
JP3531169B2 (en) Fused heterocyclic compounds and their pharmaceutical uses
EP1163225A1 (en) Compounds and methods for modulation of estrogen receptors
US20040082575A1 (en) Compounds and methods for modulation of estrogen receptors
AU2002346979B9 (en) Heterocyclic compounds for use in the treatment of disorders of the urinary tract
DE19727117A1 (en) Phenylalkyl derivatives, pharmaceutical compositions containing them and processes for their preparation
AU2002346979A1 (en) Heterocyclic compounds for use in the treatment of disorders of the urinary tract
SK26995A3 (en) Single acetamides for suppressing of diseases method of their production and their using for production of medicines pharmaceutical agents on their base and method of their production
KR20050061504A (en) Substituted 4-amino-1-(pyridylmethyl)piperidine as muscarinic receptor antagonists
KR20070046879A (en) 5-ht7 receptor antagonists
US4604389A (en) Benzazepine derivatives
US5929072A (en) 1H-2,1,3-benzothiadiazine-2,2-dioxide compounds or derivatives thereof
KR20070046878A (en) 5-ht7 receptor antagonists
HU201020B (en) Process for producine new naphthalene derivatives and pharmaceutical compositions comprising same
FI88299B (en) FRAMEWORK FOR CYCLIC CYCLING OF PHARMACEUTICAL PRODUCTS
NO166528B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE NAPHALAND AND INDANDER DERIVATIVES.
MXPA06003958A (en) Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h.
US4634713A (en) Antihypertensive 3-(ureidocyclohexyleneamino)propane-1,2-diol derivatives
FR2558835A1 (en) HYDANTINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND MEDICAMENT CONTAINING SAME
KR20070098882A (en) 5-ht7 receptor antagonists
CA1260933A (en) Bicyclic lactams, processes for their preparation and their use, and formulations containing these compounds
KR100917041B1 (en) New compounds of 5-ht7 receptor antagonist
NZ206305A (en) Benzazepine and benzodiazepine derivatives and pharmaceutical compositions
SK137597A3 (en) 1-£&#39;omega&#39;-(3,4-dihydro-2-naphthalenyl)alkyl| cyclic amine derivatives, process for producing the same, and medicinal composition containing the same
WO2019097282A1 (en) Isoindoline derivatives for the treatment of cns diseases